,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1440732,64968,DrugBank,Thymidine-5'-triphosphate,DB02452,Thymidine 5'-triphosphate,https://www.drugbank.ca/drugs/DB02452,BE0004639,"Thymidine kinase 2, mitochondrial",https://www.drugbank.ca/bio_entities/BE0004639,O00142,"Thymidine kinase 2, mitochondrial",7084.0,TK2,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
1,1440843,65016,BindingDB,Amprenavir,577,"(3S)-oxolan-3-yl N-[(2S,3R)-4-[(4-aminobenzene)(2-methylpropyl)sulfonamido]-3-hydroxy-1-phenylbutan-2-yl]carbamate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577,4431,Gag polyprotein,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4431,P05888,Gag polyprotein,,,11696,HIV-1 M:B_MN,,IC50 (nM),13,PMID:9818151|DOI:10.1016/s1074-5521(98)90117-x,https://www.ncbi.nlm.nih.gov/pubmed/9818151|https://doi.org/10.1016/s1074-5521(98)90117-x,9818151,10.1016/s1074-5521(98)90117-x,
2,1440844,65064,Drug Gene Interaction database (DGIdb),Epigallocatechin Gallate,,EPIGALLOCATECHIN GALLATE,https://www.dgidb.org/drugs/rxcui:24246,,RECQL,https://www.dgidb.org/genes/hgnc:9948,,,5965.0,RECQL,9606,Homo sapiens (human),,,,,,,,
3,1440845,65064,Drug Gene Interaction database (DGIdb),Epigallocatechin Gallate,,EPIGALLOCATECHIN GALLATE,https://www.dgidb.org/drugs/rxcui:24246,,APOB,https://www.dgidb.org/genes/hgnc:603,,,338.0,APOB,9606,Homo sapiens (human),,,,,,,,
4,1440846,65064,IUPHAR/BPS Guide to PHARMACOLOGY,Epigallocatechin Gallate,7002,epigallocatechin-3-gallate,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7002,2737,lysine acetyltransferase 2B,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2737,Q92831,Histone acetyltransferase KAT2B,8850.0,KAT2B,9606,Homo sapiens (human),Inhibition,pIC50,4.22,PMID:19147572,https://www.ncbi.nlm.nih.gov/pubmed/19147572,19147572,,
5,1440847,65064,IUPHAR/BPS Guide to PHARMACOLOGY,Epigallocatechin Gallate,7002,epigallocatechin-3-gallate,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7002,2735,E1A binding protein p300,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2735,Q09472,Histone acetyltransferase p300,2033.0,EP300,9606,Homo sapiens (human),Inhibition,pIC50,4.52,PMID:19147572,https://www.ncbi.nlm.nih.gov/pubmed/19147572,19147572,,
6,1441781,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,9736,USP34,https://ctdbase.org/detail.go?type=gene&acc=9736,,,9736.0,USP34,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of USP34 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
7,1441782,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,57602,USP36,https://ctdbase.org/detail.go?type=gene&acc=57602,,,57602.0,USP36,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of USP36 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
8,1441783,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,8078,USP5,https://ctdbase.org/detail.go?type=gene&acc=8078,,,8078.0,USP5,9606,Homo sapiens (human),Epigallocatechin gallate results in decreased expression of USP5 mRNA,,,PMID:18851785,https://www.ncbi.nlm.nih.gov/pubmed/18851785,18851785,,
9,1441784,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,9712,USP6NL,https://ctdbase.org/detail.go?type=gene&acc=9712,,,9712.0,USP6NL,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of USP6NL mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
10,1441903,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,7417,VDAC2,https://ctdbase.org/detail.go?type=gene&acc=7417,,,7417.0,VDAC2,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of VDAC2 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
11,1441904,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,9606,Homo sapiens (human),Epigallocatechin gallate inhibits the reaction [cobaltous chloride results in increased expression of VEGFA mrna],,,PMID:26800359,https://www.ncbi.nlm.nih.gov/pubmed/26800359,26800359,,
12,1442637,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,57002,YAE1,https://ctdbase.org/detail.go?type=gene&acc=57002,,,57002.0,YAE1,9606,Homo sapiens (human),Epigallocatechin gallate results in decreased expression of YAE1 mrna|[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of YAE1 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
13,1442769,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,113763,ZBED10P,https://ctdbase.org/detail.go?type=gene&acc=113763,,,113763.0,ZBED10P,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of ZBED10P mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
14,1442770,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,253461,ZBTB38,https://ctdbase.org/detail.go?type=gene&acc=253461,,,253461.0,ZBTB38,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of ZBTB38 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
15,1442771,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,51101,ZC2HC1A,https://ctdbase.org/detail.go?type=gene&acc=51101,,,51101.0,ZC2HC1A,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of ZC2HC1A mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
16,1442772,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,85364,ZCCHC3,https://ctdbase.org/detail.go?type=gene&acc=85364,,,85364.0,ZCCHC3,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of ZCCHC3 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
17,1442773,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,84240,ZCCHC9,https://ctdbase.org/detail.go?type=gene&acc=84240,,,84240.0,ZCCHC9,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of ZCCHC9 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
18,1442774,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,54503,ZDHHC13,https://ctdbase.org/detail.go?type=gene&acc=54503,,,54503.0,ZDHHC13,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of ZDHHC13 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
19,1444035,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,10592,SMC2,https://ctdbase.org/detail.go?type=gene&acc=10592,,,10592.0,SMC2,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of SMC2 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
20,1444036,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,79677,SMC6,https://ctdbase.org/detail.go?type=gene&acc=79677,,,79677.0,SMC6,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of SMC6 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
21,1444037,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,56935,SMCO4,https://ctdbase.org/detail.go?type=gene&acc=56935,,,56935.0,SMCO4,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of SMCO4 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
22,1444038,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,57150,SMIM8,https://ctdbase.org/detail.go?type=gene&acc=57150,,,57150.0,SMIM8,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of SMIM8 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
23,1444039,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,6607,SMN2,https://ctdbase.org/detail.go?type=gene&acc=6607,,,6607.0,SMN2,9606,Homo sapiens (human),Epigallocatechin gallate results in increased expression of SMN2 protein|epigallocatechin gallate affects the splicing of and results in increased expression of SMN2 mRNA alternative form,,,PMID:17962980,https://www.ncbi.nlm.nih.gov/pubmed/17962980,17962980,,
24,1444040,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,6608,SMO,https://ctdbase.org/detail.go?type=gene&acc=6608,,,6608.0,SMO,10090,Mus musculus (house mouse),Epigallocatechin gallate inhibits the reaction [diethylnitrosamine results in increased expression of SMO protein]|epigallocatechin gallate inhibits the reaction [diethylnitrosamine results in increased expression of SMO mrna],,,PMID:27058323,https://www.ncbi.nlm.nih.gov/pubmed/27058323,27058323,,
25,1444041,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,54498,SMOX,https://ctdbase.org/detail.go?type=gene&acc=54498,,,54498.0,SMOX,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of SMOX mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
26,1444042,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,23583,SMUG1,https://ctdbase.org/detail.go?type=gene&acc=23583,,,23583.0,SMUG1,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of SMUG1 mrna|epigallocatechin gallate inhibits the reaction [potassium chromate(vi) results in decreased expression of SMUG1 mrna],,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
27,1444043,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,6615,SNAI1,https://ctdbase.org/detail.go?type=gene&acc=6615,,,6615.0,SNAI1,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of SNAI1 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
28,1444536,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,94163,SNORD38B,https://ctdbase.org/detail.go?type=gene&acc=94163,,,94163.0,SNORD38B,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of SNORD38B mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
29,1444537,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,26809,SNORD42A,https://ctdbase.org/detail.go?type=gene&acc=26809,,,26809.0,SNORD42A,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of SNORD42A mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
30,1444538,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,26808,SNORD42B,https://ctdbase.org/detail.go?type=gene&acc=26808,,,26808.0,SNORD42B,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of SNORD42B mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
31,1444539,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,26807,SNORD43,https://ctdbase.org/detail.go?type=gene&acc=26807,,,26807.0,SNORD43,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of SNORD43 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
32,1444540,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,26806,SNORD44,https://ctdbase.org/detail.go?type=gene&acc=26806,,,26806.0,SNORD44,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of SNORD44 mrna|epigallocatechin gallate results in decreased expression of SNORD44 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
33,1445029,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,28966,SNX24,https://ctdbase.org/detail.go?type=gene&acc=28966,,,28966.0,SNX24,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of SNX24 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
34,1445030,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,83891,SNX25,https://ctdbase.org/detail.go?type=gene&acc=83891,,,83891.0,SNX25,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of SNX25 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
35,1445031,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,92017,SNX29,https://ctdbase.org/detail.go?type=gene&acc=92017,,,92017.0,SNX29,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of SNX29 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
36,1445032,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,8723,SNX4,https://ctdbase.org/detail.go?type=gene&acc=8723,,,8723.0,SNX4,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of SNX4 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
37,1446203,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,256126,SYCE2,https://ctdbase.org/detail.go?type=gene&acc=256126,,,256126.0,SYCE2,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of SYCE2 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
38,1446204,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,25949,SYF2,https://ctdbase.org/detail.go?type=gene&acc=25949,,,25949.0,SYF2,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of SYF2 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
39,1447309,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,23023,TMCC1,https://ctdbase.org/detail.go?type=gene&acc=23023,,,23023.0,TMCC1,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of TMCC1 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
40,1447310,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,8834,TMEM11,https://ctdbase.org/detail.go?type=gene&acc=8834,,,8834.0,TMEM11,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of TMEM11 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
41,1447311,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,84216,TMEM117,https://ctdbase.org/detail.go?type=gene&acc=84216,,,84216.0,TMEM117,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of TMEM117 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
42,1447312,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,144404,TMEM120B,https://ctdbase.org/detail.go?type=gene&acc=144404,,,144404.0,TMEM120B,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of TMEM120B mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
43,1447313,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,23240,TMEM131L,https://ctdbase.org/detail.go?type=gene&acc=23240,,,23240.0,TMEM131L,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of TMEM131L mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
44,1447314,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,65084,TMEM135,https://ctdbase.org/detail.go?type=gene&acc=65084,,,65084.0,TMEM135,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of TMEM135 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
45,1448420,65091,Comparative Toxicogenomics Database (CTD),2'-Deoxycytidine-5'-triphosphate,C024107,2'-deoxycytidine 5'-triphosphate,https://ctdbase.org/detail.go?type=chem&acc=C024107,42273,DNK,https://ctdbase.org/detail.go?type=gene&acc=42273,,,42273.0,dnk,7227,Drosophila melanogaster (fruit fly),2'-deoxycytidine 5'-triphosphate binds to DNK protein,,,PMID:18384378,https://www.ncbi.nlm.nih.gov/pubmed/18384378,18384378,,
46,1440974,65103,DrugBank,,DB02181,2'-Deoxyguanosine-5'-Triphosphate,https://www.drugbank.ca/drugs/DB02181,BE0003106,Nucleoside diphosphate kinase A,https://www.drugbank.ca/bio_entities/BE0003106,P15531,Nucleoside diphosphate kinase A,4830.0,NME1,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
47,1440975,65103,DrugBank,,DB02181,2'-Deoxyguanosine-5'-Triphosphate,https://www.drugbank.ca/drugs/DB02181,BE0001442,Anaerobic ribonucleoside-triphosphate reductase,https://www.drugbank.ca/bio_entities/BE0001442,P07071,Anaerobic ribonucleoside-triphosphate reductase,1258655.0,nrdD,10665,Escherichia virus T4,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
48,1440976,65115,DrugBank,4-Nitrophenyl-beta-D-galactopyranoside,DB02632,4-nitrophenyl-beta-D-galactoside,https://www.drugbank.ca/drugs/DB02632,BE0001404,Galactoside O-acetyltransferase,https://www.drugbank.ca/bio_entities/BE0001404,P07464,Galactoside O-acetyltransferase,945674.0,lacA,83333,Escherichia coli K-12,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
49,1441104,65115,DrugBank,4-Nitrophenyl-beta-D-galactopyranoside,DB02632,4-nitrophenyl-beta-D-galactoside,https://www.drugbank.ca/drugs/DB02632,BE0001421,Beta-galactosidase,https://www.drugbank.ca/bio_entities/BE0001421,P00722,Beta-galactosidase,945006.0,lacZ,83333,Escherichia coli K-12,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
50,1441105,65118,Comparative Toxicogenomics Database (CTD),4-Methylumbelliferyl phosphate,C005359,4-methylumbelliferyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C005359,248,ALPI,https://ctdbase.org/detail.go?type=gene&acc=248,,,248.0,ALPI,9913,Bos taurus (cattle),ALPI protein results in increased hydrolysis of 4-methylumbelliferyl phosphate,,,PMID:17705259,https://www.ncbi.nlm.nih.gov/pubmed/17705259,17705259,,
51,1441106,65177,DrugBank,"((2R,3S,4S,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate",DB02456,Aracytidine 5'-monophosphate,https://www.drugbank.ca/drugs/DB02456,BE0001600,Cytidylate kinase,https://www.drugbank.ca/bio_entities/BE0001600,P0A6I0,Cytidylate kinase,75205312.0,,83333,Escherichia coli K-12,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
52,1441107,65237,Drug Gene Interaction database (DGIdb),Neocuproine,,NEOCUPROINE,https://www.dgidb.org/drugs/chembl:CHEMBL375781,,TARDBP,https://www.dgidb.org/genes/hgnc:11571,,,23435.0,TARDBP,9606,Homo sapiens (human),,,,,,,,
53,1441108,65241,DrugBank,Monofluorophosphate ion,DB02348,Monofluorophosphate ion,https://www.drugbank.ca/drugs/DB02348,BE0000916,"Glycogen phosphorylase, muscle form",https://www.drugbank.ca/bio_entities/BE0000916,P11217,"Glycogen phosphorylase, muscle form",5837.0,PYGM,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
54,1441109,65249,DrugBank,N-Acetylserine,DB02340,N-Acetyl-Serine,https://www.drugbank.ca/drugs/DB02340,BE0000004,Coagulation factor XIII A chain,https://www.drugbank.ca/bio_entities/BE0000004,P00488,Coagulation factor XIII A chain,2162.0,F13A1,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
55,1441110,65304,DrugBank,"2',3'-Dideoxyadenosine triphosphate",DB02189,"2',3'-Dideoxyadenosine triphosphate",https://www.drugbank.ca/drugs/DB02189,BE0004486,DNA nucleotidylexotransferase,https://www.drugbank.ca/bio_entities/BE0004486,P04053,DNA nucleotidylexotransferase,1791.0,DNTT,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
56,1441111,65348,Drug Gene Interaction database (DGIdb),Epirubicin Hydrochloride,,EPIRUBICIN HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203213,,IDH1,https://www.dgidb.org/genes/hgnc:5382,,,3417.0,IDH1,9606,Homo sapiens (human),,,,,,,,
57,1441112,65351,Drug Gene Interaction database (DGIdb),Pyrrolidine dithiocarbamic acid,,PYRROLIDINE DITHIOCARBAMATE,https://www.dgidb.org/drugs/chembl:CHEMBL399491,,HSD17B10,https://www.dgidb.org/genes/hgnc:4800,,,3028.0,HSD17B10,9606,Homo sapiens (human),,,,,,,,
58,1441223,65407,Comparative Toxicogenomics Database (CTD),4-Nitrobenzylthioinosine,C001789,4-nitrobenzylthioinosine,https://ctdbase.org/detail.go?type=chem&acc=C001789,4878,NPPA,https://ctdbase.org/detail.go?type=gene&acc=4878,,,4878.0,NPPA,10116,Rattus norvegicus (Norway rat),"2,3-diethyl-4,5-dipropyl-6-phenylpyridine-3-thiocarboxylate-5-carboxylate inhibits the reaction [[9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [phenylephrine results in increased expression of NPPA mrna]]|1,3-dipropyl-8-cyclopentylxanthine inhibits the reaction [[9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [phenylephrine results in increased expression of NPPA mrna]]|8-(3-chlorostyryl)caffeine inhibits the reaction [[9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [phenylephrine results in increased expression of NPPA mrna]]|[9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [phenylephrine results in increased expression of NPPA mrna]|8-(4-sulfophenyl)theophylline inhibits the reaction [[9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [phenylephrine results in increased expression of NPPA mrna]]",,,PMID:19966059,https://www.ncbi.nlm.nih.gov/pubmed/19966059,19966059,,
59,1441224,65407,Comparative Toxicogenomics Database (CTD),4-Nitrobenzylthioinosine,C001789,4-nitrobenzylthioinosine,https://ctdbase.org/detail.go?type=chem&acc=C001789,2030,SLC29A1,https://ctdbase.org/detail.go?type=gene&acc=2030,,,2030.0,SLC29A1,9606,Homo sapiens (human),4-nitrobenzylthioinosine binds to SLC29A1 protein|dipyridamole inhibits the reaction [4-nitrobenzylthioinosine binds to SLC29A1 protein]|ticagrelor inhibits the reaction [4-nitrobenzylthioinosine binds to SLC29A1 protein]|draflazine inhibits the reaction [4-nitrobenzylthioinosine binds to SLC29A1 protein]|cilostazol inhibits the reaction [4-nitrobenzylthioinosine binds to SLC29A1 protein],,,PMID:28041785,https://www.ncbi.nlm.nih.gov/pubmed/28041785,28041785,,
60,1441225,65407,Comparative Toxicogenomics Database (CTD),4-Nitrobenzylthioinosine,C001789,4-nitrobenzylthioinosine,https://ctdbase.org/detail.go?type=chem&acc=C001789,2030,SLC29A1,https://ctdbase.org/detail.go?type=gene&acc=2030,,,2030.0,SLC29A1,9606,Homo sapiens (human),Dipyridamole promotes the reaction [4-nitrobenzylthioinosine inhibits the reaction [[SLC29A1 protein co-treated with SLC29A2 protein] results in increased uptake of uridine]]|4-nitrobenzylthioinosine inhibits the reaction [[SLC29A1 protein co-treated with SLC29A2 protein] results in increased uptake of uridine],,,PMID:10366666,https://www.ncbi.nlm.nih.gov/pubmed/10366666,10366666,,
61,1441226,65407,Comparative Toxicogenomics Database (CTD),4-Nitrobenzylthioinosine,C001789,4-nitrobenzylthioinosine,https://ctdbase.org/detail.go?type=chem&acc=C001789,2030,SLC29A1,https://ctdbase.org/detail.go?type=gene&acc=2030,,,2030.0,SLC29A1,9606,Homo sapiens (human),4-nitrobenzylthioinosine inhibits the reaction [SLC29A1 protein results in decreased susceptibility to fluorouracil]|4-nitrobenzylthioinosine inhibits the reaction [SLC29A1 protein results in increased uptake of gemcitabine],,,PMID:17695509,https://www.ncbi.nlm.nih.gov/pubmed/17695509,17695509,,
62,1441227,65407,Comparative Toxicogenomics Database (CTD),4-Nitrobenzylthioinosine,C001789,4-nitrobenzylthioinosine,https://ctdbase.org/detail.go?type=chem&acc=C001789,2030,SLC29A1,https://ctdbase.org/detail.go?type=gene&acc=2030,,,2030.0,SLC29A1,9606,Homo sapiens (human),4-nitrobenzylthioinosine inhibits the reaction [SLC29A1 protein results in increased uptake of uridine],,,PMID:9353301|PMID:9396714,https://www.ncbi.nlm.nih.gov/pubmed/9353301|https://www.ncbi.nlm.nih.gov/pubmed/9396714,9353301|9396714,,
63,1441228,65407,Comparative Toxicogenomics Database (CTD),4-Nitrobenzylthioinosine,C001789,4-nitrobenzylthioinosine,https://ctdbase.org/detail.go?type=chem&acc=C001789,2030,SLC29A1,https://ctdbase.org/detail.go?type=gene&acc=2030,,,2030.0,SLC29A1,10090,Mus musculus (house mouse),4-nitrobenzylthioinosine inhibits the reaction [SLC29A1 protein alternative form results in increased uptake of adenosine]|4-nitrobenzylthioinosine inhibits the reaction [SLC29A1 protein results in increased uptake of adenosine],,,PMID:11179696,https://www.ncbi.nlm.nih.gov/pubmed/11179696,11179696,,
64,1441363,65407,Comparative Toxicogenomics Database (CTD),4-Nitrobenzylthioinosine,C001789,4-nitrobenzylthioinosine,https://ctdbase.org/detail.go?type=chem&acc=C001789,2030,SLC29A1,https://ctdbase.org/detail.go?type=gene&acc=2030,,,2030.0,SLC29A1,10090,Mus musculus (house mouse),4-nitrobenzylthioinosine inhibits the reaction [SLC29A1 protein results in increased uptake of uridine],,,PMID:11085929,https://www.ncbi.nlm.nih.gov/pubmed/11085929,11085929,,
65,1441364,65407,Comparative Toxicogenomics Database (CTD),4-Nitrobenzylthioinosine,C001789,4-nitrobenzylthioinosine,https://ctdbase.org/detail.go?type=chem&acc=C001789,2030,SLC29A1,https://ctdbase.org/detail.go?type=gene&acc=2030,,,2030.0,SLC29A1,10090,Mus musculus (house mouse),[4-nitrobenzylthioinosine results in decreased activity of SLC29A1 protein] inhibits the reaction [oxygen deficiency results in increased abundance of adenosine],,,PMID:23437309,https://www.ncbi.nlm.nih.gov/pubmed/23437309,23437309,,
66,1441365,65407,Comparative Toxicogenomics Database (CTD),4-Nitrobenzylthioinosine,C001789,4-nitrobenzylthioinosine,https://ctdbase.org/detail.go?type=chem&acc=C001789,2030,SLC29A1,https://ctdbase.org/detail.go?type=gene&acc=2030,,,2030.0,SLC29A1,10116,Rattus norvegicus (Norway rat),4-nitrobenzylthioinosine inhibits the reaction [SLC29A1 protein results in increased uptake of uridine],,,PMID:9353301,https://www.ncbi.nlm.nih.gov/pubmed/9353301,9353301,,
67,1441366,65407,Comparative Toxicogenomics Database (CTD),4-Nitrobenzylthioinosine,C001789,4-nitrobenzylthioinosine,https://ctdbase.org/detail.go?type=chem&acc=C001789,2030,SLC29A1,https://ctdbase.org/detail.go?type=gene&acc=2030,,,2030.0,SLC29A1,9606,Homo sapiens (human),4-nitrobenzylthioinosine results in decreased activity of SLC29A1 protein,,,PMID:10366666|PMID:17167068|PMID:23437309,https://www.ncbi.nlm.nih.gov/pubmed/10366666|https://www.ncbi.nlm.nih.gov/pubmed/17167068|https://www.ncbi.nlm.nih.gov/pubmed/23437309,10366666|17167068|23437309,,
68,1441367,65407,Comparative Toxicogenomics Database (CTD),4-Nitrobenzylthioinosine,C001789,4-nitrobenzylthioinosine,https://ctdbase.org/detail.go?type=chem&acc=C001789,3177,SLC29A2,https://ctdbase.org/detail.go?type=gene&acc=3177,,,3177.0,SLC29A2,9606,Homo sapiens (human),Dipyridamole promotes the reaction [4-nitrobenzylthioinosine inhibits the reaction [[SLC29A1 protein co-treated with SLC29A2 protein] results in increased uptake of uridine]]|4-nitrobenzylthioinosine inhibits the reaction [[SLC29A1 protein co-treated with SLC29A2 protein] results in increased uptake of uridine],,,PMID:10366666,https://www.ncbi.nlm.nih.gov/pubmed/10366666,10366666,,
69,1441368,65407,BindingDB,4-Nitrobenzylthioinosine,23617,"(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-{[(4-nitrophenyl)methyl]sulfanyl}-9H-purin-9-yl)oxolane-3,4-diol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23617,2421,Equilibrative nucleoside transporter 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2421,Q99808,Equilibrative nucleoside transporter 1,2030.0,SLC29A1,9606,Homo sapiens (human),,Ki (nM),0.43,PMID:17636949|DOI:10.1021/jm070311l,https://www.ncbi.nlm.nih.gov/pubmed/17636949|https://doi.org/10.1021/jm070311l,17636949,10.1021/jm070311l,
70,1443857,73078,Drug Gene Interaction database (DGIdb),Tetrandrine,,FANCHININ,https://www.dgidb.org/drugs/chembl:CHEMBL176045,,TP53,https://www.dgidb.org/genes/hgnc:11998,,,7157.0,TP53,9606,Homo sapiens (human),,,,,,,,
71,1443858,73078,BindingDB,Tetrandrine,50478473,CHEBI:49,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50478473,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),3000,PMID:32366720|DOI:10.1128/AAC.00819-20,https://www.ncbi.nlm.nih.gov/pubmed/32366720|https://doi.org/10.1128/AAC.00819-20,32366720,10.1128/AAC.00819-20,
72,1443859,73111,BindingDB,Senna,92481,"Sennoside A, G",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=92481,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),1590,DOI:10.1101/2020.12.16.422677,https://doi.org/10.1101/2020.12.16.422677,,10.1101/2020.12.16.422677,
73,1444361,73641,Comparative Toxicogenomics Database (CTD),Arjunolic acid,C061640,arjunolic acid,https://ctdbase.org/detail.go?type=chem&acc=C061640,5580,PRKCD,https://ctdbase.org/detail.go?type=gene&acc=5580,,,5580.0,PRKCD,10116,Rattus norvegicus (Norway rat),Arjunolic acid inhibits the reaction [streptozocin results in increased expression of PRKCD protein],,,PMID:19682444,https://www.ncbi.nlm.nih.gov/pubmed/19682444,19682444,,
74,1444362,73641,Comparative Toxicogenomics Database (CTD),Arjunolic acid,C061640,arjunolic acid,https://ctdbase.org/detail.go?type=chem&acc=C061640,5581,PRKCE,https://ctdbase.org/detail.go?type=gene&acc=5581,,,5581.0,PRKCE,10116,Rattus norvegicus (Norway rat),Arjunolic acid inhibits the reaction [streptozocin results in increased expression of PRKCE protein],,,PMID:19682444,https://www.ncbi.nlm.nih.gov/pubmed/19682444,19682444,,
75,1444363,73641,Comparative Toxicogenomics Database (CTD),Arjunolic acid,C061640,arjunolic acid,https://ctdbase.org/detail.go?type=chem&acc=C061640,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10090,Mus musculus (house mouse),Arjunolic acid inhibits the reaction [cadmium chloride results in increased expression of RELA protein],,,PMID:21420465,https://www.ncbi.nlm.nih.gov/pubmed/21420465,21420465,,
76,1444364,73641,Comparative Toxicogenomics Database (CTD),Arjunolic acid,C061640,arjunolic acid,https://ctdbase.org/detail.go?type=chem&acc=C061640,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116,Rattus norvegicus (Norway rat),Arjunolic acid inhibits the reaction [streptozocin results in increased expression of RELA protein],,,PMID:19133311|PMID:19682444,https://www.ncbi.nlm.nih.gov/pubmed/19133311|https://www.ncbi.nlm.nih.gov/pubmed/19682444,19133311|19682444,,
77,1444365,73641,Comparative Toxicogenomics Database (CTD),Arjunolic acid,C061640,arjunolic acid,https://ctdbase.org/detail.go?type=chem&acc=C061640,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116,Rattus norvegicus (Norway rat),Arjunolic acid inhibits the reaction [streptozocin results in increased phosphorylation of RELA protein],,,PMID:20053369,https://www.ncbi.nlm.nih.gov/pubmed/20053369,20053369,,
78,1447143,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,100313513,CYP11A,https://ctdbase.org/detail.go?type=gene&acc=100313513,,,100313513.0,,90988,Pimephales promelas (fathead minnow),Prochloraz affects the expression of CYP11A mRNA,,,PMID:25564424,https://www.ncbi.nlm.nih.gov/pubmed/25564424,25564424,,
79,1447144,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,100313513,CYP11A,https://ctdbase.org/detail.go?type=gene&acc=100313513,,,100313513.0,,90988,Pimephales promelas (fathead minnow),Prochloraz results in increased expression of CYP11A mRNA,,,PMID:19767443,https://www.ncbi.nlm.nih.gov/pubmed/19767443,19767443,,
80,1447145,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,7955,Danio rerio (zebrafish),Prochloraz results in increased expression of CYP11A1 mRNA,,,PMID:21158436,https://www.ncbi.nlm.nih.gov/pubmed/21158436,21158436,,
81,1447146,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,9606,Homo sapiens (human),Prochloraz results in decreased expression of CYP11A1 mRNA,,,PMID:19733639,https://www.ncbi.nlm.nih.gov/pubmed/19733639,19733639,,
82,1447147,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,90988,Pimephales promelas (fathead minnow),Prochloraz results in increased expression of CYP11A1 mRNA,,,PMID:21470553,https://www.ncbi.nlm.nih.gov/pubmed/21470553,21470553,,
83,1447148,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,100135891,CYP11B,https://ctdbase.org/detail.go?type=gene&acc=100135891,,,100135891.0,,8090,Oryzias latipes (Japanese medaka),Prochloraz results in decreased expression of CYP11B mRNA,,,PMID:24992288,https://www.ncbi.nlm.nih.gov/pubmed/24992288,24992288,,
84,1447149,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,1584,CYP11B1,https://ctdbase.org/detail.go?type=gene&acc=1584,,,1584.0,CYP11B1,9606,Homo sapiens (human),Prochloraz results in decreased expression of CYP11B1 mRNA,,,PMID:19733639,https://www.ncbi.nlm.nih.gov/pubmed/19733639,19733639,,
85,1447150,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,1584,CYP11B1,https://ctdbase.org/detail.go?type=gene&acc=1584,,,1584.0,CYP11B1,10116,Rattus norvegicus (Norway rat),[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in decreased expression of CYP11B1 mRNA,,,PMID:28454766,https://www.ncbi.nlm.nih.gov/pubmed/28454766,28454766,,
86,1447151,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,791124,CYP11C1,https://ctdbase.org/detail.go?type=gene&acc=791124,,,791124.0,cyp11c1,7955,Danio rerio (zebrafish),Prochloraz results in decreased expression of CYP11C1 mRNA,,,PMID:21158436,https://www.ncbi.nlm.nih.gov/pubmed/21158436,21158436,,
87,1447152,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,105601846,CYP17,https://ctdbase.org/detail.go?type=gene&acc=105601846,,,105601846.0,CYP17,90988,Pimephales promelas (fathead minnow),Prochloraz affects the expression of CYP17 mRNA,,,PMID:25564424,https://www.ncbi.nlm.nih.gov/pubmed/25564424,25564424,,
88,1447153,73665,Comparative Toxicogenomics Database (CTD),Prochloraz,C045362,prochloraz,https://ctdbase.org/detail.go?type=chem&acc=C045362,105601846,CYP17,https://ctdbase.org/detail.go?type=gene&acc=105601846,,,105601846.0,CYP17,90988,Pimephales promelas (fathead minnow),Prochloraz results in increased expression of CYP17 mRNA,,,PMID:21470553,https://www.ncbi.nlm.nih.gov/pubmed/21470553,21470553,,
89,1440570,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1559,CYP2C9,https://ctdbase.org/detail.go?type=gene&acc=1559,,,1559.0,CYP2C9,9606,Homo sapiens (human),"CYP2C9 protein results in increased hydroxylation of 4,4'-hexafluorisopropylidene diphenol",,,PMID:23470418,https://www.ncbi.nlm.nih.gov/pubmed/23470418,23470418,,
90,1440571,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,9606,Homo sapiens (human),"CYP2E1 protein results in increased hydroxylation of 4,4'-hexafluorisopropylidene diphenol",,,PMID:23470418,https://www.ncbi.nlm.nih.gov/pubmed/23470418,23470418,,
91,1440572,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,393484,CYP2K18,https://ctdbase.org/detail.go?type=gene&acc=393484,,,393484.0,cyp2k18,7955,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CYP2K18 mRNA",,,PMID:37556959,https://www.ncbi.nlm.nih.gov/pubmed/37556959,37556959,,
92,1440573,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,120227,CYP2R1,https://ctdbase.org/detail.go?type=gene&acc=120227,,,120227.0,CYP2R1,7955,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of CYP2R1 mRNA",,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
93,1440574,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606,Homo sapiens (human),"CYP3A4 protein results in increased hydroxylation of 4,4'-hexafluorisopropylidene diphenol",,,PMID:23470418,https://www.ncbi.nlm.nih.gov/pubmed/23470418,23470418,,
94,1440575,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1577,CYP3A5,https://ctdbase.org/detail.go?type=gene&acc=1577,,,1577.0,CYP3A5,9031,Gallus gallus (chicken),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CYP3A5 mRNA",,,PMID:33730607,https://www.ncbi.nlm.nih.gov/pubmed/33730607,33730607,,
95,1440576,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,1551,CYP3A7,https://ctdbase.org/detail.go?type=gene&acc=1551,,,1551.0,CYP3A7,9031,Gallus gallus (chicken),"4,4'-hexafluorisopropylidene diphenol results in increased expression of CYP3A7 mRNA",,,PMID:33465250,https://www.ncbi.nlm.nih.gov/pubmed/33465250,33465250,,
96,1443068,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,483,ATP1B3,https://ctdbase.org/detail.go?type=gene&acc=483,,,483.0,ATP1B3,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ATP1B3 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
97,1443069,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,488,ATP2A2,https://ctdbase.org/detail.go?type=gene&acc=488,,,488.0,ATP2A2,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ATP2A2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
98,1443070,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,393940,ATP2A2A,https://ctdbase.org/detail.go?type=gene&acc=393940,,,393940.0,atp2a2a,7955,Danio rerio (zebrafish),"[bisphenol A co-treated with bisphenol B co-treated with bisphenol F co-treated with 4,4'-hexafluorisopropylidene diphenol] results in decreased expression of ATP2A2A mrna|4,4'-hexafluorisopropylidene diphenol results in decreased expression of ATP2A2A mRNA",,,PMID:37418940,https://www.ncbi.nlm.nih.gov/pubmed/37418940,37418940,,
99,1443071,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,493,ATP2B4,https://ctdbase.org/detail.go?type=gene&acc=493,,,493.0,ATP2B4,10116,Rattus norvegicus (Norway rat),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ATP2B4 mRNA",,,PMID:27567155,https://www.ncbi.nlm.nih.gov/pubmed/27567155,27567155,,
100,1443703,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,55347,ABHD10,https://ctdbase.org/detail.go?type=gene&acc=55347,,,55347.0,ABHD10,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ABHD10 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
101,1443704,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,84836,ABHD14B,https://ctdbase.org/detail.go?type=gene&acc=84836,,,84836.0,ABHD14B,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ABHD14B protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
102,1443705,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,116236,ABHD15,https://ctdbase.org/detail.go?type=gene&acc=116236,,,116236.0,ABHD15,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ABHD15 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
103,1443706,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,11057,ABHD2,https://ctdbase.org/detail.go?type=gene&acc=11057,,,11057.0,ABHD2,10116,Rattus norvegicus (Norway rat),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ABHD2 mRNA",,,PMID:27567155,https://www.ncbi.nlm.nih.gov/pubmed/27567155,27567155,,
104,1443707,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,51099,ABHD5,https://ctdbase.org/detail.go?type=gene&acc=51099,,,51099.0,ABHD5,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ABHD5 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
105,1443708,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,137735,ABRA,https://ctdbase.org/detail.go?type=gene&acc=137735,,,137735.0,ABRA,10090,Mus musculus (house mouse),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of ABRA mRNA",,,PMID:34850234,https://www.ncbi.nlm.nih.gov/pubmed/34850234,34850234,,
106,1443709,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,23172,ABRAXAS2,https://ctdbase.org/detail.go?type=gene&acc=23172,,,23172.0,ABRAXAS2,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ABRAXAS2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
107,1443710,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,30,ACAA1,https://ctdbase.org/detail.go?type=gene&acc=30,,,30.0,ACAA1,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ACAA1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
108,1444208,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,648740,ACTG1P4,https://ctdbase.org/detail.go?type=gene&acc=648740,,,648740.0,ACTG1P4,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ACTG1P4 mRNA",,,PMID:25912373,https://www.ncbi.nlm.nih.gov/pubmed/25912373,25912373,,
109,1444209,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,87,ACTN1,https://ctdbase.org/detail.go?type=gene&acc=87,,,87.0,ACTN1,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ACTN1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
110,1444210,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,81,ACTN4,https://ctdbase.org/detail.go?type=gene&acc=81,,,81.0,ACTN4,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ACTN4 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
111,1444211,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,10097,ACTR2,https://ctdbase.org/detail.go?type=gene&acc=10097,,,10097.0,ACTR2,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ACTR2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
112,1444212,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,10096,ACTR3,https://ctdbase.org/detail.go?type=gene&acc=10096,,,10096.0,ACTR3,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ACTR3 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
113,1444213,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,95,ACY1,https://ctdbase.org/detail.go?type=gene&acc=95,,,95.0,ACY1,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ACY1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
114,1444214,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,98,ACYP2,https://ctdbase.org/detail.go?type=gene&acc=98,,,98.0,ACYP2,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of ACYP2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
115,1444855,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23244,PDS5A,https://ctdbase.org/detail.go?type=gene&acc=23244,,,23244.0,PDS5A,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PDS5A mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
116,1444856,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23047,PDS5B,https://ctdbase.org/detail.go?type=gene&acc=23047,,,23047.0,PDS5B,8049,Gadus morhua (Atlantic cod),"Perfluorooctane sulfonic acid results in decreased expression of PDS5B mrna|[hydrocarbons, chlorinated co-treated with pentabromodiphenyl ether co-treated with perfluorooctane sulfonic acid] results in decreased expression of PDS5B mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
117,1444857,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23047,PDS5B,https://ctdbase.org/detail.go?type=gene&acc=23047,,,23047.0,PDS5B,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PDS5B mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
118,1444858,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,57107,PDSS2,https://ctdbase.org/detail.go?type=gene&acc=57107,,,57107.0,PDSS2,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of PDSS2 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
119,1444859,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,8566,PDXK,https://ctdbase.org/detail.go?type=gene&acc=8566,,,8566.0,PDXK,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of PDXK mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
120,1444860,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,57026,PDXP,https://ctdbase.org/detail.go?type=gene&acc=57026,,,57026.0,PDXP,8049,Gadus morhua (Atlantic cod),"[hydrocarbons, chlorinated co-treated with pentabromodiphenyl ether co-treated with perfluorooctane sulfonic acid] results in increased expression of PDXP mrna|perfluorooctane sulfonic acid results in increased expression of PDXP mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
121,1444861,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,51248,PDZD11,https://ctdbase.org/detail.go?type=gene&acc=51248,,,51248.0,PDZD11,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PDZD11 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
122,1444862,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,118987,PDZD8,https://ctdbase.org/detail.go?type=gene&acc=118987,,,118987.0,PDZD8,8049,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in decreased expression of PDZD8 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
123,1444863,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10158,PDZK1IP1,https://ctdbase.org/detail.go?type=gene&acc=10158,,,10158.0,PDZK1IP1,9606,Homo sapiens (human),Perfluorooctane sulfonic acid results in increased expression of PDZK1IP1 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
124,1445473,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5190,PEX6,https://ctdbase.org/detail.go?type=gene&acc=5190,,,5190.0,PEX6,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PEX6 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
125,1445474,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5201,PFDN1,https://ctdbase.org/detail.go?type=gene&acc=5201,,,5201.0,PFDN1,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PFDN1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
126,1445475,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5202,PFDN2,https://ctdbase.org/detail.go?type=gene&acc=5202,,,5202.0,PFDN2,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of PFDN2 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PFDN2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
127,1445476,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5203,PFDN4,https://ctdbase.org/detail.go?type=gene&acc=5203,,,5203.0,PFDN4,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PFDN4 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
128,1445477,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5207,PFKFB1,https://ctdbase.org/detail.go?type=gene&acc=5207,,,5207.0,PFKFB1,10090,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of PFKFB1 mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
129,1445478,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5207,PFKFB1,https://ctdbase.org/detail.go?type=gene&acc=5207,,,5207.0,PFKFB1,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PFKFB1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
130,1445479,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5208,PFKFB2,https://ctdbase.org/detail.go?type=gene&acc=5208,,,5208.0,PFKFB2,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PFKFB2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
131,1445602,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,80055,PGAP1,https://ctdbase.org/detail.go?type=gene&acc=80055,,,80055.0,PGAP1,8049,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in decreased expression of PGAP1 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
132,1445939,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,283871,PGP,https://ctdbase.org/detail.go?type=gene&acc=283871,,,283871.0,PGP,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of PGP mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
133,1445940,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,54858,PGPEP1,https://ctdbase.org/detail.go?type=gene&acc=54858,,,54858.0,PGPEP1,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PGPEP1 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of PGPEP1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
134,1445941,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,8049,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of PGR mrna|perfluorooctane sulfonic acid results in increased expression of PGR mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
135,1445942,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,9606,Homo sapiens (human),Perfluorooctane sulfonic acid results in increased activity of PGR protein,,,PMID:27589886,https://www.ncbi.nlm.nih.gov/pubmed/27589886,27589886,,
136,1445943,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10857,PGRMC1,https://ctdbase.org/detail.go?type=gene&acc=10857,,,10857.0,PGRMC1,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PGRMC1 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
137,1445944,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10857,PGRMC1,https://ctdbase.org/detail.go?type=gene&acc=10857,,,10857.0,PGRMC1,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of PGRMC1 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of PGRMC1 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PGRMC1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
138,1445945,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10424,PGRMC2,https://ctdbase.org/detail.go?type=gene&acc=10424,,,10424.0,PGRMC2,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PGRMC2 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
139,1446388,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,570807,PHLDB2A,https://ctdbase.org/detail.go?type=gene&acc=570807,,,570807.0,phldb2a,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PHLDB2A mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
140,1446389,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23239,PHLPP1,https://ctdbase.org/detail.go?type=gene&acc=23239,,,23239.0,PHLPP1,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of PHLPP1 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
141,1446390,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,23239,PHLPP1,https://ctdbase.org/detail.go?type=gene&acc=23239,,,23239.0,PHLPP1,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PHLPP1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
142,1447909,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,84725,PLEKHA8,https://ctdbase.org/detail.go?type=gene&acc=84725,,,84725.0,PLEKHA8,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PLEKHA8 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
143,1447910,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,55041,PLEKHB2,https://ctdbase.org/detail.go?type=gene&acc=55041,,,55041.0,PLEKHB2,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PLEKHB2 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
144,1447911,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,79156,PLEKHF1,https://ctdbase.org/detail.go?type=gene&acc=79156,,,79156.0,PLEKHF1,7955,Danio rerio (zebrafish),Perfluorooctane sulfonic acid results in decreased expression of PLEKHF1 mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
145,1447912,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,79156,PLEKHF1,https://ctdbase.org/detail.go?type=gene&acc=79156,,,79156.0,PLEKHF1,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PLEKHF1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
146,1447913,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,26030,PLEKHG3,https://ctdbase.org/detail.go?type=gene&acc=26030,,,26030.0,PLEKHG3,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of PLEKHG3 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
147,1439918,74778,Comparative Toxicogenomics Database (CTD),4-Nitrophenyl laurate,C050014,4-nitrophenyl laurate,https://ctdbase.org/detail.go?type=chem&acc=C050014,1066,CES1,https://ctdbase.org/detail.go?type=gene&acc=1066,,,1066.0,CES1,9606,Homo sapiens (human),CES1 protein binds to and results in increased hydrolysis of 4-nitrophenyl laurate,,,PMID:16282638,https://www.ncbi.nlm.nih.gov/pubmed/16282638,16282638,,
148,1439919,74866,BindingDB,3-Methoxyphenethylamine,50240698,2-(3-Methoxy-phenyl)-ethylamine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50240698,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),3160,PMID:37943932,https://www.ncbi.nlm.nih.gov/pubmed/37943932,37943932,,
149,1439920,75091,BindingDB,"Urea, dodecyl-",150791,N-Dodecyl urea (6),https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=150791,6916,Juvenile hormone epoxide hydrolase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=6916,Q25489,Juvenile hormone epoxide hydrolase,,,7130,Manduca sexta (tobacco hornworm),,IC50 (nM),>1.00e+5,PMID:25711603|DOI:10.1002/cbic.201402650,https://www.ncbi.nlm.nih.gov/pubmed/25711603|https://doi.org/10.1002/cbic.201402650,25711603,10.1002/cbic.201402650,
150,1446833,83480,Toxin and Toxin Target Database (T3DB),Tantalum pentabromide,T3D1758,Tantalum(V) bromide,http://www.t3db.ca/toxins/T3D1758,BE0005283,Chloride channel protein ClC-Kb,http://www.t3db.ca/biodb/bio_entities/BE0005283,P51801,Chloride channel protein ClC-Kb ,1188.0,CLCNKB,9606,Homo sapiens (human),,,,PMID:3047312|PMID:10050002,https://www.ncbi.nlm.nih.gov/pubmed/3047312|https://www.ncbi.nlm.nih.gov/pubmed/10050002,3047312|10050002,,
151,1446834,83480,Toxin and Toxin Target Database (T3DB),Tantalum pentabromide,T3D1758,Tantalum(V) bromide,http://www.t3db.ca/toxins/T3D1758,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,http://www.t3db.ca/biodb/bio_entities/BE0000795,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,2554.0,GABRA1,9606,Homo sapiens (human),,,,PMID:7843172,https://www.ncbi.nlm.nih.gov/pubmed/7843172,7843172,,
152,1446835,83480,Toxin and Toxin Target Database (T3DB),Tantalum pentabromide,T3D1758,Tantalum(V) bromide,http://www.t3db.ca/toxins/T3D1758,BE0002345,Gamma-aminobutyric acid receptor subunit beta-3,http://www.t3db.ca/biodb/bio_entities/BE0002345,P28472,Gamma-aminobutyric acid receptor subunit beta-3,2562.0,GABRB3,9606,Homo sapiens (human),,,,PMID:7843172,https://www.ncbi.nlm.nih.gov/pubmed/7843172,7843172,,
153,1446836,83480,Toxin and Toxin Target Database (T3DB),Tantalum pentabromide,T3D1758,Tantalum(V) bromide,http://www.t3db.ca/toxins/T3D1758,BE0003592,Gamma-aminobutyric acid receptor subunit gamma-2,http://www.t3db.ca/biodb/bio_entities/BE0003592,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,2566.0,GABRG2,9606,Homo sapiens (human),,,,PMID:7843172,https://www.ncbi.nlm.nih.gov/pubmed/7843172,7843172,,
154,1446837,83486,Toxin and Toxin Target Database (T3DB),Platinum(II) bromide,T3D1746,Platinum(II) bromide,http://www.t3db.ca/toxins/T3D1746,BE0005290,Chloride channel protein 1,http://www.t3db.ca/biodb/bio_entities/BE0005290,P35523,Chloride channel protein 1,1180.0,CLCN1,9606,Homo sapiens (human),,,,PMID:3047312|PMID:10050002,https://www.ncbi.nlm.nih.gov/pubmed/3047312|https://www.ncbi.nlm.nih.gov/pubmed/10050002,3047312|10050002,,
155,1441905,83489,Comparative Toxicogenomics Database (CTD),Eriocitrin,C114706,eriocitrin,https://ctdbase.org/detail.go?type=chem&acc=C114706,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,9606,Homo sapiens (human),Eriocitrin results in decreased expression of PCNA protein,,,PMID:34724282,https://www.ncbi.nlm.nih.gov/pubmed/34724282,34724282,,
156,1441906,83489,Comparative Toxicogenomics Database (CTD),Eriocitrin,C114706,eriocitrin,https://ctdbase.org/detail.go?type=chem&acc=C114706,6714,SRC,https://ctdbase.org/detail.go?type=gene&acc=6714,,,6714.0,SRC,9606,Homo sapiens (human),Eriocitrin results in decreased phosphorylation of SRC protein,,,PMID:34724282,https://www.ncbi.nlm.nih.gov/pubmed/34724282,34724282,,
157,1441907,83489,Comparative Toxicogenomics Database (CTD),Eriocitrin,C114706,eriocitrin,https://ctdbase.org/detail.go?type=chem&acc=C114706,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,9606,Homo sapiens (human),Eriocitrin results in decreased phosphorylation of STAT3 protein,,,PMID:34724282,https://www.ncbi.nlm.nih.gov/pubmed/34724282,34724282,,
158,1447444,83509,Toxin and Toxin Target Database (T3DB),Vanadium tribromide,T3D1768,Vanadium(III) bromide,http://www.t3db.ca/toxins/T3D1768,BE0005245,Receptor-type tyrosine-protein phosphatase H,http://www.t3db.ca/biodb/bio_entities/BE0005245,Q9HD43,Receptor-type tyrosine-protein phosphatase H,5794.0,PTPRH,9606,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
159,1447445,83509,Toxin and Toxin Target Database (T3DB),Vanadium tribromide,T3D1768,Vanadium(III) bromide,http://www.t3db.ca/toxins/T3D1768,BE0005241,Receptor-type tyrosine-protein phosphatase N2,http://www.t3db.ca/biodb/bio_entities/BE0005241,Q92932,Receptor-type tyrosine-protein phosphatase N2,5799.0,PTPRN2,9606,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
160,1447446,83509,Toxin and Toxin Target Database (T3DB),Vanadium tribromide,T3D1768,Vanadium(III) bromide,http://www.t3db.ca/toxins/T3D1768,BE0005250,Receptor-type tyrosine-protein phosphatase O,http://www.t3db.ca/biodb/bio_entities/BE0005250,Q16827,Receptor-type tyrosine-protein phosphatase O,5800.0,PTPRO,9606,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
161,1447447,83509,Toxin and Toxin Target Database (T3DB),Vanadium tribromide,T3D1768,Vanadium(III) bromide,http://www.t3db.ca/toxins/T3D1768,BE0005251,Receptor-type tyrosine-protein phosphatase R,http://www.t3db.ca/biodb/bio_entities/BE0005251,Q15256,Receptor-type tyrosine-protein phosphatase R,5801.0,PTPRR,9606,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
162,1447448,83509,Toxin and Toxin Target Database (T3DB),Vanadium tribromide,T3D1768,Vanadium(III) bromide,http://www.t3db.ca/toxins/T3D1768,BE0003567,Receptor-type tyrosine-protein phosphatase S,http://www.t3db.ca/biodb/bio_entities/BE0003567,Q13332,Receptor-type tyrosine-protein phosphatase S,5802.0,PTPRS,9606,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
163,1441908,83823,Drug Gene Interaction database (DGIdb),Orphenadrine Citrate,,ORPHENADRINE CITRATE,https://www.dgidb.org/drugs/rxcui:7716,,GRIN2A,https://www.dgidb.org/genes/hgnc:4585,,,2903.0,GRIN2A,9606,Homo sapiens (human),Inhibitor,,,,,,,
164,1441909,83823,Drug Gene Interaction database (DGIdb),Orphenadrine Citrate,,ORPHENADRINE CITRATE,https://www.dgidb.org/drugs/rxcui:7716,,GRIN1,https://www.dgidb.org/genes/hgnc:4584,,,2902.0,GRIN1,9606,Homo sapiens (human),Inhibitor,,,,,,,
165,1441910,83823,Drug Gene Interaction database (DGIdb),Orphenadrine Citrate,,ORPHENADRINE CITRATE,https://www.dgidb.org/drugs/rxcui:7716,,HRH1,https://www.dgidb.org/genes/hgnc:5182,,,3269.0,HRH1,9606,Homo sapiens (human),Inhibitor,,,,,,,
166,1375064,88409,Toxin and Toxin Target Database (T3DB),Boron phosphide (BP),T3D2408,Boron phosphide,http://www.t3db.ca/toxins/T3D2408,BE0003986,"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0003986,P13073,"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial",1327.0,COX4I1,9606,Homo sapiens (human),"Phosphine inhibits cytochrome c oxidase, preventing mitochondrial oxidative phosphorylation. this non-competitive inhibition prevents cellular respiration and leads to multi-organ dysfunction. (A291)",,,PMID:16615671,https://www.ncbi.nlm.nih.gov/pubmed/16615671,16615671,,
167,1442914,91758,Comparative Toxicogenomics Database (CTD),Fosthiazate,C493102,fosthiazate,https://ctdbase.org/detail.go?type=chem&acc=C493102,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,9606,Homo sapiens (human),Fosthiazate results in decreased activity of ACHE protein,,,PMID:21251949,https://www.ncbi.nlm.nih.gov/pubmed/21251949,21251949,,
168,1442915,91758,Comparative Toxicogenomics Database (CTD),Fosthiazate,C493102,fosthiazate,https://ctdbase.org/detail.go?type=chem&acc=C493102,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606,Homo sapiens (human),Fosthiazate metabolite affects the activity of TP53 protein,,,PMID:35435491,https://www.ncbi.nlm.nih.gov/pubmed/35435491,35435491,,
169,1442916,92151,ChEMBL,Biperiden Hydrochloride,CHEMBL1201035,BIPERIDEN HYDROCHLORIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201035/,CHEMBL216,Muscarinic acetylcholine receptor M1,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL216/,P11229,Muscarinic acetylcholine receptor M1,1128.0,CHRM1,9606,Homo sapiens (human),Muscarinic acetylcholine receptor M1 antagonist,,,,,,,
170,1442917,92153,Comparative Toxicogenomics Database (CTD),acetoacetyl-CoA,C010667,acetoacetyl CoA,https://ctdbase.org/detail.go?type=chem&acc=C010667,3294,HSD17B2,https://ctdbase.org/detail.go?type=gene&acc=3294,,,3294.0,HSD17B2,9606,Homo sapiens (human),Acetoacetyl coa binds to HSD17B2 protein,,,PMID:25526675,https://www.ncbi.nlm.nih.gov/pubmed/25526675,25526675,,
171,1442918,92249,BindingDB,7-Amino-4-methylcoumarin,71742,7-amino-4-methyl-1-benzopyran-2-one,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=71742,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),1700,PMID:37943932,https://www.ncbi.nlm.nih.gov/pubmed/37943932,37943932,,
172,1442919,92337,Drug Gene Interaction database (DGIdb),Tarenflurbil,,TARENFLURBIL,https://www.dgidb.org/drugs/ncit:C26666,,HPGD,https://www.dgidb.org/genes/hgnc:5154,,,3248.0,HPGD,9606,Homo sapiens (human),,,,,,,,
173,1442920,92467,BindingDB,1-(4-Hydroxyphenyl)piperazine,626043,EN300-17230,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=626043,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),2840,PMID:37943932,https://www.ncbi.nlm.nih.gov/pubmed/37943932,37943932,,
174,1442921,92730,Drug Gene Interaction database (DGIdb),11alpha-Hydroxyprogesterone,,CHEMBL:CHEMBL1563246,https://www.dgidb.org/drugs/chembl:CHEMBL1563246,,CALCA,https://www.dgidb.org/genes/hgnc:1437,,,796.0,CALCA,9606,Homo sapiens (human),,,,,,,,
175,1442922,92745,IUPHAR/BPS Guide to PHARMACOLOGY,"5beta-Pregnane-3,20-dione",2759,"5-pregnane-3,20-dione",https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2759,607,Constitutive androstane receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=607,Q14994,Nuclear receptor subfamily 1 group I member 3 ,9970.0,NR1I3,9606,Homo sapiens (human),Agonist,pEC50,6.17,PMID:10748001,https://www.ncbi.nlm.nih.gov/pubmed/10748001,10748001,,
176,1359198,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,6223,RPS19,https://ctdbase.org/detail.go?type=gene&acc=6223,,,6223.0,RPS19,10090,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of RPS19 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
177,1445185,99920,Comparative Toxicogenomics Database (CTD),Adenosine dialdehyde,C027579,periodate-oxidized adenosine,https://ctdbase.org/detail.go?type=chem&acc=C027579,2948,GSTM4,https://ctdbase.org/detail.go?type=gene&acc=2948,,,2948.0,GSTM4,9606,Homo sapiens (human),Periodate-oxidized adenosine affects the expression of GSTM4 mRNA,,,PMID:17097637,https://www.ncbi.nlm.nih.gov/pubmed/17097637,17097637,,
178,1445186,99920,Comparative Toxicogenomics Database (CTD),Adenosine dialdehyde,C027579,periodate-oxidized adenosine,https://ctdbase.org/detail.go?type=chem&acc=C027579,8971,H1-10,https://ctdbase.org/detail.go?type=gene&acc=8971,,,8971.0,H1-10,9606,Homo sapiens (human),Periodate-oxidized adenosine affects the expression of H1-10 mRNA,,,PMID:17097637,https://www.ncbi.nlm.nih.gov/pubmed/17097637,17097637,,
179,1445187,99920,Comparative Toxicogenomics Database (CTD),Adenosine dialdehyde,C027579,periodate-oxidized adenosine,https://ctdbase.org/detail.go?type=chem&acc=C027579,8337,H2AC18,https://ctdbase.org/detail.go?type=gene&acc=8337,,,8337.0,H2AC18,9606,Homo sapiens (human),Periodate-oxidized adenosine affects the expression of H2AC18 mRNA,,,PMID:17097637,https://www.ncbi.nlm.nih.gov/pubmed/17097637,17097637,,
180,1445188,99920,Comparative Toxicogenomics Database (CTD),Adenosine dialdehyde,C027579,periodate-oxidized adenosine,https://ctdbase.org/detail.go?type=chem&acc=C027579,3017,H2BC5,https://ctdbase.org/detail.go?type=gene&acc=3017,,,3017.0,H2BC5,9606,Homo sapiens (human),Periodate-oxidized adenosine affects the expression of H2BC5 mRNA,,,PMID:17097637,https://www.ncbi.nlm.nih.gov/pubmed/17097637,17097637,,
181,1445793,99920,Comparative Toxicogenomics Database (CTD),Adenosine dialdehyde,C027579,periodate-oxidized adenosine,https://ctdbase.org/detail.go?type=chem&acc=C027579,8508,NIPSNAP1,https://ctdbase.org/detail.go?type=gene&acc=8508,,,8508.0,NIPSNAP1,9606,Homo sapiens (human),Periodate-oxidized adenosine affects the expression of NIPSNAP1 mRNA,,,PMID:17097637,https://www.ncbi.nlm.nih.gov/pubmed/17097637,17097637,,
182,1445794,99920,Comparative Toxicogenomics Database (CTD),Adenosine dialdehyde,C027579,periodate-oxidized adenosine,https://ctdbase.org/detail.go?type=chem&acc=C027579,2631,NIPSNAP2,https://ctdbase.org/detail.go?type=gene&acc=2631,,,2631.0,NIPSNAP2,9606,Homo sapiens (human),Periodate-oxidized adenosine affects the expression of NIPSNAP2 mRNA,,,PMID:17097637,https://www.ncbi.nlm.nih.gov/pubmed/17097637,17097637,,
183,1445795,99920,Comparative Toxicogenomics Database (CTD),Adenosine dialdehyde,C027579,periodate-oxidized adenosine,https://ctdbase.org/detail.go?type=chem&acc=C027579,23530,NNT,https://ctdbase.org/detail.go?type=gene&acc=23530,,,23530.0,NNT,9606,Homo sapiens (human),Periodate-oxidized adenosine affects the expression of NNT mRNA,,,PMID:17097637,https://www.ncbi.nlm.nih.gov/pubmed/17097637,17097637,,
184,1445796,99920,Comparative Toxicogenomics Database (CTD),Adenosine dialdehyde,C027579,periodate-oxidized adenosine,https://ctdbase.org/detail.go?type=chem&acc=C027579,9971,NR1H4,https://ctdbase.org/detail.go?type=gene&acc=9971,,,9971.0,NR1H4,9606,Homo sapiens (human),Periodate-oxidized adenosine affects the expression of NR1H4 mRNA,,,PMID:17097637,https://www.ncbi.nlm.nih.gov/pubmed/17097637,17097637,,
185,1445797,99920,Comparative Toxicogenomics Database (CTD),Adenosine dialdehyde,C027579,periodate-oxidized adenosine,https://ctdbase.org/detail.go?type=chem&acc=C027579,9315,NREP,https://ctdbase.org/detail.go?type=gene&acc=9315,,,9315.0,NREP,9606,Homo sapiens (human),Periodate-oxidized adenosine affects the expression of NREP mRNA,,,PMID:17097637,https://www.ncbi.nlm.nih.gov/pubmed/17097637,17097637,,
186,1445798,99920,Comparative Toxicogenomics Database (CTD),Adenosine dialdehyde,C027579,periodate-oxidized adenosine,https://ctdbase.org/detail.go?type=chem&acc=C027579,26471,NUPR1,https://ctdbase.org/detail.go?type=gene&acc=26471,,,26471.0,NUPR1,9606,Homo sapiens (human),Periodate-oxidized adenosine affects the expression of NUPR1 mRNA,,,PMID:17097637,https://www.ncbi.nlm.nih.gov/pubmed/17097637,17097637,,
187,1445799,99920,Comparative Toxicogenomics Database (CTD),Adenosine dialdehyde,C027579,periodate-oxidized adenosine,https://ctdbase.org/detail.go?type=chem&acc=C027579,23596,OPN3,https://ctdbase.org/detail.go?type=gene&acc=23596,,,23596.0,OPN3,9606,Homo sapiens (human),Periodate-oxidized adenosine affects the expression of OPN3 mRNA,,,PMID:17097637,https://www.ncbi.nlm.nih.gov/pubmed/17097637,17097637,,
188,1445800,99920,Comparative Toxicogenomics Database (CTD),Adenosine dialdehyde,C027579,periodate-oxidized adenosine,https://ctdbase.org/detail.go?type=chem&acc=C027579,5053,PAH,https://ctdbase.org/detail.go?type=gene&acc=5053,,,5053.0,PAH,9606,Homo sapiens (human),Periodate-oxidized adenosine affects the expression of PAH mRNA,,,PMID:17097637,https://www.ncbi.nlm.nih.gov/pubmed/17097637,17097637,,
189,1446838,100768,Drug Gene Interaction database (DGIdb),Eupatoriochromene,,DEMETHYLENCECALIN,https://www.dgidb.org/drugs/chembl:CHEMBL443462,,HPGD,https://www.dgidb.org/genes/hgnc:5154,,,3248.0,HPGD,9606,Homo sapiens (human),,,,,,,,
190,1446839,100949,BindingDB,1-(2-Nitrophenyl)piperazine,625953,EN300-08605,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625953,770,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=770,P0DTD1,Replicase polyprotein 1ab,,,2697049,Severe acute respiratory syndrome coronavirus 2,,IC50 (nM),4010,PMID:37943932,https://www.ncbi.nlm.nih.gov/pubmed/37943932,37943932,,
191,1446840,101277,Drug Gene Interaction database (DGIdb),Pachyrrhizin,,PACHYRRIZINE,https://www.dgidb.org/drugs/chembl:CHEMBL479689,,CYP3A4,https://www.dgidb.org/genes/hgnc:2637,,,1576.0,CYP3A4,9606,Homo sapiens (human),,,,,,,,
192,1446841,101587,ChEMBL,Hexocyclium Methylsulfate,CHEMBL1626570,HEXOCYCLIUM METHYLSULFATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1626570/,CHEMBL216,Muscarinic acetylcholine receptor M1,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL216/,P11229,Muscarinic acetylcholine receptor M1,1128.0,CHRM1,9606,Homo sapiens (human),Muscarinic acetylcholine receptor M1 antagonist,,,PMID:8075869|PMID:9183081,https://www.ncbi.nlm.nih.gov/pubmed/8075869|https://www.ncbi.nlm.nih.gov/pubmed/9183081,8075869|9183081,,
193,1446842,101587,ChEMBL,Hexocyclium Methylsulfate,CHEMBL1626570,HEXOCYCLIUM METHYLSULFATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1626570/,CHEMBL245,Muscarinic acetylcholine receptor M3,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL245/,P20309,Muscarinic acetylcholine receptor M3,1131.0,CHRM3,9606,Homo sapiens (human),Muscarinic acetylcholine receptor M3 antagonist,,,PMID:8075869|PMID:9183081,https://www.ncbi.nlm.nih.gov/pubmed/8075869|https://www.ncbi.nlm.nih.gov/pubmed/9183081,8075869|9183081,,
194,1446843,101597,ChEMBL,Cycrimine Hydrochloride,CHEMBL1200828,CYCRIMINE HYDROCHLORIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200828/,CHEMBL216,Muscarinic acetylcholine receptor M1,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL216/,P11229,Muscarinic acetylcholine receptor M1,1128.0,CHRM1,9606,Homo sapiens (human),Muscarinic acetylcholine receptor M1 antagonist,,,PMID:1267542|PMID:13477721,https://www.ncbi.nlm.nih.gov/pubmed/1267542|https://www.ncbi.nlm.nih.gov/pubmed/13477721,1267542|13477721,,
195,1448032,104926,Comparative Toxicogenomics Database (CTD),Cyfluthrin,C052570,cyfluthrin,https://ctdbase.org/detail.go?type=chem&acc=C052570,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),Cyfluthrin results in increased expression of BCL2 mRNA,,,PMID:31330490,https://www.ncbi.nlm.nih.gov/pubmed/31330490,31330490,,
196,1448033,104926,Comparative Toxicogenomics Database (CTD),Cyfluthrin,C052570,cyfluthrin,https://ctdbase.org/detail.go?type=chem&acc=C052570,613,BCR,https://ctdbase.org/detail.go?type=gene&acc=613,,,613.0,BCR,9606,Homo sapiens (human),Cyfluthrin results in increased expression of BCR protein,,,PMID:16790487,https://www.ncbi.nlm.nih.gov/pubmed/16790487,16790487,,
197,1448034,104926,Comparative Toxicogenomics Database (CTD),Cyfluthrin,C052570,cyfluthrin,https://ctdbase.org/detail.go?type=chem&acc=C052570,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,10116,Rattus norvegicus (Norway rat),Cyfluthrin results in increased expression of BDNF mRNA,,,PMID:16166269,https://www.ncbi.nlm.nih.gov/pubmed/16166269,16166269,,
198,1448035,104926,Comparative Toxicogenomics Database (CTD),Cyfluthrin,C052570,cyfluthrin,https://ctdbase.org/detail.go?type=chem&acc=C052570,664,BNIP3,https://ctdbase.org/detail.go?type=gene&acc=664,,,664.0,BNIP3,9606,Homo sapiens (human),Melatonin inhibits the reaction [cyfluthrin results in increased expression of BNIP3 mrna]|cyfluthrin results in increased expression of BNIP3 mRNA,,,PMID:31330490,https://www.ncbi.nlm.nih.gov/pubmed/31330490,31330490,,
199,1448036,104926,Comparative Toxicogenomics Database (CTD),Cyfluthrin,C052570,cyfluthrin,https://ctdbase.org/detail.go?type=chem&acc=C052570,815,CAMK2A,https://ctdbase.org/detail.go?type=gene&acc=815,,,815.0,CAMK2A,9606,Homo sapiens (human),Cyfluthrin results in increased expression of CAMK2A mRNA,,,PMID:32028016,https://www.ncbi.nlm.nih.gov/pubmed/32028016,32028016,,
200,1448037,104926,Comparative Toxicogenomics Database (CTD),Cyfluthrin,C052570,cyfluthrin,https://ctdbase.org/detail.go?type=chem&acc=C052570,816,CAMK2B,https://ctdbase.org/detail.go?type=gene&acc=816,,,816.0,CAMK2B,9606,Homo sapiens (human),Cyfluthrin results in increased expression of CAMK2B mRNA,,,PMID:32028016,https://www.ncbi.nlm.nih.gov/pubmed/32028016,32028016,,
201,1446680,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,998,CDC42,https://ctdbase.org/detail.go?type=gene&acc=998,,,998.0,CDC42,9606,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in increased expression of CDC42 mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
202,1446681,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606,Homo sapiens (human),Grape seed proanthocyanidins results in increased expression of CDKN1A mrna|grape seed proanthocyanidins results in increased expression of CDKN1A protein,,,PMID:22749965,https://www.ncbi.nlm.nih.gov/pubmed/22749965,22749965,,
203,1446682,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,1029,CDKN2A,https://ctdbase.org/detail.go?type=gene&acc=1029,,,1029.0,CDKN2A,9606,Homo sapiens (human),Grape seed proanthocyanidins results in increased expression of CDKN2A mrna|grape seed proanthocyanidins results in increased expression of CDKN2A protein,,,PMID:22749965,https://www.ncbi.nlm.nih.gov/pubmed/22749965,22749965,,
204,1446683,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,1046,CDX4,https://ctdbase.org/detail.go?type=gene&acc=1046,,,1046.0,CDX4,9606,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in decreased expression of CDX4 mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
205,1446684,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,10136,CELA3A,https://ctdbase.org/detail.go?type=gene&acc=10136,,,10136.0,CELA3A,9606,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in increased expression of CELA3A mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
206,1446685,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,388701,CFAP141,https://ctdbase.org/detail.go?type=gene&acc=388701,,,388701.0,CFAP141,9606,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in decreased expression of CFAP141 mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
207,1446686,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,286464,CFAP47,https://ctdbase.org/detail.go?type=gene&acc=286464,,,286464.0,CFAP47,9606,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in decreased expression of CFAP47 mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
208,1446687,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,255101,CFAP65,https://ctdbase.org/detail.go?type=gene&acc=255101,,,255101.0,CFAP65,9606,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in decreased expression of CFAP65 mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
209,1446688,107876,Comparative Toxicogenomics Database (CTD),Procyanidin,C511402,Grape Seed Proanthocyanidins,https://ctdbase.org/detail.go?type=chem&acc=C511402,284067,CFAP97D1,https://ctdbase.org/detail.go?type=gene&acc=284067,,,284067.0,CFAP97D1,9606,Homo sapiens (human),[catechin co-treated with grape seed proanthocyanidins] results in increased expression of CFAP97D1 mRNA,,,PMID:24763279,https://www.ncbi.nlm.nih.gov/pubmed/24763279,24763279,,
210,1440070,123805,Comparative Toxicogenomics Database (CTD),Angiotensin (1-7),C118790,angiotensin I (1-7),https://ctdbase.org/detail.go?type=chem&acc=C118790,1636,ACE,https://ctdbase.org/detail.go?type=gene&acc=1636,,,1636.0,ACE,10090,Mus musculus (house mouse),"ACE protein affects the reaction [silicon dioxide results in decreased abundance of angiotensin I (1-7)]|ACE protein affects the reaction [AGT protein results in decreased abundance of angiotensin I (1-7)]|7-ala-angiotensin (1-7) inhibits the reaction [angiotensin I (1-7) inhibits the reaction [AGT protein results in increased expression of ACE mrna]]|2-(1-carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)ethylamino)-4-methylpentanoic acid inhibits the reaction [angiotensin I (1-7) inhibits the reaction [AGT protein results in increased expression of ACE mrna]]|angiotensin I (1-7) inhibits the reaction [AGT protein results in increased expression of ACE protein]|2-(1-carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)ethylamino)-4-methylpentanoic acid inhibits the reaction [angiotensin I (1-7) inhibits the reaction [AGT protein results in increased expression of ACE protein]]|7-ala-angiotensin (1-7) inhibits the reaction [angiotensin I (1-7) inhibits the reaction [AGT protein results in increased expression of ACE protein]]|angiotensin I (1-7) inhibits the reaction [AGT protein results in increased expression of ACE mrna]",,,PMID:33007385,https://www.ncbi.nlm.nih.gov/pubmed/33007385,33007385,,
211,1440071,123805,Comparative Toxicogenomics Database (CTD),Angiotensin (1-7),C118790,angiotensin I (1-7),https://ctdbase.org/detail.go?type=chem&acc=C118790,1636,ACE,https://ctdbase.org/detail.go?type=gene&acc=1636,,,1636.0,ACE,10116,Rattus norvegicus (Norway rat),Angiotensin I (1-7) inhibits the reaction [monocrotaline results in increased expression of ACE mrna]|angiotensin I (1-7) inhibits the reaction [bleomycin results in decreased expression of ACE protein],,,PMID:20581171,https://www.ncbi.nlm.nih.gov/pubmed/20581171,20581171,,
212,1440072,123805,Comparative Toxicogenomics Database (CTD),Angiotensin (1-7),C118790,angiotensin I (1-7),https://ctdbase.org/detail.go?type=chem&acc=C118790,1636,ACE,https://ctdbase.org/detail.go?type=gene&acc=1636,,,1636.0,ACE,10116,Rattus norvegicus (Norway rat),Angiotensin I (1-7) results in decreased activity of ACE protein,,,PMID:26895462,https://www.ncbi.nlm.nih.gov/pubmed/26895462,26895462,,
213,1440073,123805,Comparative Toxicogenomics Database (CTD),Angiotensin (1-7),C118790,angiotensin I (1-7),https://ctdbase.org/detail.go?type=chem&acc=C118790,59272,ACE2,https://ctdbase.org/detail.go?type=gene&acc=59272,,,59272.0,ACE2,9606,Homo sapiens (human),[ACE2 protein results in increased cleavage of AGT protein] which results in increased abundance of angiotensin I (1-7),,,PMID:12623933,https://www.ncbi.nlm.nih.gov/pubmed/12623933,12623933,,
214,1440074,123805,Comparative Toxicogenomics Database (CTD),Angiotensin (1-7),C118790,angiotensin I (1-7),https://ctdbase.org/detail.go?type=chem&acc=C118790,59272,ACE2,https://ctdbase.org/detail.go?type=gene&acc=59272,,,59272.0,ACE2,10090,Mus musculus (house mouse),"Angiotensin I (1-7) inhibits the reaction [AGT protein results in decreased expression of ACE2 protein]|goralatide affects the reaction [ACE2 protein affects the reaction [AGT protein results in decreased abundance of angiotensin I (1-7)]]|2-(1-carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)ethylamino)-4-methylpentanoic acid inhibits the reaction [angiotensin I (1-7) inhibits the reaction [AGT protein results in decreased expression of ACE2 mrna]]|ace2 protein affects the reaction [AGT protein results in decreased abundance of angiotensin I (1-7)]|7-ala-angiotensin (1-7) inhibits the reaction [angiotensin I (1-7) inhibits the reaction [AGT protein results in decreased expression of ACE2 protein]]|2-(1-carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)ethylamino)-4-methylpentanoic acid inhibits the reaction [angiotensin I (1-7) inhibits the reaction [AGT protein results in decreased expression of ACE2 protein]]|angiotensin I (1-7) inhibits the reaction [AGT protein results in decreased expression of ACE2 mrna]|7-ala-angiotensin (1-7) inhibits the reaction [angiotensin I (1-7) inhibits the reaction [AGT protein results in decreased expression of ACE2 mrna]]",,,PMID:33007385,https://www.ncbi.nlm.nih.gov/pubmed/33007385,33007385,,
215,1440577,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,6373,CXCL11,https://ctdbase.org/detail.go?type=gene&acc=6373,,,6373.0,CXCL11,9606,Homo sapiens (human),Methotrexate results in decreased expression of CXCL11 mRNA,,,PMID:17400583,https://www.ncbi.nlm.nih.gov/pubmed/17400583,17400583,,
216,1440578,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,6387,CXCL12,https://ctdbase.org/detail.go?type=gene&acc=6387,,,6387.0,CXCL12,9606,Homo sapiens (human),Methotrexate results in increased expression of CXCL12 mRNA,,,PMID:17400583,https://www.ncbi.nlm.nih.gov/pubmed/17400583,17400583,,
217,1440579,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,9547,CXCL14,https://ctdbase.org/detail.go?type=gene&acc=9547,,,9547.0,CXCL14,10090,Mus musculus (house mouse),Methotrexate affects the expression of CXCL14 mRNA,,,PMID:18502557,https://www.ncbi.nlm.nih.gov/pubmed/18502557,18502557,,
218,1440580,126941,Comparative Toxicogenomics Database (CTD),Methotrexate,D008727,Methotrexate,https://ctdbase.org/detail.go?type=chem&acc=D008727,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,9606,Homo sapiens (human),[methotrexate analog binds to lipids] which results in decreased expression of CXCL2 mRNA,,,PMID:24065615,https://www.ncbi.nlm.nih.gov/pubmed/24065615,24065615,,
219,1441359,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,6439,SFTPB,https://ctdbase.org/detail.go?type=gene&acc=6439,,,6439.0,SFTPB,10116,Rattus norvegicus (Norway rat),PD 156707 inhibits the reaction [nitric oxide results in decreased expression of SFTPB mrna]|bosentan inhibits the reaction [nitric oxide results in decreased expression of SFTPB mrna]|nitric oxide results in decreased expression of SFTPB mRNA,,,PMID:15640287,https://www.ncbi.nlm.nih.gov/pubmed/15640287,15640287,,
220,1441360,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,6440,SFTPC,https://ctdbase.org/detail.go?type=gene&acc=6440,,,6440.0,SFTPC,10116,Rattus norvegicus (Norway rat),PD 156707 inhibits the reaction [nitric oxide results in decreased expression of SFTPC mrna]|bosentan inhibits the reaction [nitric oxide results in decreased expression of SFTPC mrna]|nitric oxide results in decreased expression of SFTPC mRNA,,,PMID:15640287,https://www.ncbi.nlm.nih.gov/pubmed/15640287,15640287,,
221,1441361,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411.0,SIRT1,9606,Homo sapiens (human),SIRT1 protein affects the reaction [INS protein results in increased secretion of nitric oxide]|sirt1 protein affects the reaction [resveratrol inhibits the reaction [glucose inhibits the reaction [INS protein results in increased secretion of nitric oxide]]],,,PMID:20960276,https://www.ncbi.nlm.nih.gov/pubmed/20960276,20960276,,
222,1441362,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,4891,SLC11A2,https://ctdbase.org/detail.go?type=gene&acc=4891,,,4891.0,SLC11A2,10090,Mus musculus (house mouse),Nitric oxide affects the expression of SLC11A2 protein alternative form,,,PMID:16232120,https://www.ncbi.nlm.nih.gov/pubmed/16232120,16232120,,
223,1446535,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10116,Rattus norvegicus (Norway rat),Tempol inhibits the reaction [nitric oxide deficiency results in increased expression of SOD2 protein]|nitric oxide deficiency results in increased expression of SOD2 protein,,,PMID:15925750,https://www.ncbi.nlm.nih.gov/pubmed/15925750,15925750,,
224,1446536,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10116,Rattus norvegicus (Norway rat),SOD2 protein inhibits the reaction [IL1B protein results in increased chemical synthesis of nitric oxide],,,PMID:9576743,https://www.ncbi.nlm.nih.gov/pubmed/9576743,9576743,,
225,1446537,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606,Homo sapiens (human),[KL protein results in increased abundance of nitric oxide] which results in increased expression of SOD2,,,PMID:17709902,https://www.ncbi.nlm.nih.gov/pubmed/17709902,17709902,,
226,1446538,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606,Homo sapiens (human),[SOD2 protein results in decreased expression of NOS3 protein] which results in increased abundance of nitric oxide|sod2 protein results in decreased abundance of nitric oxide,,,PMID:11929863,https://www.ncbi.nlm.nih.gov/pubmed/11929863,11929863,,
227,1446539,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606,Homo sapiens (human),SOD2 protein results in increased abundance of nitric oxide,,,PMID:12677255,https://www.ncbi.nlm.nih.gov/pubmed/12677255,12677255,,
228,1446540,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,6272,SORT1,https://ctdbase.org/detail.go?type=gene&acc=6272,,,6272.0,SORT1,9606,Homo sapiens (human),SORT1 protein affects the reaction [FASL protein results in decreased abundance of nitric oxide],,,PMID:19761405,https://www.ncbi.nlm.nih.gov/pubmed/19761405,19761405,,
229,1446541,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,10090,Mus musculus (house mouse),Nitric oxide deficiency results in decreased expression of SPP1 mRNA,,,PMID:15878706,https://www.ncbi.nlm.nih.gov/pubmed/15878706,15878706,,
230,1446542,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,6714,SRC,https://ctdbase.org/detail.go?type=gene&acc=6714,,,6714.0,SRC,9606,Homo sapiens (human),[resveratrol promotes the reaction [ESR1 protein binds to CAV1 protein binds to SRC protein]] which results in increased abundance of nitric oxide,,,PMID:18296501,https://www.ncbi.nlm.nih.gov/pubmed/18296501,18296501,,
231,1446543,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,6772,STAT1,https://ctdbase.org/detail.go?type=gene&acc=6772,,,6772.0,STAT1,10090,Mus musculus (house mouse),STAT1 protein promotes the reaction [[lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of nitric oxide],,,PMID:23106696,https://www.ncbi.nlm.nih.gov/pubmed/23106696,23106696,,
232,1443702,145858,Comparative Toxicogenomics Database (CTD),Flavylium,D000872,Anthocyanins,https://ctdbase.org/detail.go?type=chem&acc=D000872,8654,PDE5A,https://ctdbase.org/detail.go?type=gene&acc=8654,,,8654.0,PDE5A,9606,Homo sapiens (human),Anthocyanins results in decreased activity of PDE5A protein,,,PMID:15769121,https://www.ncbi.nlm.nih.gov/pubmed/15769121,15769121,,
233,1442071,148192,BindingDB,Atazanavir,13934,Atazanavir,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13934,152,"Dimer of Gag-Pol polyprotein [482-580,I502K,I528M,T553A]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=152,P24740,Gag-Pol polyprotein,,,11703,Human immunodeficiency virus type 1 (STRAIN UGANDAN / ISOLATE U455),,Ki (nM),0.24,PMID:16634628|DOI:10.1021/bi051886s,https://www.ncbi.nlm.nih.gov/pubmed/16634628|https://doi.org/10.1021/bi051886s,16634628,10.1021/bi051886s,
234,1442072,148192,BindingDB,Atazanavir,13934,Atazanavir,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13934,155,"Dimer of Gag-Pol polyprotein [490-588,L523I,E525D,M526I,I544V,L553H,H559K,L579M]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=155,P05959,Gag-Pol polyprotein,,,11701,Human immunodeficiency virus type 1 (RF/HAT ISOLATE),,Ki (nM),1.1,PMID:16634628|DOI:10.1021/bi051886s,https://www.ncbi.nlm.nih.gov/pubmed/16634628|https://doi.org/10.1021/bi051886s,16634628,10.1021/bi051886s,
235,1442073,148192,BindingDB,Atazanavir,13934,Atazanavir,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13934,154,"Dimer of Gag-Pol polyprotein [490-588,L523I,E525D,M526I,I544V,L553H,H559K,V572F,L579M]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=154,P05959,Gag-Pol polyprotein,,,11701,Human immunodeficiency virus type 1 (RF/HAT ISOLATE),,Ki (nM),0.7,PMID:16634628|DOI:10.1021/bi051886s,https://www.ncbi.nlm.nih.gov/pubmed/16634628|https://doi.org/10.1021/bi051886s,16634628,10.1021/bi051886s,
236,1442074,148192,BindingDB,Atazanavir,13934,Atazanavir,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13934,150,Dimer of Gag-Pol polyprotein [501-599],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=150,P03367,Gag-Pol polyprotein,,,11686,Human immunodeficiency virus type 1 (BRU ISOLATE),,Ki (nM),0.48,PMID:16634628|DOI:10.1021/bi051886s,https://www.ncbi.nlm.nih.gov/pubmed/16634628|https://doi.org/10.1021/bi051886s,16634628,10.1021/bi051886s,
237,1442075,148192,BindingDB,Atazanavir,13934,Atazanavir,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=13934,151,"Dimer of Gag-Pol polyprotein [501-599,V583F]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=151,P03367,Gag-Pol polyprotein,,,11686,Human immunodeficiency virus type 1 (BRU ISOLATE),,Ki (nM),0.56,PMID:16634628|DOI:10.1021/bi051886s,https://www.ncbi.nlm.nih.gov/pubmed/16634628|https://doi.org/10.1021/bi051886s,16634628,10.1021/bi051886s,
238,1442076,148192,Drug Gene Interaction database (DGIdb),Atazanavir,,ATAZANAVIR,https://www.dgidb.org/drugs/rxcui:343047,,ABCC2,https://www.dgidb.org/genes/hgnc:53,,,1244.0,ABCC2,9606,Homo sapiens (human),,,,,,,,
239,1444707,151723,Comparative Toxicogenomics Database (CTD),Methylmercury cysteine,C030589,methylmercury cysteine,https://ctdbase.org/detail.go?type=chem&acc=C030589,258835,OR10AG60,https://ctdbase.org/detail.go?type=gene&acc=258835,,,258835.0,Or10ag60,10090,Mus musculus (house mouse),Methylmercury cysteine results in increased expression of OR10AG60 mRNA,,,PMID:19465457,https://www.ncbi.nlm.nih.gov/pubmed/19465457,19465457,,
240,1444708,151723,Comparative Toxicogenomics Database (CTD),Methylmercury cysteine,C030589,methylmercury cysteine,https://ctdbase.org/detail.go?type=chem&acc=C030589,392138,OR2A25,https://ctdbase.org/detail.go?type=gene&acc=392138,,,392138.0,OR2A25,10090,Mus musculus (house mouse),Methylmercury cysteine results in decreased expression of OR2A25 mRNA,,,PMID:19465457,https://www.ncbi.nlm.nih.gov/pubmed/19465457,19465457,,
241,1444709,151723,Comparative Toxicogenomics Database (CTD),Methylmercury cysteine,C030589,methylmercury cysteine,https://ctdbase.org/detail.go?type=chem&acc=C030589,258466,OR4C126,https://ctdbase.org/detail.go?type=gene&acc=258466,,,258466.0,Or4c126,10090,Mus musculus (house mouse),Methylmercury cysteine results in decreased expression of OR4C126 mRNA,,,PMID:19465457,https://www.ncbi.nlm.nih.gov/pubmed/19465457,19465457,,
242,1444710,151723,Comparative Toxicogenomics Database (CTD),Methylmercury cysteine,C030589,methylmercury cysteine,https://ctdbase.org/detail.go?type=chem&acc=C030589,259115,OR51A5,https://ctdbase.org/detail.go?type=gene&acc=259115,,,259115.0,Or51a5,10090,Mus musculus (house mouse),Methylmercury cysteine results in increased expression of OR51A5 mRNA,,,PMID:19465457,https://www.ncbi.nlm.nih.gov/pubmed/19465457,19465457,,
243,1444711,151723,Comparative Toxicogenomics Database (CTD),Methylmercury cysteine,C030589,methylmercury cysteine,https://ctdbase.org/detail.go?type=chem&acc=C030589,10471,PFDN6,https://ctdbase.org/detail.go?type=gene&acc=10471,,,10471.0,PFDN6,10090,Mus musculus (house mouse),Methylmercury cysteine results in increased expression of PFDN6 mRNA,,,PMID:19465457,https://www.ncbi.nlm.nih.gov/pubmed/19465457,19465457,,
244,1444712,151723,Comparative Toxicogenomics Database (CTD),Methylmercury cysteine,C030589,methylmercury cysteine,https://ctdbase.org/detail.go?type=chem&acc=C030589,58473,PLEKHB1,https://ctdbase.org/detail.go?type=gene&acc=58473,,,58473.0,PLEKHB1,10090,Mus musculus (house mouse),Methylmercury cysteine results in decreased expression of PLEKHB1 mRNA,,,PMID:19465457,https://www.ncbi.nlm.nih.gov/pubmed/19465457,19465457,,
245,1444713,151723,Comparative Toxicogenomics Database (CTD),Methylmercury cysteine,C030589,methylmercury cysteine,https://ctdbase.org/detail.go?type=chem&acc=C030589,90826,PRMT9,https://ctdbase.org/detail.go?type=gene&acc=90826,,,90826.0,PRMT9,10090,Mus musculus (house mouse),Methylmercury cysteine results in decreased expression of PRMT9 mRNA,,,PMID:19465457,https://www.ncbi.nlm.nih.gov/pubmed/19465457,19465457,,
246,1444714,151723,Comparative Toxicogenomics Database (CTD),Methylmercury cysteine,C030589,methylmercury cysteine,https://ctdbase.org/detail.go?type=chem&acc=C030589,158471,PRUNE2,https://ctdbase.org/detail.go?type=gene&acc=158471,,,158471.0,PRUNE2,10090,Mus musculus (house mouse),Methylmercury cysteine results in decreased expression of PRUNE2 mRNA,,,PMID:19465457,https://www.ncbi.nlm.nih.gov/pubmed/19465457,19465457,,
247,1444715,151723,Comparative Toxicogenomics Database (CTD),Methylmercury cysteine,C030589,methylmercury cysteine,https://ctdbase.org/detail.go?type=chem&acc=C030589,104384,RHOX9,https://ctdbase.org/detail.go?type=gene&acc=104384,,,104384.0,Rhox9,10090,Mus musculus (house mouse),Methylmercury cysteine results in increased expression of RHOX9 mRNA,,,PMID:19465457,https://www.ncbi.nlm.nih.gov/pubmed/19465457,19465457,,
248,1443230,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,27429,HTRA2,https://ctdbase.org/detail.go?type=gene&acc=27429,,,27429.0,HTRA2,9606,Homo sapiens (human),[cannabidiol co-treated with moringin] results in decreased expression of HTRA2 mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
249,1443231,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,3419,IDH3A,https://ctdbase.org/detail.go?type=gene&acc=3419,,,3419.0,IDH3A,9606,Homo sapiens (human),[cannabidiol co-treated with moringin] results in increased expression of IDH3A mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
250,1443232,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,3421,IDH3G,https://ctdbase.org/detail.go?type=gene&acc=3421,,,3421.0,IDH3G,9606,Homo sapiens (human),[cannabidiol co-treated with moringin] results in increased expression of IDH3G mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
251,1443233,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,3551,IKBKB,https://ctdbase.org/detail.go?type=gene&acc=3551,,,3551.0,IKBKB,9606,Homo sapiens (human),[cannabidiol co-treated with moringin] results in decreased expression of IKBKB mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
252,1443234,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,8517,IKBKG,https://ctdbase.org/detail.go?type=gene&acc=8517,,,8517.0,IKBKG,9606,Homo sapiens (human),[cannabidiol co-treated with moringin] results in decreased expression of IKBKG mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
253,1443235,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,3554,IL1R1,https://ctdbase.org/detail.go?type=gene&acc=3554,,,3554.0,IL1R1,9606,Homo sapiens (human),Moringin results in increased expression of IL1R1 mRNA,,,PMID:31801206,https://www.ncbi.nlm.nih.gov/pubmed/31801206,31801206,,
254,1443236,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,3572,IL6ST,https://ctdbase.org/detail.go?type=gene&acc=3572,,,3572.0,IL6ST,9606,Homo sapiens (human),Moringin results in decreased expression of IL6ST mRNA,,,PMID:31801206,https://www.ncbi.nlm.nih.gov/pubmed/31801206,31801206,,
255,1443369,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,9448,MAP4K4,https://ctdbase.org/detail.go?type=gene&acc=9448,,,9448.0,MAP4K4,9606,Homo sapiens (human),[cannabidiol co-treated with moringin] results in decreased expression of MAP4K4 mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
256,1443850,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,51422,PRKAG2,https://ctdbase.org/detail.go?type=gene&acc=51422,,,51422.0,PRKAG2,9606,Homo sapiens (human),[cannabidiol co-treated with moringin] results in increased expression of PRKAG2 mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
257,1443851,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,5631,PRPS1,https://ctdbase.org/detail.go?type=gene&acc=5631,,,5631.0,PRPS1,9606,Homo sapiens (human),[cannabidiol co-treated with moringin] results in increased expression of PRPS1 mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
258,1443852,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,5728,PTEN,https://ctdbase.org/detail.go?type=gene&acc=5728,,,5728.0,PTEN,9606,Homo sapiens (human),[cannabidiol co-treated with moringin] results in decreased expression of PTEN mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
259,1443853,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,10399,RACK1,https://ctdbase.org/detail.go?type=gene&acc=10399,,,10399.0,RACK1,9606,Homo sapiens (human),Moringin results in increased expression of RACK1 mRNA,,,PMID:31801206,https://www.ncbi.nlm.nih.gov/pubmed/31801206,31801206,,
260,1443854,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,5934,RBL2,https://ctdbase.org/detail.go?type=gene&acc=5934,,,5934.0,RBL2,9606,Homo sapiens (human),[cannabidiol co-treated with moringin] results in decreased expression of RBL2 mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
261,1443855,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606,Homo sapiens (human),[cannabidiol co-treated with moringin] results in increased expression of RELA mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
262,1443856,153557,Comparative Toxicogenomics Database (CTD),Moringin,C000614007,moringin,https://ctdbase.org/detail.go?type=chem&acc=C000614007,6009,RHEB,https://ctdbase.org/detail.go?type=gene&acc=6009,,,6009.0,RHEB,9606,Homo sapiens (human),[cannabidiol co-treated with moringin] results in increased expression of RHEB mRNA,,,PMID:30096889,https://www.ncbi.nlm.nih.gov/pubmed/30096889,30096889,,
263,1440075,153994,Drug Gene Interaction database (DGIdb),Clevidipine,,CLEVIDIPINE,https://www.dgidb.org/drugs/rxcui:233603,,CACNA1S,https://www.dgidb.org/genes/hgnc:1397,,,779.0,CACNA1S,9606,Homo sapiens (human),Blocker,,,,,,,
264,1440076,153994,Drug Gene Interaction database (DGIdb),Clevidipine,,CLEVIDIPINE,https://www.dgidb.org/drugs/rxcui:233603,,CACNA1C,https://www.dgidb.org/genes/hgnc:1390,,,775.0,CACNA1C,9606,Homo sapiens (human),Blocker,,,,,,,
265,1440077,153994,Drug Gene Interaction database (DGIdb),Clevidipine,,CLEVIDIPINE,https://www.dgidb.org/drugs/rxcui:233603,,CACNA1F,https://www.dgidb.org/genes/hgnc:1393,,,778.0,CACNA1F,9606,Homo sapiens (human),Blocker,,,,,,,
266,1440078,153994,ChEMBL,Clevidipine,CHEMBL1237132,CLEVIDIPINE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1237132/,CHEMBL2095229,Voltage-gated L-type calcium channel,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2095229/,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,775.0,CACNA1C,9606,Homo sapiens (human),Voltage-gated L-type calcium channel blocker,,,,,,,
267,1440079,153999,ChEMBL,Ruboxistaurin,CHEMBL91829,RUBOXISTAURIN,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL91829/,CHEMBL3045,Protein kinase C beta,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3045/,P05771,Protein kinase C beta type,5579.0,PRKCB,9606,Homo sapiens (human),Protein kinase C beta inhibitor,,,PMID:8614835,https://www.ncbi.nlm.nih.gov/pubmed/8614835,8614835,,
268,1440080,154044,DrugBank,Mozenavir,DB02102,Mozenavir,https://www.drugbank.ca/drugs/DB02102,BE0001594,Gag-Pol polyprotein,https://www.drugbank.ca/bio_entities/BE0001594,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706,HIV-1 M:B_HXB2R,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
269,1444854,154256,Comparative Toxicogenomics Database (CTD),Bazedoxifene acetate,C447119,bazedoxifene,https://ctdbase.org/detail.go?type=chem&acc=C447119,1959,EGR2,https://ctdbase.org/detail.go?type=gene&acc=1959,,,1959.0,EGR2,9606,Homo sapiens (human),Bazedoxifene results in increased expression of EGR2 mRNA,,,PMID:19914376,https://www.ncbi.nlm.nih.gov/pubmed/19914376,19914376,,
270,1445338,154256,Comparative Toxicogenomics Database (CTD),Bazedoxifene acetate,C447119,bazedoxifene,https://ctdbase.org/detail.go?type=chem&acc=C447119,26470,SEZ6L2,https://ctdbase.org/detail.go?type=gene&acc=26470,,,26470.0,SEZ6L2,9606,Homo sapiens (human),Bazedoxifene results in decreased expression of SEZ6L2 mRNA,,,PMID:19914376,https://www.ncbi.nlm.nih.gov/pubmed/19914376,19914376,,
271,1445339,154256,Comparative Toxicogenomics Database (CTD),Bazedoxifene acetate,C447119,bazedoxifene,https://ctdbase.org/detail.go?type=chem&acc=C447119,6582,SLC22A2,https://ctdbase.org/detail.go?type=gene&acc=6582,,,6582.0,SLC22A2,9606,Homo sapiens (human),Bazedoxifene inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium],,,PMID:21599003,https://www.ncbi.nlm.nih.gov/pubmed/21599003,21599003,,
272,1445340,154256,Comparative Toxicogenomics Database (CTD),Bazedoxifene acetate,C447119,bazedoxifene,https://ctdbase.org/detail.go?type=chem&acc=C447119,6690,SPINK1,https://ctdbase.org/detail.go?type=gene&acc=6690,,,6690.0,SPINK1,10090,Mus musculus (house mouse),[progesterone co-treated with bazedoxifene] results in increased expression of SPINK1 mRNA,,,PMID:18367319,https://www.ncbi.nlm.nih.gov/pubmed/18367319,18367319,,
273,1445341,154256,Comparative Toxicogenomics Database (CTD),Bazedoxifene acetate,C447119,bazedoxifene,https://ctdbase.org/detail.go?type=chem&acc=C447119,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,9606,Homo sapiens (human),Bazedoxifene inhibits the reaction [IL4 protein results in increased phosphorylation of STAT3 protein]|bazedoxifene results in decreased phosphorylation of STAT3 protein,,,PMID:24456369,https://www.ncbi.nlm.nih.gov/pubmed/24456369,24456369,,
274,1445342,154256,Comparative Toxicogenomics Database (CTD),Bazedoxifene acetate,C447119,bazedoxifene,https://ctdbase.org/detail.go?type=chem&acc=C447119,7039,TGFA,https://ctdbase.org/detail.go?type=gene&acc=7039,,,7039.0,TGFA,9606,Homo sapiens (human),Bazedoxifene inhibits the reaction [TGFA protein results in increased phosphorylation of AKT1 protein],,,PMID:35007301,https://www.ncbi.nlm.nih.gov/pubmed/35007301,35007301,,
275,1440196,154575,DrugBank,Piclamilast,DB01791,Piclamilast,https://www.drugbank.ca/drugs/DB01791,BE0002353,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",https://www.drugbank.ca/bio_entities/BE0002353,Q08493,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",5143.0,PDE4C,9606,Homo sapiens (human),,,,PMID:15765929,https://www.ncbi.nlm.nih.gov/pubmed/15765929,15765929,,
276,1440197,154575,DrugBank,Piclamilast,DB01791,Piclamilast,https://www.drugbank.ca/drugs/DB01791,BE0001287,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",https://www.drugbank.ca/bio_entities/BE0001287,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",5144.0,PDE4D,9606,Homo sapiens (human),,,,PMID:15765929|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/15765929|https://www.ncbi.nlm.nih.gov/pubmed/10592235,15765929|10592235,,
277,1445178,154575,BindingDB,Piclamilast,14775,"3-(cyclopentyloxy)-N-(3,5-dichloropyridin-4-yl)-4-methoxybenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14775,1578,"cAMP-specific 3',5'-cyclic phosphodiesterase 7B [91-450]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1578,Q9NP56,"cAMP-specific 3',5'-cyclic phosphodiesterase 7B",27115.0,PDE7B,9606,Homo sapiens (human),,IC50 (nM),8800,PMID:15576036|DOI:10.1016/j.str.2004.10.004,https://www.ncbi.nlm.nih.gov/pubmed/15576036|https://doi.org/10.1016/j.str.2004.10.004,15576036,10.1016/j.str.2004.10.004,
278,1445179,154575,BindingDB,Piclamilast,14775,"3-(cyclopentyloxy)-N-(3,5-dichloropyridin-4-yl)-4-methoxybenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14775,1579,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1579,O60658,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A",5151.0,PDE8A,9606,Homo sapiens (human),,IC50 (nM),>200000,PMID:15576036|DOI:10.1016/j.str.2004.10.004,https://www.ncbi.nlm.nih.gov/pubmed/15576036|https://doi.org/10.1016/j.str.2004.10.004,15576036,10.1016/j.str.2004.10.004,
279,1445180,154575,BindingDB,Piclamilast,14775,"3-(cyclopentyloxy)-N-(3,5-dichloropyridin-4-yl)-4-methoxybenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14775,1580,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A [226-593]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1580,O76083,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",5152.0,PDE9A,9606,Homo sapiens (human),,IC50 (nM),>200000,PMID:15576036|DOI:10.1016/j.str.2004.10.004,https://www.ncbi.nlm.nih.gov/pubmed/15576036|https://doi.org/10.1016/j.str.2004.10.004,15576036,10.1016/j.str.2004.10.004,
280,1445181,154575,BindingDB,Piclamilast,14775,"3-(cyclopentyloxy)-N-(3,5-dichloropyridin-4-yl)-4-methoxybenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14775,1582,"Isoform 4 of Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (PDE11A1) 35-489]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1582,Q9HCR9,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",50940.0,PDE11A,9606,Homo sapiens (human),,IC50 (nM),1600,PMID:15576036|DOI:10.1016/j.str.2004.10.004,https://www.ncbi.nlm.nih.gov/pubmed/15576036|https://doi.org/10.1016/j.str.2004.10.004,15576036,10.1016/j.str.2004.10.004,
281,1445182,154575,BindingDB,Piclamilast,14775,"3-(cyclopentyloxy)-N-(3,5-dichloropyridin-4-yl)-4-methoxybenzamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14775,1581,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A [432-779]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1581,Q9Y233,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",10846.0,PDE10A,9606,Homo sapiens (human),,IC50 (nM),21000,PMID:15576036|DOI:10.1016/j.str.2004.10.004,https://www.ncbi.nlm.nih.gov/pubmed/15576036|https://doi.org/10.1016/j.str.2004.10.004,15576036,10.1016/j.str.2004.10.004,
282,1440198,155166,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexabromodiphenyl ether",C478854,"2,2',4,4',5,5'-hexabrominated diphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C478854,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116,Rattus norvegicus (Norway rat),"2,2',4,4',5,5'-hexabrominated diphenyl ether results in increased phosphorylation of MAPK1 protein",,,PMID:20171977,https://www.ncbi.nlm.nih.gov/pubmed/20171977,20171977,,
283,1440199,155166,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexabromodiphenyl ether",C478854,"2,2',4,4',5,5'-hexabrominated diphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C478854,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116,Rattus norvegicus (Norway rat),"2,2',4,4',5,5'-hexabrominated diphenyl ether results in increased phosphorylation of MAPK3 protein",,,PMID:20171977,https://www.ncbi.nlm.nih.gov/pubmed/20171977,20171977,,
284,1445183,155434,Drug Gene Interaction database (DGIdb),Acamprosate Calcium,,ACAMPROSATE CALCIUM,https://www.dgidb.org/drugs/rxcui:152761,,GABRB3,https://www.dgidb.org/genes/hgnc:4083,,,2562.0,GABRB3,9606,Homo sapiens (human),Positive modulator,,,,,,,
285,1445184,155434,Drug Gene Interaction database (DGIdb),Acamprosate Calcium,,ACAMPROSATE CALCIUM,https://www.dgidb.org/drugs/rxcui:152761,,GABRA2,https://www.dgidb.org/genes/hgnc:4076,,,2555.0,GABRA2,9606,Homo sapiens (human),Positive modulator,,,,,,,
286,1440200,155435,ChEMBL,Acolbifene,CHEMBL68055,ACOLBIFENE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL68055/,CHEMBL2093866,Estrogen receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093866/,P03372,Estrogen receptor,2099.0,ESR1,9606,Homo sapiens (human),Estrogen receptor modulator,,,PMID:11850228|PMID:22196312,https://www.ncbi.nlm.nih.gov/pubmed/11850228|https://www.ncbi.nlm.nih.gov/pubmed/22196312,11850228|22196312,,
287,1440201,155435,ChEMBL,Acolbifene,CHEMBL68055,ACOLBIFENE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL68055/,CHEMBL2093866,Estrogen receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093866/,Q92731,Estrogen receptor beta,2100.0,ESR2,9606,Homo sapiens (human),Estrogen receptor modulator,,,PMID:11850228|PMID:22196312,https://www.ncbi.nlm.nih.gov/pubmed/11850228|https://www.ncbi.nlm.nih.gov/pubmed/22196312,11850228|22196312,,
288,1440202,155448,Therapeutic Target Database (TTD),Nonyl beta-D-glucopyranoside,D0K1UI,B-Nonylglucoside,https://idrblab.net/ttd/data/drug/details/D0K1UI,T10091,Rhodopsin (RHO),https://idrblab.net/ttd/data/target/details/T10091,P08100,Rhodopsin,6010.0,RHO,9606,Homo sapiens (human),Inhibitor,,,,,,,
289,1440203,155448,Therapeutic Target Database (TTD),Nonyl beta-D-glucopyranoside,D0K1UI,B-Nonylglucoside,https://idrblab.net/ttd/data/drug/details/D0K1UI,T94309,Pancreatic triacylglycerol lipase (PNLIP),https://idrblab.net/ttd/data/target/details/T94309,P16233,Pancreatic triacylglycerol lipase,5406.0,PNLIP,9606,Homo sapiens (human),Inhibitor,,,,,,,
290,1440204,155922,Comparative Toxicogenomics Database (CTD),(3-{[3-(2-Amino-2-Oxoethyl)-1-Benzyl-2-Ethyl-1h-Indol-5-Yl]oxy}propyl)phosphonic Acid,C095553,LY 311727,https://ctdbase.org/detail.go?type=chem&acc=C095553,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,10090,Mus musculus (house mouse),LY 311727 inhibits the reaction [lipopolysaccharides results in increased localization of [RELA protein co-treated with NFKB1 protein]],,,PMID:11094054,https://www.ncbi.nlm.nih.gov/pubmed/11094054,11094054,,
291,1440205,155922,Comparative Toxicogenomics Database (CTD),(3-{[3-(2-Amino-2-Oxoethyl)-1-Benzyl-2-Ethyl-1h-Indol-5-Yl]oxy}propyl)phosphonic Acid,C095553,LY 311727,https://ctdbase.org/detail.go?type=chem&acc=C095553,5320,PLA2G2A,https://ctdbase.org/detail.go?type=gene&acc=5320,,,5320.0,PLA2G2A,9606,Homo sapiens (human),LY 311727 results in decreased activity of PLA2G2A protein,,,PMID:11741884,https://www.ncbi.nlm.nih.gov/pubmed/11741884,11741884,,
292,1440316,155922,Comparative Toxicogenomics Database (CTD),(3-{[3-(2-Amino-2-Oxoethyl)-1-Benzyl-2-Ethyl-1h-Indol-5-Yl]oxy}propyl)phosphonic Acid,C095553,LY 311727,https://ctdbase.org/detail.go?type=chem&acc=C095553,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10090,Mus musculus (house mouse),LY 311727 inhibits the reaction [lipopolysaccharides results in increased localization of [RELA protein co-treated with NFKB1 protein]],,,PMID:11094054,https://www.ncbi.nlm.nih.gov/pubmed/11094054,11094054,,
293,1440317,155922,Comparative Toxicogenomics Database (CTD),(3-{[3-(2-Amino-2-Oxoethyl)-1-Benzyl-2-Ethyl-1h-Indol-5-Yl]oxy}propyl)phosphonic Acid,C095553,LY 311727,https://ctdbase.org/detail.go?type=chem&acc=C095553,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090,Mus musculus (house mouse),LY 311727 inhibits the reaction [TNF protein results in increased abundance of fatty acids],,,PMID:10588948,https://www.ncbi.nlm.nih.gov/pubmed/10588948,10588948,,
294,1440318,156333,Drug Gene Interaction database (DGIdb),Nemonapride,,MK-2461,https://www.dgidb.org/drugs/iuphar.ligand:7962,,MST1R,https://www.dgidb.org/genes/hgnc:7381,,,4486.0,MST1R,9606,Homo sapiens (human),,,,,,,,
295,1440319,156333,Drug Gene Interaction database (DGIdb),Nemonapride,,MK-2461,https://www.dgidb.org/drugs/iuphar.ligand:7962,,FLT4,https://www.dgidb.org/genes/hgnc:3767,,,2324.0,FLT4,9606,Homo sapiens (human),,,,,,,,
296,1440320,156333,Drug Gene Interaction database (DGIdb),Nemonapride,,MK-2461,https://www.dgidb.org/drugs/iuphar.ligand:7962,,MERTK,https://www.dgidb.org/genes/hgnc:7027,,,10461.0,MERTK,9606,Homo sapiens (human),,,,,,,,
297,1440321,156333,Drug Gene Interaction database (DGIdb),Nemonapride,,MK-2461,https://www.dgidb.org/drugs/iuphar.ligand:7962,,FGFR1,https://www.dgidb.org/genes/hgnc:3688,,,2260.0,FGFR1,9606,Homo sapiens (human),,,,,,,,
298,1440322,156333,Drug Gene Interaction database (DGIdb),Nemonapride,,MK-2461,https://www.dgidb.org/drugs/iuphar.ligand:7962,,MET,https://www.dgidb.org/genes/hgnc:7029,,,4233.0,MET,9606,Homo sapiens (human),,,,,,,,
299,1440323,156413,Drug Gene Interaction database (DGIdb),Canertinib dihydrochloride,,CANERTINIB DIHYDROCHLORIDE,https://www.dgidb.org/drugs/ncit:C1880,,CXCL8,https://www.dgidb.org/genes/hgnc:6025,,,3576.0,CXCL8,9606,Homo sapiens (human),,,,,,,,
300,1440324,156413,Drug Gene Interaction database (DGIdb),Canertinib dihydrochloride,,CANERTINIB DIHYDROCHLORIDE,https://www.dgidb.org/drugs/ncit:C1880,,EGFR,https://www.dgidb.org/genes/hgnc:3236,,,1956.0,EGFR,9606,Homo sapiens (human),Inhibitor,,,,,,,
301,1440325,156413,ChEMBL,Canertinib dihydrochloride,CHEMBL545315,CANERTINIB DIHYDROCHLORIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL545315/,CHEMBL203,Epidermal growth factor receptor erbB1,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL203/,P00533,Epidermal growth factor receptor,1956.0,EGFR,9606,Homo sapiens (human),Epidermal growth factor receptor erbb1 inhibitor,,,PMID:12648472|PMID:11706399,https://www.ncbi.nlm.nih.gov/pubmed/12648472|https://www.ncbi.nlm.nih.gov/pubmed/11706399,12648472|11706399,,
302,1445935,157350,Comparative Toxicogenomics Database (CTD),Hydroxyl radical,D017665,Hydroxyl Radical,https://ctdbase.org/detail.go?type=chem&acc=D017665,100874203,COL4A2-AS1,https://ctdbase.org/detail.go?type=gene&acc=100874203,,,100874203.0,COL4A2-AS1,9606,Homo sapiens (human),[[hydroxyl radical results in increased oxidation of dimethylselenide] which results in decreased expression of COL4A2-AS1 mrna] which results in decreased expression of COL4A2 mrna|[hydroxyl radical results in increased oxidation of dimethylselenide] which results in decreased expression of COL4A2-AS1 mRNA,,,PMID:33656867,https://www.ncbi.nlm.nih.gov/pubmed/33656867,33656867,,
303,1445936,157350,Comparative Toxicogenomics Database (CTD),Hydroxyl radical,D017665,Hydroxyl Radical,https://ctdbase.org/detail.go?type=chem&acc=D017665,11151,CORO1A,https://ctdbase.org/detail.go?type=gene&acc=11151,,,11151.0,CORO1A,9606,Homo sapiens (human),[[hydroxyl radical results in increased oxidation of dimethylselenide] which results in decreased expression of CORO1A-AS1 mrna] which results in decreased expression of CORO1A mRNA,,,PMID:33656867,https://www.ncbi.nlm.nih.gov/pubmed/33656867,33656867,,
304,1445937,157350,Comparative Toxicogenomics Database (CTD),Hydroxyl radical,D017665,Hydroxyl Radical,https://ctdbase.org/detail.go?type=chem&acc=D017665,107984834,CORO1A-AS1,https://ctdbase.org/detail.go?type=gene&acc=107984834,,,107984834.0,CORO1A-AS1,9606,Homo sapiens (human),[[hydroxyl radical results in increased oxidation of dimethylselenide] which results in decreased expression of CORO1A-AS1 mrna] which results in decreased expression of CORO1A mrna|[hydroxyl radical results in increased oxidation of dimethylselenide] which results in decreased expression of CORO1A-AS1 mRNA,,,PMID:33656867,https://www.ncbi.nlm.nih.gov/pubmed/33656867,33656867,,
305,1445938,157350,Comparative Toxicogenomics Database (CTD),Hydroxyl radical,D017665,Hydroxyl Radical,https://ctdbase.org/detail.go?type=chem&acc=D017665,105376580,CSRP3-AS1,https://ctdbase.org/detail.go?type=gene&acc=105376580,,,105376580.0,CSRP3-AS1,9606,Homo sapiens (human),[hydroxyl radical results in increased oxidation of dimethylselenide] which results in increased expression of CSRP3-AS1 mrna|[[hydroxyl radical results in increased oxidation of dimethylselenide] which results in increased expression of CSRP3-AS1 mrna] which results in increased expression of E2F8 mRNA,,,PMID:33656867,https://www.ncbi.nlm.nih.gov/pubmed/33656867,33656867,,
306,1447727,159399,Toxin and Toxin Target Database (T3DB),Tricopper phosphide,T3D1203,Copper(I) phosphide,http://www.t3db.ca/toxins/T3D1203,BE0004990,"Cytochrome c oxidase subunit 7B2, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0004990,Q8TF08,"Cytochrome c oxidase subunit 7B2, mitochondrial",170712.0,COX7B2,9606,Homo sapiens (human),"Phosphine inhibits cytochrome c oxidase, preventing mitochondrial oxidative phosphorylation. this non-competitive inhibition prevents cellular respiration and leads to multi-organ dysfunction. (A291)",,,PMID:16615671,https://www.ncbi.nlm.nih.gov/pubmed/16615671,16615671,,
307,1447728,159399,Toxin and Toxin Target Database (T3DB),Tricopper phosphide,T3D1203,Copper(I) phosphide,http://www.t3db.ca/toxins/T3D1203,BE0003992,"Cytochrome c oxidase subunit 7C, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0003992,P15954,"Cytochrome c oxidase subunit 7C, mitochondrial",1350.0,COX7C,9606,Homo sapiens (human),"Phosphine inhibits cytochrome c oxidase, preventing mitochondrial oxidative phosphorylation. this non-competitive inhibition prevents cellular respiration and leads to multi-organ dysfunction. (A291)",,,PMID:16615671,https://www.ncbi.nlm.nih.gov/pubmed/16615671,16615671,,
308,1447729,159399,Toxin and Toxin Target Database (T3DB),Tricopper phosphide,T3D1203,Copper(I) phosphide,http://www.t3db.ca/toxins/T3D1203,BE0003993,"Cytochrome c oxidase subunit 8A, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0003993,P10176,"Cytochrome c oxidase subunit 8A, mitochondrial",1351.0,COX8A,9606,Homo sapiens (human),"Phosphine inhibits cytochrome c oxidase, preventing mitochondrial oxidative phosphorylation. this non-competitive inhibition prevents cellular respiration and leads to multi-organ dysfunction. (A291)",,,PMID:16615671,https://www.ncbi.nlm.nih.gov/pubmed/16615671,16615671,,
309,1447730,159399,Toxin and Toxin Target Database (T3DB),Tricopper phosphide,T3D1203,Copper(I) phosphide,http://www.t3db.ca/toxins/T3D1203,BE0005022,"Cytochrome c oxidase subunit 8C, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0005022,Q7Z4L0,"Cytochrome c oxidase subunit 8C, mitochondrial",341947.0,COX8C,9606,Homo sapiens (human),"Phosphine inhibits cytochrome c oxidase, preventing mitochondrial oxidative phosphorylation. this non-competitive inhibition prevents cellular respiration and leads to multi-organ dysfunction. (A291)",,,PMID:16615671,https://www.ncbi.nlm.nih.gov/pubmed/16615671,16615671,,
310,1447731,159399,Toxin and Toxin Target Database (T3DB),Tricopper phosphide,T3D1203,Copper(I) phosphide,http://www.t3db.ca/toxins/T3D1203,BE0005082,"Putative cytochrome c oxidase subunit 7A3, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0005082,O60397,"Putative cytochrome c oxidase subunit 7A3, mitochondrial",,,9606,Homo sapiens (human),"Phosphine inhibits cytochrome c oxidase, preventing mitochondrial oxidative phosphorylation. this non-competitive inhibition prevents cellular respiration and leads to multi-organ dysfunction. (A291)",,,PMID:16615671,https://www.ncbi.nlm.nih.gov/pubmed/16615671,16615671,,
311,1448604,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,342132,ZNF774,https://ctdbase.org/detail.go?type=gene&acc=342132,,,342132.0,ZNF774,9606,Homo sapiens (human),Abrine results in increased expression of ZNF774 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
312,1448605,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,285971,ZNF775,https://ctdbase.org/detail.go?type=gene&acc=285971,,,285971.0,ZNF775,9606,Homo sapiens (human),Abrine results in increased expression of ZNF775 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
313,1448606,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,284309,ZNF776,https://ctdbase.org/detail.go?type=gene&acc=284309,,,284309.0,ZNF776,9606,Homo sapiens (human),Abrine results in increased expression of ZNF776 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
314,1448607,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,27153,ZNF777,https://ctdbase.org/detail.go?type=gene&acc=27153,,,27153.0,ZNF777,9606,Homo sapiens (human),Abrine results in increased expression of ZNF777 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
315,1445791,164448,Comparative Toxicogenomics Database (CTD),"Monoisoamyl-2,3-dimercaptosuccinate",C091888,"monoisoamyl-2,3-dimercaptosuccinate",https://ctdbase.org/detail.go?type=chem&acc=C091888,947,CD34,https://ctdbase.org/detail.go?type=gene&acc=947,,,947.0,CD34,9606,Homo sapiens (human),"Monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of CD34 mrna]",,,PMID:19615344,https://www.ncbi.nlm.nih.gov/pubmed/19615344,19615344,,
316,1445792,164448,Comparative Toxicogenomics Database (CTD),"Monoisoamyl-2,3-dimercaptosuccinate",C091888,"monoisoamyl-2,3-dimercaptosuccinate",https://ctdbase.org/detail.go?type=chem&acc=C091888,928,CD9,https://ctdbase.org/detail.go?type=gene&acc=928,,,928.0,CD9,9606,Homo sapiens (human),"Monoisoamyl-2,3-dimercaptosuccinate results in increased expression of CD9 mRNA",,,PMID:19615344,https://www.ncbi.nlm.nih.gov/pubmed/19615344,19615344,,
317,1447440,166888,Toxin and Toxin Target Database (T3DB),Vanadium trisulfate,T3D1635,Vanadium(III) sulfate,http://www.t3db.ca/toxins/T3D1635,BE0005034,Sodium/potassium-transporting ATPase subunit alpha-2,http://www.t3db.ca/biodb/bio_entities/BE0005034,P50993,Sodium/potassium-transporting ATPase subunit alpha-2,477.0,ATP1A2,9606,Homo sapiens (human),"The pentavalent form of vanadium, vanadate, is a potent inhibitor of the ca+-atpase and na+,k+-atpase of plasma membranes, which decreases intracellular ATP concentration. (L837, A250)",,,PMID:18319605,https://www.ncbi.nlm.nih.gov/pubmed/18319605,18319605,,
318,1447441,166888,Toxin and Toxin Target Database (T3DB),Vanadium trisulfate,T3D1635,Vanadium(III) sulfate,http://www.t3db.ca/toxins/T3D1635,BE0005047,Sodium/potassium-transporting ATPase subunit alpha-3,http://www.t3db.ca/biodb/bio_entities/BE0005047,P13637,Sodium/potassium-transporting ATPase subunit alpha-3,478.0,ATP1A3,9606,Homo sapiens (human),"The pentavalent form of vanadium, vanadate, is a potent inhibitor of the ca+-atpase and na+,k+-atpase of plasma membranes, which decreases intracellular ATP concentration. (L837, A250)",,,PMID:18319605,https://www.ncbi.nlm.nih.gov/pubmed/18319605,18319605,,
319,1447442,166888,Toxin and Toxin Target Database (T3DB),Vanadium trisulfate,T3D1635,Vanadium(III) sulfate,http://www.t3db.ca/toxins/T3D1635,BE0005031,Sodium/potassium-transporting ATPase subunit alpha-4,http://www.t3db.ca/biodb/bio_entities/BE0005031,Q13733,Sodium/potassium-transporting ATPase subunit alpha-4,480.0,ATP1A4,9606,Homo sapiens (human),"The pentavalent form of vanadium, vanadate, is a potent inhibitor of the ca+-atpase and na+,k+-atpase of plasma membranes, which decreases intracellular ATP concentration. (L837, A250)",,,PMID:18319605,https://www.ncbi.nlm.nih.gov/pubmed/18319605,18319605,,
320,1447443,166888,Toxin and Toxin Target Database (T3DB),Vanadium trisulfate,T3D1635,Vanadium(III) sulfate,http://www.t3db.ca/toxins/T3D1635,BE0004994,Sodium/potassium-transporting ATPase subunit beta-1,http://www.t3db.ca/biodb/bio_entities/BE0004994,P05026,Sodium/potassium-transporting ATPase subunit beta-1,481.0,ATP1B1,9606,Homo sapiens (human),"The pentavalent form of vanadium, vanadate, is a potent inhibitor of the ca+-atpase and na+,k+-atpase of plasma membranes, which decreases intracellular ATP concentration. (L837, A250)",,,PMID:18319605,https://www.ncbi.nlm.nih.gov/pubmed/18319605,18319605,,
321,1443061,168971,Comparative Toxicogenomics Database (CTD),beta-Solamarine,C026609,beta-solamarine,https://ctdbase.org/detail.go?type=chem&acc=C026609,8772,FADD,https://ctdbase.org/detail.go?type=gene&acc=8772,,,8772.0,FADD,9606,Homo sapiens (human),Beta-solamarine results in increased expression of FADD protein,,,PMID:17619073,https://www.ncbi.nlm.nih.gov/pubmed/17619073,17619073,,
322,1443062,168971,Comparative Toxicogenomics Database (CTD),beta-Solamarine,C026609,beta-solamarine,https://ctdbase.org/detail.go?type=chem&acc=C026609,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355.0,FAS,9606,Homo sapiens (human),Beta-solamarine results in increased expression of FAS protein,,,PMID:17619073,https://www.ncbi.nlm.nih.gov/pubmed/17619073,17619073,,
323,1443063,168971,Comparative Toxicogenomics Database (CTD),beta-Solamarine,C026609,beta-solamarine,https://ctdbase.org/detail.go?type=chem&acc=C026609,7132,TNFRSF1A,https://ctdbase.org/detail.go?type=gene&acc=7132,,,7132.0,TNFRSF1A,9606,Homo sapiens (human),Beta-solamarine results in increased expression of TNFRSF1A protein,,,PMID:17619073,https://www.ncbi.nlm.nih.gov/pubmed/17619073,17619073,,
324,1443064,168971,Comparative Toxicogenomics Database (CTD),beta-Solamarine,C026609,beta-solamarine,https://ctdbase.org/detail.go?type=chem&acc=C026609,8717,TRADD,https://ctdbase.org/detail.go?type=gene&acc=8717,,,8717.0,TRADD,9606,Homo sapiens (human),Beta-solamarine results in increased expression of TRADD protein,,,PMID:17619073,https://www.ncbi.nlm.nih.gov/pubmed/17619073,17619073,,
325,1443065,169017,Comparative Toxicogenomics Database (CTD),Erysodine,C097135,erysodine,https://ctdbase.org/detail.go?type=chem&acc=C097135,590,BCHE,https://ctdbase.org/detail.go?type=gene&acc=590,,,590.0,BCHE,9606,Homo sapiens (human),Erysodine binds to BCHE protein,,,PMID:34532215,https://www.ncbi.nlm.nih.gov/pubmed/34532215,34532215,,
326,1443066,169132,Toxin and Toxin Target Database (T3DB),Isophorone diisocyanate,T3D1662,Isophorone diisocyanate,http://www.t3db.ca/toxins/T3D1662,BE0000896,"Alkaline phosphatase, placental-like",http://www.t3db.ca/biodb/bio_entities/BE0000896,P10696,"Alkaline phosphatase, germ cell type",251.0,ALPG,9606,Homo sapiens (human),Cyanide inhibits alkaline phosphatases. (A73),,,PMID:924371,https://www.ncbi.nlm.nih.gov/pubmed/924371,924371,,
327,1443067,169132,Toxin and Toxin Target Database (T3DB),Isophorone diisocyanate,T3D1662,Isophorone diisocyanate,http://www.t3db.ca/toxins/T3D1662,BE0003546,"Alkaline phosphatase, tissue-nonspecific isozyme",http://www.t3db.ca/biodb/bio_entities/BE0003546,P05186,"Alkaline phosphatase, tissue-nonspecific isozyme",249.0,ALPL,9606,Homo sapiens (human),Cyanide inhibits alkaline phosphatases. (A73),,,PMID:924371,https://www.ncbi.nlm.nih.gov/pubmed/924371,924371,,
328,1439788,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,13107,CYP2F2,https://ctdbase.org/detail.go?type=gene&acc=13107,,,13107.0,Cyp2f2,10090,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of CYP2F2 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
329,1439789,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,313373,CYP2J10,https://ctdbase.org/detail.go?type=gene&acc=313373,,,313373.0,Cyp2j10,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of CYP2J10 mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
330,1446205,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9889,ZBED4,https://ctdbase.org/detail.go?type=gene&acc=9889,,,9889.0,ZBED4,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ZBED4 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
331,1446206,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,58486,ZBED5,https://ctdbase.org/detail.go?type=gene&acc=58486,,,58486.0,ZBED5,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ZBED5 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
332,1446207,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,100381270,ZBED6,https://ctdbase.org/detail.go?type=gene&acc=100381270,,,100381270.0,ZBED6,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of ZBED6 mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
333,1446208,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,81030,ZBP1,https://ctdbase.org/detail.go?type=gene&acc=81030,,,81030.0,ZBP1,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ZBP1 intron|aflatoxin B1 results in decreased methylation of ZBP1 polya tail,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
334,1446209,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,81030,ZBP1,https://ctdbase.org/detail.go?type=gene&acc=81030,,,81030.0,ZBP1,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ZBP1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
335,1446210,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,81030,ZBP1,https://ctdbase.org/detail.go?type=gene&acc=81030,,,81030.0,ZBP1,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of ZBP1 mRNA,,,PMID:25378103,https://www.ncbi.nlm.nih.gov/pubmed/25378103,25378103,,
336,1446211,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,22890,ZBTB1,https://ctdbase.org/detail.go?type=gene&acc=22890,,,22890.0,ZBTB1,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ZBTB1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
337,1446212,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,65986,ZBTB10,https://ctdbase.org/detail.go?type=gene&acc=65986,,,65986.0,ZBTB10,9606,Homo sapiens (human),Aflatoxin B1 affects the expression of ZBTB10 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
338,1446689,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,653121,ZBTB8A,https://ctdbase.org/detail.go?type=gene&acc=653121,,,653121.0,ZBTB8A,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ZBTB8A intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
339,1446690,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,728116,ZBTB8B,https://ctdbase.org/detail.go?type=gene&acc=728116,,,728116.0,ZBTB8B,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ZBTB8B gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
340,1448430,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,284406,ZFP82,https://ctdbase.org/detail.go?type=gene&acc=284406,,,284406.0,ZFP82,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of ZFP82 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
341,1440742,213037,Drug Gene Interaction database (DGIdb),Ataciguat,,ATACIGUAT,https://www.dgidb.org/drugs/ncit:C79587,,GUCY1A1,https://www.dgidb.org/genes/hgnc:4685,,,2982.0,GUCY1A1,9606,Homo sapiens (human),Activator,,,,,,,
342,1441501,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,140766,ADAMTS14,https://ctdbase.org/detail.go?type=gene&acc=140766,,,140766.0,ADAMTS14,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of ADAMTS14 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
343,1441502,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,170689,ADAMTS15,https://ctdbase.org/detail.go?type=gene&acc=170689,,,170689.0,ADAMTS15,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of ADAMTS15 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
344,1441503,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,9509,ADAMTS2,https://ctdbase.org/detail.go?type=gene&acc=9509,,,9509.0,ADAMTS2,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of ADAMTS2 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
345,1441504,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,9507,ADAMTS4,https://ctdbase.org/detail.go?type=gene&acc=9507,,,9507.0,ADAMTS4,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of ADAMTS4 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
346,1441505,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,11096,ADAMTS5,https://ctdbase.org/detail.go?type=gene&acc=11096,,,11096.0,ADAMTS5,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of ADAMTS5 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
347,1441506,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,11174,ADAMTS6,https://ctdbase.org/detail.go?type=gene&acc=11174,,,11174.0,ADAMTS6,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of ADAMTS6 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
348,1441507,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,55803,ADAP2,https://ctdbase.org/detail.go?type=gene&acc=55803,,,55803.0,ADAP2,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of ADAP2 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
349,1442235,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,344905,ATP13A5,https://ctdbase.org/detail.go?type=gene&acc=344905,,,344905.0,ATP13A5,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in decreased expression of ATP13A5 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
350,1442236,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,476,ATP1A1,https://ctdbase.org/detail.go?type=gene&acc=476,,,476.0,ATP1A1,10116,Rattus norvegicus (Norway rat),Estradiol 3-benzoate results in increased expression of and results in increased activity of ATP1A1 protein,,,PMID:22759964,https://www.ncbi.nlm.nih.gov/pubmed/22759964,22759964,,
351,1442237,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,51761,ATP8A2,https://ctdbase.org/detail.go?type=gene&acc=51761,,,51761.0,ATP8A2,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in decreased expression of ATP8A2 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
352,1442238,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,79895,ATP8B4,https://ctdbase.org/detail.go?type=gene&acc=79895,,,79895.0,ATP8B4,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of ATP8B4 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
353,1442239,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,551,AVP,https://ctdbase.org/detail.go?type=gene&acc=551,,,551.0,AVP,93934,Coturnix japonica (Japanese quail),Tamoxifen inhibits the reaction [estradiol 3-benzoate results in increased expression of AVP protein]|estradiol 3-benzoate results in increased expression of AVP protein,,,PMID:20170655,https://www.ncbi.nlm.nih.gov/pubmed/20170655,20170655,,
354,1442240,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,553,AVPR1B,https://ctdbase.org/detail.go?type=gene&acc=553,,,553.0,AVPR1B,93934,Coturnix japonica (Japanese quail),Estradiol 3-benzoate results in increased expression of AVPR1B mrna|tamoxifen inhibits the reaction [estradiol 3-benzoate results in increased expression of AVPR1B mrna],,,PMID:20170655,https://www.ncbi.nlm.nih.gov/pubmed/20170655,20170655,,
355,1442364,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of BAX mrna]|estradiol 3-benzoate results in increased expression of BAX protein|quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of BAX protein]|estradiol 3-benzoate results in increased expression of BAX mRNA,,,PMID:24316378,https://www.ncbi.nlm.nih.gov/pubmed/24316378,24316378,,
356,1442365,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of BCL2 protein]|estradiol 3-benzoate results in increased expression of BCL2 mrna|estradiol 3-benzoate results in increased expression of BCL2 protein|quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of BCL2 mrna],,,PMID:24316378,https://www.ncbi.nlm.nih.gov/pubmed/24316378,24316378,,
357,1442366,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,10116,Rattus norvegicus (Norway rat),Estradiol 3-benzoate affects the expression of BCL2L1 mRNA,,,PMID:15664431,https://www.ncbi.nlm.nih.gov/pubmed/15664431,15664431,,
358,1442367,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,602,BCL3,https://ctdbase.org/detail.go?type=gene&acc=602,,,602.0,BCL3,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of BCL3 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
359,1442488,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,330,BIRC3,https://ctdbase.org/detail.go?type=gene&acc=330,,,330.0,BIRC3,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of BIRC3 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
360,1442489,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,89927,BMERB1,https://ctdbase.org/detail.go?type=gene&acc=89927,,,89927.0,BMERB1,10116,Rattus norvegicus (Norway rat),Estradiol 3-benzoate results in increased expression of BMERB1 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
361,1442490,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,655,BMP7,https://ctdbase.org/detail.go?type=gene&acc=655,,,655.0,BMP7,10116,Rattus norvegicus (Norway rat),Estradiol 3-benzoate results in decreased expression of BMP7 mrna|[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in decreased expression of BMP7 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
362,1442491,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,168667,BMPER,https://ctdbase.org/detail.go?type=gene&acc=168667,,,168667.0,BMPER,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of BMPER mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
363,1442492,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,339479,BRINP3,https://ctdbase.org/detail.go?type=gene&acc=339479,,,339479.0,BRINP3,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of BRINP3 mrna|estradiol 3-benzoate results in increased expression of BRINP3 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
364,1444366,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,63967,CLSPN,https://ctdbase.org/detail.go?type=gene&acc=63967,,,63967.0,CLSPN,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CLSPN mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
365,1444367,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,57393,CLTRN,https://ctdbase.org/detail.go?type=gene&acc=57393,,,57393.0,CLTRN,10116,Rattus norvegicus (Norway rat),Estradiol 3-benzoate results in increased methylation of CLTRN promoter,,,PMID:27415467,https://www.ncbi.nlm.nih.gov/pubmed/27415467,27415467,,
366,1444368,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,1191,CLU,https://ctdbase.org/detail.go?type=gene&acc=1191,,,1191.0,CLU,10116,Rattus norvegicus (Norway rat),Estradiol 3-benzoate affects the expression of CLU mRNA,,,PMID:15925091,https://www.ncbi.nlm.nih.gov/pubmed/15925091,15925091,,
367,1444369,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,79645,CLXN,https://ctdbase.org/detail.go?type=gene&acc=79645,,,79645.0,CLXN,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CLXN mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
368,1444370,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,134147,CMBL,https://ctdbase.org/detail.go?type=gene&acc=134147,,,134147.0,CMBL,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in decreased expression of CMBL mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
369,1444371,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,1240,CMKLR1,https://ctdbase.org/detail.go?type=gene&acc=1240,,,1240.0,CMKLR1,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CMKLR1 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
370,1444864,222757,Comparative Toxicogenomics Database (CTD),Estradiol Benzoate,C074283,estradiol 3-benzoate,https://ctdbase.org/detail.go?type=chem&acc=C074283,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of CXCL2 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
371,1445612,232446,Comparative Toxicogenomics Database (CTD),"1,1-Bis(4-hydroxyphenyl)cyclohexane",C517113,"1,1-bis(4-hydroxyphenyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517113,6782,HSPA13,https://ctdbase.org/detail.go?type=gene&acc=6782,,,6782.0,HSPA13,9606,Homo sapiens (human),"1,1-bis(4-hydroxyphenyl)cyclohexane results in increased expression of HSPA13 mRNA",,,PMID:32387340,https://www.ncbi.nlm.nih.gov/pubmed/32387340,32387340,,
372,1446054,232446,Comparative Toxicogenomics Database (CTD),"1,1-Bis(4-hydroxyphenyl)cyclohexane",C517113,"1,1-bis(4-hydroxyphenyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517113,8140,SLC7A5,https://ctdbase.org/detail.go?type=gene&acc=8140,,,8140.0,SLC7A5,9606,Homo sapiens (human),"1,1-bis(4-hydroxyphenyl)cyclohexane results in increased expression of SLC7A5 mRNA",,,PMID:32387340,https://www.ncbi.nlm.nih.gov/pubmed/32387340,32387340,,
373,1446055,232446,Comparative Toxicogenomics Database (CTD),"1,1-Bis(4-hydroxyphenyl)cyclohexane",C517113,"1,1-bis(4-hydroxyphenyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517113,780851,SNORD3A,https://ctdbase.org/detail.go?type=gene&acc=780851,,,780851.0,SNORD3A,9606,Homo sapiens (human),"1,1-bis(4-hydroxyphenyl)cyclohexane results in increased expression of SNORD3A mRNA",,,PMID:32387340,https://www.ncbi.nlm.nih.gov/pubmed/32387340,32387340,,
374,1446056,232446,Comparative Toxicogenomics Database (CTD),"1,1-Bis(4-hydroxyphenyl)cyclohexane",C517113,"1,1-bis(4-hydroxyphenyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517113,6781,STC1,https://ctdbase.org/detail.go?type=gene&acc=6781,,,6781.0,STC1,9606,Homo sapiens (human),"1,1-bis(4-hydroxyphenyl)cyclohexane results in increased expression of STC1 mRNA",,,PMID:28591870,https://www.ncbi.nlm.nih.gov/pubmed/28591870,28591870,,
375,1446057,232446,Comparative Toxicogenomics Database (CTD),"1,1-Bis(4-hydroxyphenyl)cyclohexane",C517113,"1,1-bis(4-hydroxyphenyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517113,8614,STC2,https://ctdbase.org/detail.go?type=gene&acc=8614,,,8614.0,STC2,9606,Homo sapiens (human),"1,1-bis(4-hydroxyphenyl)cyclohexane results in increased expression of STC2 mRNA",,,PMID:32387340,https://www.ncbi.nlm.nih.gov/pubmed/32387340,32387340,,
376,1446058,232446,Comparative Toxicogenomics Database (CTD),"1,1-Bis(4-hydroxyphenyl)cyclohexane",C517113,"1,1-bis(4-hydroxyphenyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517113,7035,TFPI,https://ctdbase.org/detail.go?type=gene&acc=7035,,,7035.0,TFPI,9606,Homo sapiens (human),"1,1-bis(4-hydroxyphenyl)cyclohexane results in decreased expression of TFPI mRNA",,,PMID:28591870,https://www.ncbi.nlm.nih.gov/pubmed/28591870,28591870,,
377,1446059,232446,Comparative Toxicogenomics Database (CTD),"1,1-Bis(4-hydroxyphenyl)cyclohexane",C517113,"1,1-bis(4-hydroxyphenyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517113,7067,THRA,https://ctdbase.org/detail.go?type=gene&acc=7067,,,7067.0,THRA,10116,Rattus norvegicus (Norway rat),"1,1-bis(4-hydroxyphenyl)cyclohexane results in decreased expression of THRA mRNA",,,PMID:28167136,https://www.ncbi.nlm.nih.gov/pubmed/28167136,28167136,,
378,1446060,232446,Comparative Toxicogenomics Database (CTD),"1,1-Bis(4-hydroxyphenyl)cyclohexane",C517113,"1,1-bis(4-hydroxyphenyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517113,7068,THRB,https://ctdbase.org/detail.go?type=gene&acc=7068,,,7068.0,THRB,10116,Rattus norvegicus (Norway rat),"1,1-bis(4-hydroxyphenyl)cyclohexane results in decreased expression of THRB mRNA",,,PMID:28167136,https://www.ncbi.nlm.nih.gov/pubmed/28167136,28167136,,
379,1446061,232446,Comparative Toxicogenomics Database (CTD),"1,1-Bis(4-hydroxyphenyl)cyclohexane",C517113,"1,1-bis(4-hydroxyphenyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517113,7069,THRSP,https://ctdbase.org/detail.go?type=gene&acc=7069,,,7069.0,THRSP,9031,Gallus gallus (chicken),"1,1-bis(4-hydroxyphenyl)cyclohexane results in decreased expression of THRSP mRNA",,,PMID:33683738,https://www.ncbi.nlm.nih.gov/pubmed/33683738,33683738,,
380,1446062,232446,Comparative Toxicogenomics Database (CTD),"1,1-Bis(4-hydroxyphenyl)cyclohexane",C517113,"1,1-bis(4-hydroxyphenyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517113,388564,TMEM238,https://ctdbase.org/detail.go?type=gene&acc=388564,,,388564.0,TMEM238,9606,Homo sapiens (human),"1,1-bis(4-hydroxyphenyl)cyclohexane results in decreased expression of TMEM238 mRNA",,,PMID:32387340,https://www.ncbi.nlm.nih.gov/pubmed/32387340,32387340,,
381,1446063,232446,Comparative Toxicogenomics Database (CTD),"1,1-Bis(4-hydroxyphenyl)cyclohexane",C517113,"1,1-bis(4-hydroxyphenyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517113,7252,TSHB,https://ctdbase.org/detail.go?type=gene&acc=7252,,,7252.0,TSHB,7955,Danio rerio (zebrafish),"1,1-bis(4-hydroxyphenyl)cyclohexane results in increased expression of TSHB mRNA",,,PMID:30639807,https://www.ncbi.nlm.nih.gov/pubmed/30639807,30639807,,
382,1440733,236702,DrugBank,Dexamethasone acetate,DB14649,Dexamethasone acetate,https://www.drugbank.ca/drugs/DB14649,BE0001069,Canalicular multispecific organic anion transporter 1,https://www.drugbank.ca/bio_entities/BE0001069,Q92887,Canalicular multispecific organic anion transporter 1,1244.0,ABCC2,9606,Homo sapiens (human),Inducer,,,PMID:9929003|PMID:11323161,https://www.ncbi.nlm.nih.gov/pubmed/9929003|https://www.ncbi.nlm.nih.gov/pubmed/11323161,9929003|11323161,,
383,1440734,236702,DrugBank,Dexamethasone acetate,DB14649,Dexamethasone acetate,https://www.drugbank.ca/drugs/DB14649,BE0003642,Solute carrier organic anion transporter family member 1A2,https://www.drugbank.ca/bio_entities/BE0003642,P46721,Solute carrier organic anion transporter family member 1A2,6579.0,SLCO1A2,9606,Homo sapiens (human),Inhibitor,,,PMID:9539145|PMID:8786566,https://www.ncbi.nlm.nih.gov/pubmed/9539145|https://www.ncbi.nlm.nih.gov/pubmed/8786566,9539145|8786566,,
384,1440735,236702,DrugBank,Dexamethasone acetate,DB14649,Dexamethasone acetate,https://www.drugbank.ca/drugs/DB14649,BE0001067,ATP-binding cassette sub-family G member 2,https://www.drugbank.ca/bio_entities/BE0001067,Q9UNQ0,Broad substrate specificity ATP-binding cassette transporter ABCG2,9429.0,ABCG2,9606,Homo sapiens (human),Inhibitor,,,PMID:20307139,https://www.ncbi.nlm.nih.gov/pubmed/20307139,20307139,,
385,1440736,236702,DrugBank,Dexamethasone acetate,DB14649,Dexamethasone acetate,https://www.drugbank.ca/drugs/DB14649,BE0003645,Solute carrier family 22 member 8,https://www.drugbank.ca/bio_entities/BE0003645,Q8TCC7,Solute carrier family 22 member 8,9376.0,SLC22A8,9606,Homo sapiens (human),Substrate,,,PMID:19953504,https://www.ncbi.nlm.nih.gov/pubmed/19953504,19953504,,
386,1440737,236702,DrugBank,Dexamethasone acetate,DB14649,Dexamethasone acetate,https://www.drugbank.ca/drugs/DB14649,BE0000530,Serum albumin,https://www.drugbank.ca/bio_entities/BE0000530,P02768,Albumin,213.0,ALB,9606,Homo sapiens (human),Binder,,,PMID:2316228,https://www.ncbi.nlm.nih.gov/pubmed/2316228,2316228,,
387,1440738,241060,BindingDB,"2,2'-Methylenebis(4-t-butylphenol)",34131,"2,2-methanediylbis(4-tert-butylphenol), 5a",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=34131,50003506,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50003506,P04191,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,100037716.0,ATP2A1,9986,Oryctolagus cuniculus (rabbit),,IC50 (nM),11800,PMID:19117760|DOI:10.1016/j.bmc.2008.12.010,https://www.ncbi.nlm.nih.gov/pubmed/19117760|https://doi.org/10.1016/j.bmc.2008.12.010,19117760,10.1016/j.bmc.2008.12.010,
388,1440739,242777,Comparative Toxicogenomics Database (CTD),"Benzothiazole, 2-(methylsulfonyl)-",C576094,methylsulfonyl benzothiazole,https://ctdbase.org/detail.go?type=chem&acc=C576094,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9606,Homo sapiens (human),Methylsulfonyl benzothiazole binds to ALB protein,,,PMID:26675335,https://www.ncbi.nlm.nih.gov/pubmed/26675335,26675335,,
389,1440740,242777,Comparative Toxicogenomics Database (CTD),"Benzothiazole, 2-(methylsulfonyl)-",C576094,methylsulfonyl benzothiazole,https://ctdbase.org/detail.go?type=chem&acc=C576094,695,BTK,https://ctdbase.org/detail.go?type=gene&acc=695,,,695.0,BTK,9606,Homo sapiens (human),Methylsulfonyl benzothiazole binds to BTK protein,,,PMID:26675335,https://www.ncbi.nlm.nih.gov/pubmed/26675335,26675335,,
390,1440741,242777,Comparative Toxicogenomics Database (CTD),"Benzothiazole, 2-(methylsulfonyl)-",C576094,methylsulfonyl benzothiazole,https://ctdbase.org/detail.go?type=chem&acc=C576094,3043,HBB,https://ctdbase.org/detail.go?type=gene&acc=3043,,,3043.0,HBB,9606,Homo sapiens (human),Methylsulfonyl benzothiazole binds to HBB protein,,,PMID:26675335,https://www.ncbi.nlm.nih.gov/pubmed/26675335,26675335,,
391,1440848,243274,Drug Gene Interaction database (DGIdb),"Ethyl 2-cyano-3,3-diphenylacrylate",,ETOCRYLENE,https://www.dgidb.org/drugs/ncit:C80797,,AR,https://www.dgidb.org/genes/hgnc:644,,,367.0,AR,9606,Homo sapiens (human),,,,,,,,
392,1440849,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,22848,AAK1,https://ctdbase.org/detail.go?type=gene&acc=22848,,,22848.0,AAK1,10116,Rattus norvegicus (Norway rat),Aconitine results in increased expression of AAK1 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
393,1440850,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,57505,AARS2,https://ctdbase.org/detail.go?type=gene&acc=57505,,,57505.0,AARS2,10116,Rattus norvegicus (Norway rat),Aconitine results in increased expression of AARS2 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
394,1440851,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606,Homo sapiens (human),ABCB1 affects the transport of aconitine|abcb1 results in decreased susceptibility to aconitine,,,PMID:23562926,https://www.ncbi.nlm.nih.gov/pubmed/23562926,23562926,,
395,1440977,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,141,ADPRH,https://ctdbase.org/detail.go?type=gene&acc=141,,,141.0,ADPRH,10116,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of ADPRH protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
396,1440978,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,26523,AGO1,https://ctdbase.org/detail.go?type=gene&acc=26523,,,26523.0,AGO1,10116,Rattus norvegicus (Norway rat),Aconitine results in increased expression of AGO1 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
397,1440979,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,56894,AGPAT3,https://ctdbase.org/detail.go?type=gene&acc=56894,,,56894.0,AGPAT3,10116,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of AGPAT3 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
398,1440980,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,199,AIF1,https://ctdbase.org/detail.go?type=gene&acc=199,,,199.0,AIF1,10116,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of AIF1 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
399,1440981,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,7965,AIMP2,https://ctdbase.org/detail.go?type=gene&acc=7965,,,7965.0,AIMP2,10116,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of AIMP2 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
400,1440982,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,210,ALAD,https://ctdbase.org/detail.go?type=gene&acc=210,,,210.0,ALAD,10116,Rattus norvegicus (Norway rat),Aconitine results in increased expression of ALAD protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
401,1440983,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,224,ALDH3A2,https://ctdbase.org/detail.go?type=gene&acc=224,,,224.0,ALDH3A2,10116,Rattus norvegicus (Norway rat),Aconitine results in increased expression of ALDH3A2 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
402,1441508,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,570772,BCL2A,https://ctdbase.org/detail.go?type=gene&acc=570772,,,570772.0,bcl2a,7955,Danio rerio (zebrafish),Aconitine affects the expression of BCL2A mRNA,,,PMID:31975431,https://www.ncbi.nlm.nih.gov/pubmed/31975431,31975431,,
403,1441509,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,274,BIN1,https://ctdbase.org/detail.go?type=gene&acc=274,,,274.0,BIN1,10116,Rattus norvegicus (Norway rat),Aconitine results in increased expression of BIN1 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
404,1441510,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,148362,BROX,https://ctdbase.org/detail.go?type=gene&acc=148362,,,148362.0,BROX,10116,Rattus norvegicus (Norway rat),Aconitine results in increased expression of BROX protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
405,1441511,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,684,BST2,https://ctdbase.org/detail.go?type=gene&acc=684,,,684.0,BST2,10116,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of BST2 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
406,1441634,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,775,CACNA1C,https://ctdbase.org/detail.go?type=gene&acc=775,,,775.0,CACNA1C,10116,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of CACNA1C protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
407,1441635,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,783,CACNB2,https://ctdbase.org/detail.go?type=gene&acc=783,,,783.0,CACNB2,10116,Rattus norvegicus (Norway rat),Aconitine results in increased expression of CACNB2 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
408,1441636,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,8536,CAMK1,https://ctdbase.org/detail.go?type=gene&acc=8536,,,8536.0,CAMK1,10116,Rattus norvegicus (Norway rat),Aconitine results in increased expression of CAMK1 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
409,1441637,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,84270,CARD19,https://ctdbase.org/detail.go?type=gene&acc=84270,,,84270.0,CARD19,10116,Rattus norvegicus (Norway rat),Aconitine results in increased expression of CARD19 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
410,1441638,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,834,CASP1,https://ctdbase.org/detail.go?type=gene&acc=834,,,834.0,CASP1,10090,Mus musculus (house mouse),Aconitine results in increased expression of CASP1 protein|nod2 protein affects the reaction [aconitine results in increased expression of CASP1 protein]|nlrp3 protein affects the reaction [aconitine results in increased expression of CASP1 protein]|nod1 protein affects the reaction [aconitine results in increased expression of CASP1 protein],,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
411,1441639,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090,Mus musculus (house mouse),[aconitine co-treated with ruthenium red] results in increased cleavage of CASP3 protein|[aconitine co-treated with spermine] results in increased cleavage of CASP3 protein|aconitine results in increased cleavage of CASP3 protein,,,PMID:37506855,https://www.ncbi.nlm.nih.gov/pubmed/37506855,37506855,,
412,1441640,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),Aconitine results in increased expression of CASP3 protein,,,PMID:24840785|PMID:31975431,https://www.ncbi.nlm.nih.gov/pubmed/24840785|https://www.ncbi.nlm.nih.gov/pubmed/31975431,24840785|31975431,,
413,1441641,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,140621,CASP3A,https://ctdbase.org/detail.go?type=gene&acc=140621,,,140621.0,casp3a,7955,Danio rerio (zebrafish),Aconitine affects the expression of CASP3A mRNA,,,PMID:31975431,https://www.ncbi.nlm.nih.gov/pubmed/31975431,31975431,,
414,1442241,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,1559,CYP2C9,https://ctdbase.org/detail.go?type=gene&acc=1559,,,1559.0,CYP2C9,9606,Homo sapiens (human),[amiodarone results in decreased activity of CYP2C9 protein] which results in decreased chemical synthesis of aconitine metabolite|[cyp2c9 protein results in increased metabolism of aconitine] which results in increased chemical synthesis of 16-O-demethylaconitine|cyp2c9 protein results in increased metabolism of aconitine,,,PMID:21277363,https://www.ncbi.nlm.nih.gov/pubmed/21277363,21277363,,
415,1442242,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,1565,CYP2D6,https://ctdbase.org/detail.go?type=gene&acc=1565,,,1565.0,CYP2D6,9606,Homo sapiens (human),CYP2D6 protein results in increased metabolism of aconitine|[cyp2d6 protein results in increased metabolism of aconitine] which results in increased chemical synthesis of 16-O-demethylaconitine|[quinidine results in decreased activity of CYP2D6 protein] which results in decreased chemical synthesis of aconitine metabolite,,,PMID:21277363,https://www.ncbi.nlm.nih.gov/pubmed/21277363,21277363,,
416,1442243,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606,Homo sapiens (human),[aconitine co-treated with mesaconitine co-treated with hypaconitine] results in increased expression of CYP3A4 mrna|aconitine results in increased expression of CYP3A4 mRNA,,,PMID:30303438,https://www.ncbi.nlm.nih.gov/pubmed/30303438,30303438,,
417,1442244,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606,Homo sapiens (human),CYP3A4 protein results in increased metabolism of aconitine|[cyp3a4 protein results in increased metabolism of aconitine] which results in increased chemical synthesis of 16-O-demethylaconitine,,,PMID:21277363,https://www.ncbi.nlm.nih.gov/pubmed/21277363,21277363,,
418,1442245,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,1577,CYP3A5,https://ctdbase.org/detail.go?type=gene&acc=1577,,,1577.0,CYP3A5,9606,Homo sapiens (human),[CYP3A5 protein results in increased metabolism of aconitine] which results in increased chemical synthesis of 16-O-demethylaconitine|cyp3a5 protein results in increased metabolism of aconitine,,,PMID:21277363,https://www.ncbi.nlm.nih.gov/pubmed/21277363,21277363,,
419,1442368,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,51071,DERA,https://ctdbase.org/detail.go?type=gene&acc=51071,,,51071.0,DERA,10116,Rattus norvegicus (Norway rat),Aconitine results in increased expression of DERA protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
420,1442369,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,201140,DHRS7C,https://ctdbase.org/detail.go?type=gene&acc=201140,,,201140.0,DHRS7C,10116,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of DHRS7C protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
421,1442370,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,9231,DLG5,https://ctdbase.org/detail.go?type=gene&acc=9231,,,9231.0,DLG5,10116,Rattus norvegicus (Norway rat),Aconitine results in increased expression of DLG5 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
422,1442371,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,27109,DMAC2L,https://ctdbase.org/detail.go?type=gene&acc=27109,,,27109.0,DMAC2L,10116,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of DMAC2L protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
423,1442372,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,201625,DNAH12,https://ctdbase.org/detail.go?type=gene&acc=201625,,,201625.0,DNAH12,10116,Rattus norvegicus (Norway rat),Aconitine results in increased expression of DNAH12 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
424,1442373,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,3301,DNAJA1,https://ctdbase.org/detail.go?type=gene&acc=3301,,,3301.0,DNAJA1,10116,Rattus norvegicus (Norway rat),Aconitine results in increased expression of DNAJA1 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
425,1442493,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,55715,DOK4,https://ctdbase.org/detail.go?type=gene&acc=55715,,,55715.0,DOK4,10116,Rattus norvegicus (Norway rat),Aconitine results in increased expression of DOK4 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
426,1442494,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,8813,DPM1,https://ctdbase.org/detail.go?type=gene&acc=8813,,,8813.0,DPM1,10116,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of DPM1 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
427,1442495,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,1809,DPYSL3,https://ctdbase.org/detail.go?type=gene&acc=1809,,,1809.0,DPYSL3,10116,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of DPYSL3 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
428,1442496,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,1781,DYNC1I2,https://ctdbase.org/detail.go?type=gene&acc=1781,,,1781.0,DYNC1I2,10116,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of DYNC1I2 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
429,1442497,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,8655,DYNLL1,https://ctdbase.org/detail.go?type=gene&acc=8655,,,8655.0,DYNLL1,10116,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of DYNLL1 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
430,1442498,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,23167,EFR3A,https://ctdbase.org/detail.go?type=gene&acc=23167,,,23167.0,EFR3A,10116,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of EFR3A protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
431,1446544,249930,BindingDB,"2,5-Diisobutylphenol",34123,"phenol derivative, 1a",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=34123,50003506,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50003506,P04191,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,100037716.0,ATP2A1,9986,Oryctolagus cuniculus (rabbit),,IC50 (nM),18800,PMID:19117760|DOI:10.1016/j.bmc.2008.12.010,https://www.ncbi.nlm.nih.gov/pubmed/19117760|https://doi.org/10.1016/j.bmc.2008.12.010,19117760,10.1016/j.bmc.2008.12.010,
432,1446992,259846,Comparative Toxicogenomics Database (CTD),Lupeol,C010480,lupeol,https://ctdbase.org/detail.go?type=chem&acc=C010480,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606,Homo sapiens (human),Lupeol results in increased expression of CASP9 mrna|lupeol results in increased expression of CASP9 protein,,,PMID:30506710,https://www.ncbi.nlm.nih.gov/pubmed/30506710,30506710,,
433,1446993,259846,Comparative Toxicogenomics Database (CTD),Lupeol,C010480,lupeol,https://ctdbase.org/detail.go?type=chem&acc=C010480,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,10116,Rattus norvegicus (Norway rat),Lupeol inhibits the reaction [COL2A1 results in decreased expression of CASP9 protein],,,PMID:35446470,https://www.ncbi.nlm.nih.gov/pubmed/35446470,35446470,,
434,1446994,259846,Comparative Toxicogenomics Database (CTD),Lupeol,C010480,lupeol,https://ctdbase.org/detail.go?type=chem&acc=C010480,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),Lupeol inhibits the reaction [mancozeb results in decreased activity of CAT protein],,,PMID:27235710,https://www.ncbi.nlm.nih.gov/pubmed/27235710,27235710,,
435,1446995,259846,Comparative Toxicogenomics Database (CTD),Lupeol,C010480,lupeol,https://ctdbase.org/detail.go?type=chem&acc=C010480,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Lupeol inhibits the reaction [[cholesterol co-treated with cholic acid] results in decreased activity of CAT protein],,,PMID:16933029,https://www.ncbi.nlm.nih.gov/pubmed/16933029,16933029,,
436,1446996,259846,Comparative Toxicogenomics Database (CTD),Lupeol,C010480,lupeol,https://ctdbase.org/detail.go?type=chem&acc=C010480,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Lupeol inhibits the reaction [sodium selenite results in decreased activity of CAT protein],,,PMID:26697995,https://www.ncbi.nlm.nih.gov/pubmed/26697995,26697995,,
437,1447574,259846,Comparative Toxicogenomics Database (CTD),Lupeol,C010480,lupeol,https://ctdbase.org/detail.go?type=chem&acc=C010480,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,10116,Rattus norvegicus (Norway rat),Lupeol inhibits the reaction [COL2A1 results in increased activity of MPO protein],,,PMID:35446470,https://www.ncbi.nlm.nih.gov/pubmed/35446470,35446470,,
438,1447575,259846,Comparative Toxicogenomics Database (CTD),Lupeol,C010480,lupeol,https://ctdbase.org/detail.go?type=chem&acc=C010480,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,10090,Mus musculus (house mouse),Lupeol results in decreased expression of MYC mRNA,,,PMID:20732907,https://www.ncbi.nlm.nih.gov/pubmed/20732907,20732907,,
439,1447576,259846,Comparative Toxicogenomics Database (CTD),Lupeol,C010480,lupeol,https://ctdbase.org/detail.go?type=chem&acc=C010480,79923,NANOG,https://ctdbase.org/detail.go?type=gene&acc=79923,,,79923.0,NANOG,10090,Mus musculus (house mouse),Lupeol results in decreased expression of NANOG protein,,,PMID:20979057,https://www.ncbi.nlm.nih.gov/pubmed/20979057,20979057,,
440,1448242,278492,Toxin and Toxin Target Database (T3DB),Nickel(II) bromide,T3D0691,Nickel bromide,http://www.t3db.ca/toxins/T3D0691,BE0005094,Histone H4-like protein type G,http://www.t3db.ca/biodb/bio_entities/BE0005094,Q99525,Histone H4-like protein type G,8369.0,H4C7,9606,Homo sapiens (human),"Nickel has a high affinity for chromatin proteins, particularly histones and protamines. the complexing of nickel ions with heterochromatin results in a number of alterations including condensation, DNA hypermethylation, gene silencing, and inhibition of histone acetylation, which have been shown to disturb gene expression. (L41)",,,,,,,
441,1448243,278492,Toxin and Toxin Target Database (T3DB),Nickel(II) bromide,T3D0691,Nickel bromide,http://www.t3db.ca/toxins/T3D0691,BE0005176,Lysine-specific demethylase 3A,http://www.t3db.ca/biodb/bio_entities/BE0005176,Q9Y4C1,Lysine-specific demethylase 3A,55818.0,KDM3A,9606,Homo sapiens (human),"Nickel substitutes for iron in jmjc domain-containing histone demethylation proteins, inhibiting their demethylation activity. (A109)",,,PMID:19096759,https://www.ncbi.nlm.nih.gov/pubmed/19096759,19096759,,
442,1439921,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,301,ANXA1,https://ctdbase.org/detail.go?type=gene&acc=301,,,301.0,ANXA1,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of ANXA1 mRNA,,,PMID:23179753|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|26272509|28001369,,
443,1439922,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,311,ANXA11,https://ctdbase.org/detail.go?type=gene&acc=311,,,311.0,ANXA11,9483,Callithrix jacchus (white-tufted-ear marmoset),Methylmercuric chloride affects the expression of ANXA11 protein,,,PMID:27012723,https://www.ncbi.nlm.nih.gov/pubmed/27012723,27012723,,
444,1439923,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,311,ANXA11,https://ctdbase.org/detail.go?type=gene&acc=311,,,311.0,ANXA11,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ANXA11 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
445,1439924,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,334724,ANXA1A,https://ctdbase.org/detail.go?type=gene&acc=334724,,,334724.0,anxa1a,7955,Danio rerio (zebrafish),Methylmercuric chloride results in increased expression of ANXA1A mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
446,1439925,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,302,ANXA2,https://ctdbase.org/detail.go?type=gene&acc=302,,,302.0,ANXA2,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of ANXA2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
447,1439926,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,325557,ANXA2A,https://ctdbase.org/detail.go?type=gene&acc=325557,,,325557.0,anxa2a,7955,Danio rerio (zebrafish),Methylmercuric chloride results in increased expression of ANXA2A mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
448,1439927,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,304,ANXA2P2,https://ctdbase.org/detail.go?type=gene&acc=304,,,304.0,ANXA2P2,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of ANXA2P2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
449,1439928,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,306,ANXA3,https://ctdbase.org/detail.go?type=gene&acc=306,,,306.0,ANXA3,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ANXA3 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
450,1441103,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,177950,NKB-2,https://ctdbase.org/detail.go?type=gene&acc=177950,,,177950.0,nkb-2,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of NKB-2 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
451,1441229,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4820,NKTR,https://ctdbase.org/detail.go?type=gene&acc=4820,,,4820.0,NKTR,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of NKTR mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
452,1441230,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4824,NKX3-1,https://ctdbase.org/detail.go?type=gene&acc=4824,,,4824.0,NKX3-1,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of NKX3-1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
453,1441231,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4825,NKX6-1,https://ctdbase.org/detail.go?type=gene&acc=4825,,,4825.0,NKX6-1,10116,Rattus norvegicus (Norway rat),Methylmercuric chloride affects the expression of NKX6-1 mRNA,,,PMID:20864626,https://www.ncbi.nlm.nih.gov/pubmed/20864626,20864626,,
454,1441232,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,84504,NKX6-2,https://ctdbase.org/detail.go?type=gene&acc=84504,,,84504.0,NKX6-2,10116,Rattus norvegicus (Norway rat),Methylmercuric chloride affects the expression of NKX6-2 mRNA,,,PMID:20864626,https://www.ncbi.nlm.nih.gov/pubmed/20864626,20864626,,
455,1441233,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,40913,NLG1,https://ctdbase.org/detail.go?type=gene&acc=40913,,,40913.0,Nlg1,7227,Drosophila melanogaster (fruit fly),NLG1 affects the susceptibility to methylmercuric chloride|methylmercuric chloride results in decreased expression of NLG1 mRNA,,,PMID:34546366,https://www.ncbi.nlm.nih.gov/pubmed/34546366,34546366,,
456,1441777,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,80161,ASMTL-AS1,https://ctdbase.org/detail.go?type=gene&acc=80161,,,80161.0,ASMTL-AS1,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of ASMTL-AS1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
457,1441778,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,440,ASNS,https://ctdbase.org/detail.go?type=gene&acc=440,,,440.0,ASNS,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of ASNS mRNA,,,PMID:23179753|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|26272509|28001369,,
458,1441779,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,440,ASNS,https://ctdbase.org/detail.go?type=gene&acc=440,,,440.0,ASNS,9606,Homo sapiens (human),"[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASNS mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
459,1441780,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,181121,ASNS-2,https://ctdbase.org/detail.go?type=gene&acc=181121,,,181121.0,asns-2,6239,Caenorhabditis elegans,ASNS-2 protein results in decreased susceptibility to methylmercuric chloride,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
460,1442077,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606,Homo sapiens (human),"[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
461,1442078,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10090,Mus musculus (house mouse),Methylmercuric chloride results in decreased expression of NQO1 mRNA,,,PMID:23202902,https://www.ncbi.nlm.nih.gov/pubmed/23202902,23202902,,
462,1442079,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10090,Mus musculus (house mouse),Methylmercuric chloride results in increased expression of NQO1 mRNA,,,PMID:20061341,https://www.ncbi.nlm.nih.gov/pubmed/20061341,20061341,,
463,1442912,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,64343,AZI2,https://ctdbase.org/detail.go?type=gene&acc=64343,,,64343.0,AZI2,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of AZI2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
464,1442913,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,178041,B0035.13,https://ctdbase.org/detail.go?type=gene&acc=178041,,,178041.0,B0035.13,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of B0035.13 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
465,1443237,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,9423,NTN1,https://ctdbase.org/detail.go?type=gene&acc=9423,,,9423.0,NTN1,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of NTN1 mRNA,,,PMID:34089799,https://www.ncbi.nlm.nih.gov/pubmed/34089799,34089799,,
466,1443238,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,84628,NTNG2,https://ctdbase.org/detail.go?type=gene&acc=84628,,,84628.0,NTNG2,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of NTNG2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
467,1443239,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4914,NTRK1,https://ctdbase.org/detail.go?type=gene&acc=4914,,,4914.0,NTRK1,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of NTRK1 mRNA,,,PMID:37210002,https://www.ncbi.nlm.nih.gov/pubmed/37210002,37210002,,
468,1443240,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4915,NTRK2,https://ctdbase.org/detail.go?type=gene&acc=4915,,,4915.0,NTRK2,10090,Mus musculus (house mouse),Methylmercuric chloride affects the expression of NTRK2 mRNA,,,PMID:21613230,https://www.ncbi.nlm.nih.gov/pubmed/21613230,21613230,,
469,1443370,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,10726,NUDC,https://ctdbase.org/detail.go?type=gene&acc=10726,,,10726.0,NUDC,7955,Danio rerio (zebrafish),Methylmercuric chloride results in decreased expression of NUDC mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
470,1443371,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,84955,NUDCD1,https://ctdbase.org/detail.go?type=gene&acc=84955,,,84955.0,NUDCD1,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of NUDCD1 mRNA,,,PMID:23179753|PMID:27188386|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|27188386|28001369,,
471,1443372,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,134492,NUDCD2,https://ctdbase.org/detail.go?type=gene&acc=134492,,,134492.0,NUDCD2,7955,Danio rerio (zebrafish),Methylmercuric chloride results in decreased expression of NUDCD2 mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
472,1443373,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,23386,NUDCD3,https://ctdbase.org/detail.go?type=gene&acc=23386,,,23386.0,NUDCD3,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of NUDCD3 mRNA,,,PMID:34089799,https://www.ncbi.nlm.nih.gov/pubmed/34089799,34089799,,
473,1443374,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,83594,NUDT12,https://ctdbase.org/detail.go?type=gene&acc=83594,,,83594.0,NUDT12,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of NUDT12 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
474,1443375,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,200035,NUDT17,https://ctdbase.org/detail.go?type=gene&acc=200035,,,200035.0,NUDT17,7955,Danio rerio (zebrafish),Methylmercuric chloride results in decreased expression of NUDT17 mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
475,1443376,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,11051,NUDT21,https://ctdbase.org/detail.go?type=gene&acc=11051,,,11051.0,NUDT21,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of NUDT21 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
476,1443377,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,11163,NUDT4,https://ctdbase.org/detail.go?type=gene&acc=11163,,,11163.0,NUDT4,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of NUDT4 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
477,1443378,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,378990,NUDT4A,https://ctdbase.org/detail.go?type=gene&acc=378990,,,378990.0,nudt4a,7955,Danio rerio (zebrafish),Methylmercuric chloride results in increased expression of NUDT4A mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
478,1443379,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,11162,NUDT6,https://ctdbase.org/detail.go?type=gene&acc=11162,,,11162.0,NUDT6,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of NUDT6 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
479,1444044,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,55509,BATF3,https://ctdbase.org/detail.go?type=gene&acc=55509,,,55509.0,BATF3,10116,Rattus norvegicus (Norway rat),Methylmercuric chloride results in increased expression of BATF3 mRNA,,,PMID:31378766,https://www.ncbi.nlm.nih.gov/pubmed/31378766,31378766,,
480,1444215,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,55301,OLAH,https://ctdbase.org/detail.go?type=gene&acc=55301,,,55301.0,OLAH,7955,Danio rerio (zebrafish),Methylmercuric chloride results in decreased expression of OLAH mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
481,1444216,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,10439,OLFM1,https://ctdbase.org/detail.go?type=gene&acc=10439,,,10439.0,OLFM1,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of OLFM1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
482,1444217,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,93145,OLFM2,https://ctdbase.org/detail.go?type=gene&acc=93145,,,93145.0,OLFM2,8049,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of OLFM2 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
483,1444218,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,118427,OLFM3,https://ctdbase.org/detail.go?type=gene&acc=118427,,,118427.0,OLFM3,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of OLFM3 mRNA,,,PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,26272509|28001369,,
484,1444541,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,10116,Rattus norvegicus (Norway rat),Methylmercuric chloride results in decreased expression of BCL2L1 protein,,,PMID:28821999,https://www.ncbi.nlm.nih.gov/pubmed/28821999,28821999,,
485,1444542,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,10017,BCL2L10,https://ctdbase.org/detail.go?type=gene&acc=10017,,,10017.0,BCL2L10,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of BCL2L10 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
486,1444543,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,10018,BCL2L11,https://ctdbase.org/detail.go?type=gene&acc=10018,,,10018.0,BCL2L11,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of BCL2L11 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
487,1444544,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,602,BCL3,https://ctdbase.org/detail.go?type=gene&acc=602,,,602.0,BCL3,10116,Rattus norvegicus (Norway rat),Methylmercuric chloride results in increased expression of BCL3 mRNA,,,PMID:31378766,https://www.ncbi.nlm.nih.gov/pubmed/31378766,31378766,,
488,1444545,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,604,BCL6,https://ctdbase.org/detail.go?type=gene&acc=604,,,604.0,BCL6,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of BCL6 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
489,1444546,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,173733,BCMO-2,https://ctdbase.org/detail.go?type=gene&acc=173733,,,173733.0,bcmo-2,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of BCMO-2 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
490,1444716,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,23440,OTP,https://ctdbase.org/detail.go?type=gene&acc=23440,,,23440.0,OTP,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of OTP mRNA,,,PMID:34089799,https://www.ncbi.nlm.nih.gov/pubmed/34089799,34089799,,
491,1445333,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,183785,PALS-38,https://ctdbase.org/detail.go?type=gene&acc=183785,,,183785.0,pals-38,6239,Caenorhabditis elegans,PALS-38 protein results in increased susceptibility to methylmercuric chloride,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
492,1445334,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,182750,PALS-7,https://ctdbase.org/detail.go?type=gene&acc=182750,,,182750.0,pals-7,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of PALS-7 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
493,1445335,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,51025,PAM16,https://ctdbase.org/detail.go?type=gene&acc=51025,,,51025.0,PAM16,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of PAM16 mRNA,,,PMID:34089799,https://www.ncbi.nlm.nih.gov/pubmed/34089799,34089799,,
494,1445336,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,25891,PAMR1,https://ctdbase.org/detail.go?type=gene&acc=25891,,,25891.0,PAMR1,8049,Gadus morhua (Atlantic cod),Methylmercuric chloride results in decreased expression of PAMR1 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
495,1445337,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,25891,PAMR1,https://ctdbase.org/detail.go?type=gene&acc=25891,,,25891.0,PAMR1,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of PAMR1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
496,1447577,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,180165,PGP-9,https://ctdbase.org/detail.go?type=gene&acc=180165,,,180165.0,pgp-9,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of PGP-9 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
497,1447578,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,178963,PGPH-1,https://ctdbase.org/detail.go?type=gene&acc=178963,,,178963.0,pgph-1,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of PGPH-1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
498,1447579,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,178964,PGPH-3,https://ctdbase.org/detail.go?type=gene&acc=178964,,,178964.0,pgph-3,6239,Caenorhabditis elegans,PGPH-3 protein results in decreased susceptibility to methylmercuric chloride|methylmercuric chloride results in increased expression of PGPH-3 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
499,1447580,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,10116,Rattus norvegicus (Norway rat),Methylmercuric chloride results in increased expression of PGR mRNA,,,PMID:20864626,https://www.ncbi.nlm.nih.gov/pubmed/20864626,20864626,,
500,1447581,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,38858,PGRP-SD,https://ctdbase.org/detail.go?type=gene&acc=38858,,,38858.0,PGRP-SD,7227,Drosophila melanogaster (fruit fly),[methylmercuric chloride results in decreased susceptibility to methylmercuric chloride] which results in decreased expression of PGRP-SD mRNA,,,PMID:20375079,https://www.ncbi.nlm.nih.gov/pubmed/20375079,20375079,,
501,1447582,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,43623,PH4ALPHASG2,https://ctdbase.org/detail.go?type=gene&acc=43623,,,43623.0,PH4alphaSG2,7227,Drosophila melanogaster (fruit fly),[methylmercuric chloride results in decreased susceptibility to methylmercuric chloride] which results in decreased expression of PH4ALPHASG2 mRNA,,,PMID:20375079,https://www.ncbi.nlm.nih.gov/pubmed/20375079,20375079,,
502,1447583,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,9749,PHACTR2,https://ctdbase.org/detail.go?type=gene&acc=9749,,,9749.0,PHACTR2,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of PHACTR2 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
503,1447903,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,55022,PID1,https://ctdbase.org/detail.go?type=gene&acc=55022,,,55022.0,PID1,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of PID1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
504,1447904,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,145788,PIERCE2,https://ctdbase.org/detail.go?type=gene&acc=145788,,,145788.0,PIERCE2,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of PIERCE2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
505,1447905,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,80119,PIF1,https://ctdbase.org/detail.go?type=gene&acc=80119,,,80119.0,PIF1,8049,Gadus morhua (Atlantic cod),Methylmercuric chloride results in decreased expression of PIF1 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
506,1447906,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,31303,PIG1,https://ctdbase.org/detail.go?type=gene&acc=31303,,,31303.0,Pig1,7227,Drosophila melanogaster (fruit fly),Methylmercuric chloride results in decreased expression of PIG1 mRNA,,,PMID:20375079,https://www.ncbi.nlm.nih.gov/pubmed/20375079,20375079,,
507,1447907,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,5281,PIGF,https://ctdbase.org/detail.go?type=gene&acc=5281,,,5281.0,PIGF,7955,Danio rerio (zebrafish),Methylmercuric chloride results in decreased expression of PIGF mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
508,1447908,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,10026,PIGK,https://ctdbase.org/detail.go?type=gene&acc=10026,,,10026.0,PIGK,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of PIGK mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
509,1448233,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,8544,PIR,https://ctdbase.org/detail.go?type=gene&acc=8544,,,8544.0,PIR,9606,Homo sapiens (human),"[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PIR mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
510,1448234,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,8544,PIR,https://ctdbase.org/detail.go?type=gene&acc=8544,,,8544.0,PIR,10116,Rattus norvegicus (Norway rat),"[hydrocarbons, chlorinated co-treated with polychlorinated biphenyls co-treated with methylmercuric chloride] results in increased expression of PIR mRNA",,,PMID:30744511,https://www.ncbi.nlm.nih.gov/pubmed/30744511,30744511,,
511,1448235,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,26207,PITPNC1,https://ctdbase.org/detail.go?type=gene&acc=26207,,,26207.0,PITPNC1,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of PITPNC1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
512,1448236,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,83394,PITPNM3,https://ctdbase.org/detail.go?type=gene&acc=83394,,,83394.0,PITPNM3,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of PITPNM3 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
513,1448237,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,174883,PITR-6,https://ctdbase.org/detail.go?type=gene&acc=174883,,,174883.0,pitr-6,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of PITR-6 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
514,1448238,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,10531,PITRM1,https://ctdbase.org/detail.go?type=gene&acc=10531,,,10531.0,PITRM1,9483,Callithrix jacchus (white-tufted-ear marmoset),Methylmercuric chloride affects the expression of PITRM1 protein,,,PMID:27012723,https://www.ncbi.nlm.nih.gov/pubmed/27012723,27012723,,
515,1448239,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,10531,PITRM1,https://ctdbase.org/detail.go?type=gene&acc=10531,,,10531.0,PITRM1,9483,Callithrix jacchus (white-tufted-ear marmoset),Methylmercuric chloride results in decreased expression of PITRM1 protein,,,PMID:25809596,https://www.ncbi.nlm.nih.gov/pubmed/25809596,25809596,,
516,1448240,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,5307,PITX1,https://ctdbase.org/detail.go?type=gene&acc=5307,,,5307.0,PITX1,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of PITX1 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
517,1448241,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,5308,PITX2,https://ctdbase.org/detail.go?type=gene&acc=5308,,,5308.0,PITX2,10116,Rattus norvegicus (Norway rat),Methylmercuric chloride results in decreased expression of PITX2 mRNA,,,PMID:20864626,https://www.ncbi.nlm.nih.gov/pubmed/20864626,20864626,,
518,1445482,414513,BindingDB,"1-N,4-N-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]phthalazine-1,4-diamine",33257,"phthalazine-based compound, 8",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=33257,289,"Genome polyprotein [1066-1250,R1182K]/[1394-1440,K1405R,D1408E]",https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=289,P14340,Genome polyprotein,,,11065,Dengue virus 2 Thailand/NGS-C/1944,,IC50 (nM),10200,PMID:19682971|DOI:10.1016/j.ab.2009.08.013,https://www.ncbi.nlm.nih.gov/pubmed/19682971|https://doi.org/10.1016/j.ab.2009.08.013,19682971,10.1016/j.ab.2009.08.013,
519,1445480,421610,Comparative Toxicogenomics Database (CTD),"2-[[3-[[2-(dimethylamino)phenyl]methyl]-2-pyridin-4-yl-1,3-diazinan-1-yl]methyl]-N,N-dimethylaniline",C551027,GANT 61,https://ctdbase.org/detail.go?type=chem&acc=C551027,3815,KIT,https://ctdbase.org/detail.go?type=gene&acc=3815,,,3815.0,KIT,9606,Homo sapiens (human),GANT 61 results in decreased expression of KIT mRNA,,,PMID:27793025,https://www.ncbi.nlm.nih.gov/pubmed/27793025,27793025,,
520,1445481,421610,Comparative Toxicogenomics Database (CTD),"2-[[3-[[2-(dimethylamino)phenyl]methyl]-2-pyridin-4-yl-1,3-diazinan-1-yl]methyl]-N,N-dimethylaniline",C551027,GANT 61,https://ctdbase.org/detail.go?type=chem&acc=C551027,3880,KRT19,https://ctdbase.org/detail.go?type=gene&acc=3880,,,3880.0,KRT19,10090,Mus musculus (house mouse),GANT 61 inhibits the reaction [carbon tetrachloride results in increased expression of KRT19 mrna],,,PMID:32996673,https://www.ncbi.nlm.nih.gov/pubmed/32996673,32996673,,
521,1445603,421610,Comparative Toxicogenomics Database (CTD),"2-[[3-[[2-(dimethylamino)phenyl]methyl]-2-pyridin-4-yl-1,3-diazinan-1-yl]methyl]-N,N-dimethylaniline",C551027,GANT 61,https://ctdbase.org/detail.go?type=chem&acc=C551027,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,10090,Mus musculus (house mouse),GANT 61 inhibits the reaction [carbon tetrachloride results in increased expression of MYC mrna],,,PMID:31816328,https://www.ncbi.nlm.nih.gov/pubmed/31816328,31816328,,
522,1445604,421610,Comparative Toxicogenomics Database (CTD),"2-[[3-[[2-(dimethylamino)phenyl]methyl]-2-pyridin-4-yl-1,3-diazinan-1-yl]methyl]-N,N-dimethylaniline",C551027,GANT 61,https://ctdbase.org/detail.go?type=chem&acc=C551027,5080,PAX6,https://ctdbase.org/detail.go?type=gene&acc=5080,,,5080.0,PAX6,9606,Homo sapiens (human),GANT 61 results in increased expression of PAX6 mrna|gant 61 results in increased expression of PAX6 protein,,,PMID:36205257,https://www.ncbi.nlm.nih.gov/pubmed/36205257,36205257,,
523,1445605,421610,Comparative Toxicogenomics Database (CTD),"2-[[3-[[2-(dimethylamino)phenyl]methyl]-2-pyridin-4-yl-1,3-diazinan-1-yl]methyl]-N,N-dimethylaniline",C551027,GANT 61,https://ctdbase.org/detail.go?type=chem&acc=C551027,553216,PM20D1.1,https://ctdbase.org/detail.go?type=gene&acc=553216,,,553216.0,pm20d1.1,7955,Danio rerio (zebrafish),GANT 61 results in increased expression of PM20D1.1 mRNA,,,PMID:22265815,https://www.ncbi.nlm.nih.gov/pubmed/22265815,22265815,,
524,1445606,421610,Comparative Toxicogenomics Database (CTD),"2-[[3-[[2-(dimethylamino)phenyl]methyl]-2-pyridin-4-yl-1,3-diazinan-1-yl]methyl]-N,N-dimethylaniline",C551027,GANT 61,https://ctdbase.org/detail.go?type=chem&acc=C551027,5727,PTCH1,https://ctdbase.org/detail.go?type=gene&acc=5727,,,5727.0,PTCH1,10090,Mus musculus (house mouse),GANT 61 inhibits the reaction [carbon tetrachloride results in increased expression of PTCH1 mrna],,,PMID:31816328,https://www.ncbi.nlm.nih.gov/pubmed/31816328,31816328,,
525,1445607,421610,Comparative Toxicogenomics Database (CTD),"2-[[3-[[2-(dimethylamino)phenyl]methyl]-2-pyridin-4-yl-1,3-diazinan-1-yl]methyl]-N,N-dimethylaniline",C551027,GANT 61,https://ctdbase.org/detail.go?type=chem&acc=C551027,6469,SHH,https://ctdbase.org/detail.go?type=gene&acc=6469,,,6469.0,SHH,9606,Homo sapiens (human),GANT 61 inhibits the reaction [AGT protein results in increased expression of SHH protein],,,PMID:31181250,https://www.ncbi.nlm.nih.gov/pubmed/31181250,31181250,,
526,1445608,421610,Comparative Toxicogenomics Database (CTD),"2-[[3-[[2-(dimethylamino)phenyl]methyl]-2-pyridin-4-yl-1,3-diazinan-1-yl]methyl]-N,N-dimethylaniline",C551027,GANT 61,https://ctdbase.org/detail.go?type=chem&acc=C551027,6608,SMO,https://ctdbase.org/detail.go?type=gene&acc=6608,,,6608.0,SMO,9606,Homo sapiens (human),GANT 61 inhibits the reaction [AGT protein results in increased expression of SMO protein],,,PMID:31181250,https://www.ncbi.nlm.nih.gov/pubmed/31181250,31181250,,
527,1445609,421610,Comparative Toxicogenomics Database (CTD),"2-[[3-[[2-(dimethylamino)phenyl]methyl]-2-pyridin-4-yl-1,3-diazinan-1-yl]methyl]-N,N-dimethylaniline",C551027,GANT 61,https://ctdbase.org/detail.go?type=chem&acc=C551027,6608,SMO,https://ctdbase.org/detail.go?type=gene&acc=6608,,,6608.0,SMO,10090,Mus musculus (house mouse),GANT 61 inhibits the reaction [carbon tetrachloride results in increased expression of SMO protein]|gant 61 inhibits the reaction [carbon tetrachloride results in increased expression of SMO mrna],,,PMID:31816328,https://www.ncbi.nlm.nih.gov/pubmed/31816328,31816328,,
528,1445610,421610,Comparative Toxicogenomics Database (CTD),"2-[[3-[[2-(dimethylamino)phenyl]methyl]-2-pyridin-4-yl-1,3-diazinan-1-yl]methyl]-N,N-dimethylaniline",C551027,GANT 61,https://ctdbase.org/detail.go?type=chem&acc=C551027,6608,SMO,https://ctdbase.org/detail.go?type=gene&acc=6608,,,6608.0,SMO,9606,Homo sapiens (human),GANT 61 binds to and results in decreased activity of SMO protein,,,PMID:24094913,https://www.ncbi.nlm.nih.gov/pubmed/24094913,24094913,,
529,1445611,421610,Comparative Toxicogenomics Database (CTD),"2-[[3-[[2-(dimethylamino)phenyl]methyl]-2-pyridin-4-yl-1,3-diazinan-1-yl]methyl]-N,N-dimethylaniline",C551027,GANT 61,https://ctdbase.org/detail.go?type=chem&acc=C551027,6615,SNAI1,https://ctdbase.org/detail.go?type=gene&acc=6615,,,6615.0,SNAI1,9606,Homo sapiens (human),GANT 61 results in decreased expression of SNAI1 mRNA,,,PMID:30983542,https://www.ncbi.nlm.nih.gov/pubmed/30983542,30983542,,
530,1448421,440667,Comparative Toxicogenomics Database (CTD),Dehydroascorbic acid,D003683,Dehydroascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D003683,6513,SLC2A1,https://ctdbase.org/detail.go?type=gene&acc=6513,,,6513.0,SLC2A1,9606,Homo sapiens (human),SLC2A1 mRNA affects the uptake of dehydroascorbic acid,,,PMID:16142743,https://www.ncbi.nlm.nih.gov/pubmed/16142743,16142743,,
531,1448422,440667,Comparative Toxicogenomics Database (CTD),Dehydroascorbic acid,D003683,Dehydroascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D003683,6513,SLC2A1,https://ctdbase.org/detail.go?type=gene&acc=6513,,,6513.0,SLC2A1,9606,Homo sapiens (human),SLC2A1 protein mutant form results in decreased transport of dehydroascorbic acid,,,PMID:11603379,https://www.ncbi.nlm.nih.gov/pubmed/11603379,11603379,,
532,1448423,440667,Comparative Toxicogenomics Database (CTD),Dehydroascorbic acid,D003683,Dehydroascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D003683,6513,SLC2A1,https://ctdbase.org/detail.go?type=gene&acc=6513,,,6513.0,SLC2A1,10116,Rattus norvegicus (Norway rat),SLC2A1 protein affects the transport of dehydroascorbic acid,,,PMID:15590689,https://www.ncbi.nlm.nih.gov/pubmed/15590689,15590689,,
533,1448424,440667,Comparative Toxicogenomics Database (CTD),Dehydroascorbic acid,D003683,Dehydroascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D003683,6513,SLC2A1,https://ctdbase.org/detail.go?type=gene&acc=6513,,,6513.0,SLC2A1,9606,Homo sapiens (human),SLC2A1 protein results in increased uptake of dehydroascorbic acid,,,PMID:23396969,https://www.ncbi.nlm.nih.gov/pubmed/23396969,23396969,,
534,1448425,440667,Comparative Toxicogenomics Database (CTD),Dehydroascorbic acid,D003683,Dehydroascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D003683,6514,SLC2A2,https://ctdbase.org/detail.go?type=gene&acc=6514,,,6514.0,SLC2A2,9606,Homo sapiens (human),Ethylidene glucose inhibits the reaction [SLC2A2 protein results in increased uptake of dehydroascorbic acid]|phloretin inhibits the reaction [SLC2A2 protein results in increased uptake of dehydroascorbic acid]|glucose inhibits the reaction [SLC2A2 protein results in increased uptake of dehydroascorbic acid]|slc2a2 protein results in increased uptake of dehydroascorbic acid|cytochalasin B inhibits the reaction [SLC2A2 protein results in increased uptake of dehydroascorbic acid]|quercetin inhibits the reaction [SLC2A2 protein results in increased uptake of dehydroascorbic acid],,,PMID:23396969,https://www.ncbi.nlm.nih.gov/pubmed/23396969,23396969,,
535,1448426,440667,Comparative Toxicogenomics Database (CTD),Dehydroascorbic acid,D003683,Dehydroascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D003683,6515,SLC2A3,https://ctdbase.org/detail.go?type=gene&acc=6515,,,6515.0,SLC2A3,9606,Homo sapiens (human),SLC2A3 protein affects the transport of dehydroascorbic acid,,,PMID:15590689,https://www.ncbi.nlm.nih.gov/pubmed/15590689,15590689,,
536,1448427,440667,Comparative Toxicogenomics Database (CTD),Dehydroascorbic acid,D003683,Dehydroascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D003683,29988,SLC2A8,https://ctdbase.org/detail.go?type=gene&acc=29988,,,29988.0,SLC2A8,10090,Mus musculus (house mouse),Glucose inhibits the reaction [SLC2A8 protein results in increased uptake of dehydroascorbic acid]|quercetin inhibits the reaction [SLC2A8 protein results in increased uptake of dehydroascorbic acid]|phloretin inhibits the reaction [SLC2A8 protein results in increased uptake of dehydroascorbic acid]|cytochalasin B inhibits the reaction [SLC2A8 protein results in increased uptake of dehydroascorbic acid]|slc2a8 protein results in increased uptake of dehydroascorbic acid|ethylidene glucose inhibits the reaction [SLC2A8 protein results in increased uptake of dehydroascorbic acid],,,PMID:23396969,https://www.ncbi.nlm.nih.gov/pubmed/23396969,23396969,,
537,1448428,440667,Comparative Toxicogenomics Database (CTD),Dehydroascorbic acid,D003683,Dehydroascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D003683,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606,Homo sapiens (human),Cytochalasin B inhibits the reaction [dehydroascorbic acid results in increased expression of SOD2 protein]|dehydroascorbic acid results in increased expression of SOD2 protein|[dehydroascorbic acid co-treated with lipopolysaccharides] results in increased expression of SOD2 protein,,,PMID:20166893,https://www.ncbi.nlm.nih.gov/pubmed/20166893,20166893,,
538,1448429,440908,Comparative Toxicogenomics Database (CTD),Nivalenol,C038405,nivalenol,https://ctdbase.org/detail.go?type=chem&acc=C038405,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606,Homo sapiens (human),Nivalenol results in decreased activity of AR protein,,,PMID:27481073,https://www.ncbi.nlm.nih.gov/pubmed/27481073,27481073,,
539,1441642,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,64577,ALDH8A1,https://ctdbase.org/detail.go?type=gene&acc=64577,,,64577.0,ALDH8A1,10116,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of ALDH8A1 protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
540,1441643,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,10116,Rattus norvegicus (Norway rat),[sodium arsenite co-treated with cadmium chloride co-treated with lead acetate co-treated with mercuric chloride co-treated with chromium trioxide co-treated with nickel chloride co-treated with manganese chloride co-treated with ferric chloride] results in decreased expression of ALB protein,,,PMID:17657459,https://www.ncbi.nlm.nih.gov/pubmed/17657459,17657459,,
541,1442628,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,246,ALOX15,https://ctdbase.org/detail.go?type=gene&acc=246,,,246.0,ALOX15,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of ALOX15 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
542,1442629,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,246,ALOX15,https://ctdbase.org/detail.go?type=gene&acc=246,,,246.0,ALOX15,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of ALOX15 mRNA,,,PMID:25065748|PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/25065748|https://www.ncbi.nlm.nih.gov/pubmed/36209798,25065748|36209798,,
543,1442630,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,247,ALOX15B,https://ctdbase.org/detail.go?type=gene&acc=247,,,247.0,ALOX15B,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of and affects the splicing of ALOX15B mRNA,,,PMID:25879800,https://www.ncbi.nlm.nih.gov/pubmed/25879800,25879800,,
544,1442631,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,240,ALOX5,https://ctdbase.org/detail.go?type=gene&acc=240,,,240.0,ALOX5,9606,Homo sapiens (human),[sodium arsenite co-treated with platelet activating factor co-treated with arachidonic acid] results in increased phosphorylation of and results in increased activity of ALOX5 protein|sb 203580 inhibits the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of ALOX5 protein]|sb 203580 inhibits the reaction [sodium arsenite results in increased activity of ALOX5 protein]|sodium arsenite results in increased phosphorylation of and results in increased activity of ALOX5 protein,,,PMID:10779545,https://www.ncbi.nlm.nih.gov/pubmed/10779545,10779545,,
545,1442632,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,240,ALOX5,https://ctdbase.org/detail.go?type=gene&acc=240,,,240.0,ALOX5,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of ALOX5 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
546,1442633,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,240,ALOX5,https://ctdbase.org/detail.go?type=gene&acc=240,,,240.0,ALOX5,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of ALOX5 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
547,1442634,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,240,ALOX5,https://ctdbase.org/detail.go?type=gene&acc=240,,,240.0,ALOX5,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of ALOX5 mRNA,,,PMID:25065748,https://www.ncbi.nlm.nih.gov/pubmed/25065748,25065748,,
548,1442635,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,240,ALOX5,https://ctdbase.org/detail.go?type=gene&acc=240,,,240.0,ALOX5,9606,Homo sapiens (human),[sodium arsenite co-treated with calcimycin co-treated with arachidonic acid] results in increased activity of ALOX5 protein,,,PMID:11698504,https://www.ncbi.nlm.nih.gov/pubmed/11698504,11698504,,
549,1442636,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,241,ALOX5AP,https://ctdbase.org/detail.go?type=gene&acc=241,,,241.0,ALOX5AP,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of ALOX5AP mRNA,,,PMID:16507463|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/16507463|https://www.ncbi.nlm.nih.gov/pubmed/34032870,16507463|34032870,,
550,1442765,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,115701,ALPK2,https://ctdbase.org/detail.go?type=gene&acc=115701,,,115701.0,ALPK2,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of ALPK2 mRNA,,,PMID:22714537|PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/22714537|https://www.ncbi.nlm.nih.gov/pubmed/29301061,22714537|29301061,,
551,1442766,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,115701,ALPK2,https://ctdbase.org/detail.go?type=gene&acc=115701,,,115701.0,ALPK2,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of ALPK2 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
552,1442767,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,249,ALPL,https://ctdbase.org/detail.go?type=gene&acc=249,,,249.0,ALPL,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of ALPL mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
553,1442768,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,249,ALPL,https://ctdbase.org/detail.go?type=gene&acc=249,,,249.0,ALPL,9606,Homo sapiens (human),Sodium arsenite affects the methylation of ALPL gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
554,1443529,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,29945,ANAPC4,https://ctdbase.org/detail.go?type=gene&acc=29945,,,29945.0,ANAPC4,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of ANAPC4 mRNA,,,PMID:16014739,https://www.ncbi.nlm.nih.gov/pubmed/16014739,16014739,,
555,1443530,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,51433,ANAPC5,https://ctdbase.org/detail.go?type=gene&acc=51433,,,51433.0,ANAPC5,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ANAPC5 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
556,1443531,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,283,ANG,https://ctdbase.org/detail.go?type=gene&acc=283,,,283.0,ANG,9606,Homo sapiens (human),ANG protein promotes the reaction [sodium arsenite results in increased cleavage of TRA-CGC3-1],,,PMID:30442959,https://www.ncbi.nlm.nih.gov/pubmed/30442959,30442959,,
557,1443532,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,283,ANG,https://ctdbase.org/detail.go?type=gene&acc=283,,,283.0,ANG,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of ANG mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
558,1443533,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,283,ANG,https://ctdbase.org/detail.go?type=gene&acc=283,,,283.0,ANG,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of ANG mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
559,1443534,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,11731,ANG2,https://ctdbase.org/detail.go?type=gene&acc=11731,,,11731.0,Ang2,10090,Mus musculus (house mouse),Sodium arsenite affects the expression of ANG2 mRNA,,,PMID:26674514,https://www.ncbi.nlm.nih.gov/pubmed/26674514,26674514,,
560,1443535,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23357,ANGEL1,https://ctdbase.org/detail.go?type=gene&acc=23357,,,23357.0,ANGEL1,9606,Homo sapiens (human),Sodium arsenite results in increased expression of ANGEL1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
561,1443536,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,284,ANGPT1,https://ctdbase.org/detail.go?type=gene&acc=284,,,284.0,ANGPT1,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of ANGPT1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
562,1443537,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,284,ANGPT1,https://ctdbase.org/detail.go?type=gene&acc=284,,,284.0,ANGPT1,9606,Homo sapiens (human),Sodium arsenite results in decreased secretion of ANGPT1 protein|sodium arsenite results in increased expression of ANGPT1 protein,,,PMID:19622383,https://www.ncbi.nlm.nih.gov/pubmed/19622383,19622383,,
563,1444034,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,11147,ANKRD13C-DT,https://ctdbase.org/detail.go?type=gene&acc=11147,,,11147.0,ANKRD13C-DT,9606,Homo sapiens (human),Sodium arsenite results in increased expression of ANKRD13C-DT mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
564,1445022,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,306,ANXA3,https://ctdbase.org/detail.go?type=gene&acc=306,,,306.0,ANXA3,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of ANXA3 mRNA,,,PMID:22714537|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/22714537|https://www.ncbi.nlm.nih.gov/pubmed/34032870,22714537|34032870,,
565,1445023,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,306,ANXA3,https://ctdbase.org/detail.go?type=gene&acc=306,,,306.0,ANXA3,9606,Homo sapiens (human),Sodium arsenite results in increased expression of ANXA3 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
566,1445024,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,306,ANXA3,https://ctdbase.org/detail.go?type=gene&acc=306,,,306.0,ANXA3,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of ANXA3 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
567,1445025,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,308,ANXA5,https://ctdbase.org/detail.go?type=gene&acc=308,,,308.0,ANXA5,9606,Homo sapiens (human),Sodium arsenite results in increased expression of ANXA5 protein,,,PMID:24100277,https://www.ncbi.nlm.nih.gov/pubmed/24100277,24100277,,
568,1445026,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,308,ANXA5,https://ctdbase.org/detail.go?type=gene&acc=308,,,308.0,ANXA5,10116,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of ANXA5 protein,,,PMID:29459688,https://www.ncbi.nlm.nih.gov/pubmed/29459688,29459688,,
569,1445027,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,309,ANXA6,https://ctdbase.org/detail.go?type=gene&acc=309,,,309.0,ANXA6,9606,Homo sapiens (human),Sodium arsenite promotes the reaction [ANXA6 protein binds to CAPRIN1 protein],,,PMID:33939924,https://www.ncbi.nlm.nih.gov/pubmed/33939924,33939924,,
570,1445028,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,309,ANXA6,https://ctdbase.org/detail.go?type=gene&acc=309,,,309.0,ANXA6,9541,Macaca fascicularis (crab-eating macaque),Sodium arsenite results in decreased expression of ANXA6 protein,,,PMID:24866292,https://www.ncbi.nlm.nih.gov/pubmed/24866292,24866292,,
571,1446391,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,358,AQP1,https://ctdbase.org/detail.go?type=gene&acc=358,,,358.0,AQP1,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of AQP1 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
572,1446392,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,348,APOE,https://ctdbase.org/detail.go?type=gene&acc=348,,,348.0,APOE,10090,Mus musculus (house mouse),AS3MT protein affects the reaction [[APOE protein affects the susceptibility to sodium arsenite] which results in decreased expression of ACTA2 protein]|apoe protein affects the susceptibility to sodium arsenite|as3mt protein affects the reaction [APOE protein affects the susceptibility to sodium arsenite]|[apoe protein affects the susceptibility to sodium arsenite] which results in decreased expression of ACTA2 protein,,,PMID:28728140,https://www.ncbi.nlm.nih.gov/pubmed/28728140,28728140,,
573,1446393,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,348,APOE,https://ctdbase.org/detail.go?type=gene&acc=348,,,348.0,APOE,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of APOE mRNA,,,PMID:19822182|PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/19822182|https://www.ncbi.nlm.nih.gov/pubmed/37682722,19822182|37682722,,
574,1446394,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,348,APOE,https://ctdbase.org/detail.go?type=gene&acc=348,,,348.0,APOE,10116,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of APOE protein,,,PMID:31874112,https://www.ncbi.nlm.nih.gov/pubmed/31874112,31874112,,
575,1446395,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,30314,APOEB,https://ctdbase.org/detail.go?type=gene&acc=30314,,,30314.0,apoeb,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of APOEB mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
576,1446396,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,319,APOF,https://ctdbase.org/detail.go?type=gene&acc=319,,,319.0,APOF,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of APOF mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
577,1446397,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,319,APOF,https://ctdbase.org/detail.go?type=gene&acc=319,,,319.0,APOF,9606,Homo sapiens (human),Sodium arsenite results in increased expression of APOF mRNA,,,PMID:25879800,https://www.ncbi.nlm.nih.gov/pubmed/25879800,25879800,,
578,1446987,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,441432,AQP7P3,https://ctdbase.org/detail.go?type=gene&acc=441432,,,441432.0,AQP7P3,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of AQP7P3 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
579,1446988,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,447923,AQP8A.1,https://ctdbase.org/detail.go?type=gene&acc=447923,,,447923.0,aqp8a.1,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of AQP8A.1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
580,1446989,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,366,AQP9,https://ctdbase.org/detail.go?type=gene&acc=366,,,366.0,AQP9,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of AQP9 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
581,1446990,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,366,AQP9,https://ctdbase.org/detail.go?type=gene&acc=366,,,366.0,AQP9,10090,Mus musculus (house mouse),AQP9 protein affects the transport of sodium arsenite|aqp9 gene mutant form results in increased susceptibility to sodium arsenite,,,PMID:19805235,https://www.ncbi.nlm.nih.gov/pubmed/19805235,19805235,,
582,1446991,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,366,AQP9,https://ctdbase.org/detail.go?type=gene&acc=366,,,366.0,AQP9,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of AQP9 mRNA,,,PMID:29108910,https://www.ncbi.nlm.nih.gov/pubmed/29108910,29108910,,
583,1447304,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,55738,ARFGAP1,https://ctdbase.org/detail.go?type=gene&acc=55738,,,55738.0,ARFGAP1,7955,Danio rerio (zebrafish),[sodium arsenite results in increased abundance of arsenic] which results in increased expression of ARFGAP1 mRNA,,,PMID:33147493,https://www.ncbi.nlm.nih.gov/pubmed/33147493,33147493,,
584,1447305,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,55738,ARFGAP1,https://ctdbase.org/detail.go?type=gene&acc=55738,,,55738.0,ARFGAP1,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ARFGAP1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
585,1447306,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,84364,ARFGAP2,https://ctdbase.org/detail.go?type=gene&acc=84364,,,84364.0,ARFGAP2,9606,Homo sapiens (human),Sodium arsenite promotes the reaction [ARFGAP2 protein binds to CAPRIN1 protein],,,PMID:33939924,https://www.ncbi.nlm.nih.gov/pubmed/33939924,33939924,,
586,1447307,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,26286,ARFGAP3,https://ctdbase.org/detail.go?type=gene&acc=26286,,,26286.0,ARFGAP3,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of ARFGAP3 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
587,1447308,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,26286,ARFGAP3,https://ctdbase.org/detail.go?type=gene&acc=26286,,,26286.0,ARFGAP3,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of ARFGAP3 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
588,1447721,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23092,ARHGAP26,https://ctdbase.org/detail.go?type=gene&acc=23092,,,23092.0,ARHGAP26,9606,Homo sapiens (human),Sodium arsenite affects the expression of ARHGAP26 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
589,1447722,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23092,ARHGAP26,https://ctdbase.org/detail.go?type=gene&acc=23092,,,23092.0,ARHGAP26,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of ARHGAP26 mRNA,,,PMID:28595984,https://www.ncbi.nlm.nih.gov/pubmed/28595984,28595984,,
590,1447723,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,201176,ARHGAP27,https://ctdbase.org/detail.go?type=gene&acc=201176,,,201176.0,ARHGAP27,9606,Homo sapiens (human),Sodium arsenite affects the expression of ARHGAP27 mRNA,,,PMID:29319823,https://www.ncbi.nlm.nih.gov/pubmed/29319823,29319823,,
591,1447724,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,566523,ARHGAP27L,https://ctdbase.org/detail.go?type=gene&acc=566523,,,566523.0,arhgap27l,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of ARHGAP27L mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
592,1447725,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,79822,ARHGAP28,https://ctdbase.org/detail.go?type=gene&acc=79822,,,79822.0,ARHGAP28,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of ARHGAP28 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
593,1447726,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9411,ARHGAP29,https://ctdbase.org/detail.go?type=gene&acc=9411,,,9411.0,ARHGAP29,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of ARHGAP29 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
594,1448038,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,397,ARHGDIB,https://ctdbase.org/detail.go?type=gene&acc=397,,,397.0,ARHGDIB,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of ARHGDIB mRNA,,,PMID:12634122|PMID:12727804,https://www.ncbi.nlm.nih.gov/pubmed/12634122|https://www.ncbi.nlm.nih.gov/pubmed/12727804,12634122|12727804,,
595,1448039,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,397,ARHGDIB,https://ctdbase.org/detail.go?type=gene&acc=397,,,397.0,ARHGDIB,10090,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of ARHGDIB mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
596,1448040,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,398,ARHGDIG,https://ctdbase.org/detail.go?type=gene&acc=398,,,398.0,ARHGDIG,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of ARHGDIG mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
597,1448041,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,398,ARHGDIG,https://ctdbase.org/detail.go?type=gene&acc=398,,,398.0,ARHGDIG,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of ARHGDIG mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
598,1448042,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9639,ARHGEF10,https://ctdbase.org/detail.go?type=gene&acc=9639,,,9639.0,ARHGEF10,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ARHGEF10 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
599,1448599,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,379,ARL4D,https://ctdbase.org/detail.go?type=gene&acc=379,,,379.0,ARL4D,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of ARL4D mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
600,1448600,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,379,ARL4D,https://ctdbase.org/detail.go?type=gene&acc=379,,,379.0,ARL4D,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of ARL4D mRNA,,,PMID:33145626,https://www.ncbi.nlm.nih.gov/pubmed/33145626,33145626,,
601,1448601,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,390790,ARL5C,https://ctdbase.org/detail.go?type=gene&acc=390790,,,390790.0,ARL5C,10090,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of ARL5C mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
602,1448602,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23204,ARL6IP1,https://ctdbase.org/detail.go?type=gene&acc=23204,,,23204.0,ARL6IP1,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ARL6IP1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
603,1448603,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,51329,ARL6IP4,https://ctdbase.org/detail.go?type=gene&acc=51329,,,51329.0,ARL6IP4,9606,Homo sapiens (human),Sodium arsenite results in increased expression of ARL6IP4 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
604,1960477,11370470,Therapeutic Target Database (TTD),(D)-Ala-Pro-Glu,D0S5OQ,(D)-Ala-Pro-Glu,https://idrblab.net/ttd/data/drug/details/D0S5OQ,T62276,Glutamate receptor ionotropic NMDA 1 (NMDAR1),https://idrblab.net/ttd/data/target/details/T62276,Q05586,"Glutamate receptor ionotropic, NMDA 1",2902.0,GRIN1,9606,Homo sapiens (human),Inhibitor,,,,,,,
605,1990073,11669760,BindingDB,N-[5-bromo-2-(morpholin-4-yl)phenyl]-8-methoxy-2-oxo-2H-chromene-3-carboxamide,16743,"Coumarin Compound, 10a",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16743,5093,Beta-secretase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5093,P56817,Beta-secretase 1,23621.0,BACE1,9606,Homo sapiens (human),,IC50 (nM),>10000,PMID:16821787|DOI:10.1021/jm0602864,https://www.ncbi.nlm.nih.gov/pubmed/16821787|https://doi.org/10.1021/jm0602864,16821787,10.1021/jm0602864,
606,1990074,11669798,BindingDB,"N-{5-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]pentyl}-1H-indole-3-carboxamide",9031,"1H-Indole-3-carboxylic Acid [5-(6-Chloro-1,2,3,4-tetrahydroacridin-9-ylamino)pentyl]amide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=9031,1045,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1045,P23795,Acetylcholinesterase ,540446.0,ACHE,9913,Bos taurus (cattle),,IC50 (nM),180,PMID:16279781|DOI:10.1021/jm0503289,https://www.ncbi.nlm.nih.gov/pubmed/16279781|https://doi.org/10.1021/jm0503289,16279781,10.1021/jm0503289,
607,1990075,11669798,BindingDB,"N-{5-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]pentyl}-1H-indole-3-carboxamide",9031,"1H-Indole-3-carboxylic Acid [5-(6-Chloro-1,2,3,4-tetrahydroacridin-9-ylamino)pentyl]amide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=9031,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606,Homo sapiens (human),,IC50 (nM),9.5,PMID:16279781|DOI:10.1021/jm0503289,https://www.ncbi.nlm.nih.gov/pubmed/16279781|https://doi.org/10.1021/jm0503289,16279781,10.1021/jm0503289,
608,1990076,11673647,Therapeutic Target Database (TTD),3-naphthalen-2-ylsulfonyl-1H-pyridazin-6-one,D08JEI,6-(Naphthalene-2-sulfonyl)-2H-pyridazin-3-one,https://idrblab.net/ttd/data/drug/details/D08JEI,T26623,Aldose reductase (AKR1B1),https://idrblab.net/ttd/data/target/details/T26623,P15121,Aldo-keto reductase family 1 member B1,231.0,AKR1B1,9606,Homo sapiens (human),Inhibitor,,,,,,,
